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SUMMARY
The work reported in this thesis is concerned with 
the isolation and characterization of conditional lethal 
amber nonsense mutants of the rhabdovirus vesicular 
stomatitis virus (VSV), Indiana serotype. Two murine cell 
lines were employed in this work. L39 (su+ ) cells carried 
an amber suppressor tRNA gene, which was expressed, albeit 
at a relatively low level. These cells thus represented the 
permissive host for virus containing a conditional lethal 
amber mutation. The second cell line used was the cell line 
LMTK” (s u ~ ). This was the parental line from which the L39 
cell line was derived, and represented the non-permissive 
host for virus containing a nonsense mutation in an 
essential gene. A screen was set up to detect conditional 
lethal nonsense mutants of VSV, by assaying growth of 
mutagenized isolates on su+ and su~ cells and retaining 
those which grew only on su+ cells.
A wt stock of VSV (Indiana serotype) was mutagenized
by the chemical mutagen 5-fluorouraci1. The mutagenized 
virus was plated on the su+ cells to produce well isolated 
plaques. Small plaques were picked to screen for a mutation 
affecting host range. Screening was performed by infecting 
monolayers of su~ cells and inspecting the monolayers for 
the presence or absence of cpe. Any isolates which did not 
give rise to cpe were subsequently used to infect monolayers 
of su+ cells. The virus from productive infections was 
harvested and titrated on both cell lines to quantify the 
restriction in host range. Of 2 614 plaques picked
originally, 82 did not give rise to cpe on the su” cells and
of these 13 produced a difference in tit re between the two 
cell lines of 30 fold or more. Viral protein synthesis in 
su+ and su- cells infected by each of these host range 
mutants was investigated by polyacrylamide gel 
electrophoresis. In comparison to the characteristic 
protein species synthesized by wt virus, seven mutants 
exhibited little virus specific protein synthesis in su” 
cells.
Complementation analysis was carried out for each of 
these seven mutants with ts mutants representing each of the 
five VSV complementation groups. Five of the mutants were 
assigned to complementation group I (the L cistron), one to 
complementation group V (the G cistron) while a seventh 
mutant could not be complemented. No intragenic 
complementation was observed between any of the group I 
mutants.
The five group I mutants (retrospectively named AmbLl 
to AmbL5) did not synthesize any detectable full length L 
protein in the su+ cells. Four (AmbLl to AmbL4) synthesized 
an additional protein species in the su+ cells. An 
additional protein could not be identified for the fifth 
mutant, however. The molecular weights of the additional 
proteins were estimated to be 37000, 150000, 230000 and 
227000 for AmbLl, AmbL2, AmbL3 and AmbL4 respectively (full 
length L protein has a molecular weight of 241012). The 
additional proteins were also detected by in vitro 
translation of mRNA isolated from su+ cells infected by the 
mutants AmbLl and AmbL2. These proteins were proposed to be 
fragments of the L protein produced by premature termination 
of translation within the L mRNA at an amber codon.
The mutants were found to be greatly restricted in 
the su” cells. Analysis of the proteins synthesized in su” 
cells revealed that the inhibition of host protein synthesis 
associated with wt infection of su~ cells was markedly 
reduced. The additional protein synthesized by these 
mutants in su+ cells was only observed in su” cells with 
some of the mutants (AmbLl, AmbL3 and AmbL4) after prolonged 
incubation. This is thought to be caused by outgrowth of 
revertants complementing the mutant late in infection. 
Analysis of the protein composition of the virion of these 
mutants showed that the shortened form of the L protein was 
not packaged.
The additional protein synthesized by AmbLl and AmbL2 
(and possibly AmbL4) in the su+ cells was present in 
considerably higher abundance than either wild-type L 
protein or the truncated L protein found in AmbL3 infected 
cells. This is thought to reflect the action of a control
system on L protein synthesis.
Immunoprecipitation and immunoblotting analysis of 
the group I mutants with monospecific antisera directed 
against the N and C termini of the wt L protein provided 
direct evidence that the additional proteins produced by the 
group I mutants were derivatives of L protein and possessed 
N-terminal specific sequences but not C-terminal specific 
sequences. Immunoprecipitation and immunoblotting studies 
with AmbL5 each revealed a possible (but distinct) candidate 
for an L truncation protein. These results reinforce the 
interpretation that the mutants synthesize a truncated form 
of the L protein in the su+ cells as a result of premature 
termination at an amber nonsense codon within the L mRNA.
Revertants of the group I mutants AmbLl, AmbL2, AmbL3 
and AmbL4 were isolated by plating stocks of each mutant to 
give isolated plaques on the su~ cells. Such revertants 
were found at frequencies of 10“3 to 10“4 Q f the mutant 
titre and all had regained the normal plaque morphology of 
wt virus. All the revertants analysed synthesized an L 
protein of normal abundance and mobility in su+ and su~ 
cells. The truncated version of L was not detected. The 
revertants are thus the product of back mutations in the 
same codon as the original mutation. No revertants of AmbL5 
could be isolated, suggesting that AmbL5 may represent a 
multisite mutation within the L gene.
The sixth mutant (retrospectively named AmbG) 
assigned by complementation analysis to complementation 
group V, representing the G gene, synthesized a glycoprotein 
which possessed a slightly higher mobility than wt G 
protein. In vitro translation of mRNA isolated from AmbG 
infected cells showed that the altered mobility exhibited by 
the G protein was not the result of a difference in 
glycosylation. However, the mutant also synthesized this 
altered G protein after infection of the su~ cells, as did 
putative revertants isolated on the su" cells. The 
difference in titre between the su+ and su~ cells obtained 
for this mutant was only 30 fold. Thus it is proposed that 
this mutant is 'leaky' in the su~ cells.
A seventh mutant hrTK~7 synthesized N and NS proteins
in su+ cells which possessed altered mobilities in 
polyacrylamide gels. This mutant is also thought to be a 
multiple mutant, since no revertants were isolated and 
attempts to assign the mutation to a specific 
complementation group were unsuccessful.
The aminoglycoside G418 which had been reported 
previously to facilitate readthrough of amber mutations in 
various systems, by affecting the fidelity of translation, 
failed to suppress the mutation (as judged by virus growth) 
in the group I mutant AmbLl.
In conclusion, short of actual nucleotide sequencing, 
the results obtained are entirely consistent with the 
interpretation that these are indeed conditional lethal 
amber mutants. They are thus the first such conditional 
lethal nonsense mutants to be isolated for an animal virus.
INTRODUCTION
1INTRODUCTION 
CHAPTER 1 NONSENSE MUTATIONS AND SUPPRESSION
Conditional mutants have proven to be an 
indispensable tool in the genetics and study of gene 
expression in bacteria and yeast. This approach has been at 
its most powerful in these systems with the employment of 
suppressible mutations. Among eukaryotic organisms however, 
due to the lack of suppressing cell lines, suppressible 
mutants have been studied extensively only in yeast and to a 
lesser extent in Aspergillus nidulans and in the nematode 
Caenorhabditis elegans. As a result, the development of 
animal virus genetics has instead relied on the use of 
temperature sensitive mutations for conditional lethal 
mutants. Now however, this situation is changing rapidly: 
advances in genetic construction techniques have allowed the 
development of a variety of suppressor tRNAs which, after 
introduction into the host cell, have been shown to suppress 
known nonsense mutations. Potentially the most useful 
development has been the construction of suppressor cell 
lines which contain a functional integrated suppressor tRNA 
gene. The objective of this thesis has been to investigate 
the use of a particular suppressor cell line in the 
isolation and characterization of conditional lethal amber 
nonsense mutants of the negative strand RNA virus vesicular 
stomatitis virus.
Since this study encompasses both the general fields 
of animal virology and nonsense mutations and suppression, 
the introduction to this thesis is divided into two 
chapters. Chapter 1 is entitled Nonsense mutations and 
suppression, and Chapter 2 is entitled The genetics of 
vesiculovi ruses.
1.(a) NONSENSE MUTATIONS AND SUPPRESSION
The main aim of this chapter is to provide an 
overview of the field of translational suppression, 
specifically nonsense mutations and tRNA suppressors. The
2chapter covers classic work on nonsense suppressors in 
bacteria and yeast as well as the latest developments in the 
search for nonsense mutations and tRNA suppressors in higher 
eukaryotes. Initially, however, I shall deal with the topic 
of nonsense mutations and their significance in gene 
expression. This will include related topics such as 
polarity and peptide chain termination. The second half of 
this chapter wil concentrate on the phenomenon of 
suppression in various organisms, ranging from prokaryotes 
(Escherichia coli), through lower eukaryotes (yeast, A. 
nidulans and the nematode C. elegans) and concluding with a 
section devoted to the relatively recent developments in 
mammalian cell suppression.
1 . (a ).1 NONSENSE MUTATIONS
In prokaryotes and eukaryotes the nonsense triplets 
UAA (ochre), UAG (amber) and UGA (opal) signal termination 
of translation and release of the polypeptide chain from the 
tRNA on the ribosome (Brenner et a l . , 19 65; Weigart and 
Garen, 1965; Stretton and Brenner, 1965; Sambrook et a l . , 
1967; Zipser, 1967; Beaudet and Caskey, 1971; Stewart and 
Sherman, 19 72, 19 73). However, when nonsense mutations 
occur within a polypeptide coding region, they cause 
premature chain termination at the point of mutation and 
release a fragment of the complete polypeptide (Sarabhai et 
a l ., 1964; Celis et a l ., 1973). Nonsense mutations were 
first discovered in bacteria when it was found that 
shortened forms of bacterial cell or bacterial virus 
proteins resulted from certain types of mutation. Nonsense 
mutations are considered conditional mutations since the 
mutant phenotype can be suppressed in the presence of a 
suppressor tRNA which inserts an amino acid at the nonsense 
codon allowing completion of the protein chain (suppression 
is dealt with in section l.(b).l below).
Nonsense mutations are classified according to the 
suppressor loci to which they respond. Amber (UAG) mutants 
were isolated by Benzer and Champe (19 61) from a study of 
the rll mutants of phage T4 . Brenner and Beckwith (19 65) 
uncovered another class of chain termination mutation,
3termed ochre (UAA), which were not suppressed by amber 
suppressors. However, suppressors of the ochre mutants also 
suppressed amber mutants implying that although the two 
classes of mutant were distinct, they must be related. 
Sambrook et a l . (1967 ) and Zipser (1967) found a third class 
of nonsense mutant, termed opal (UGA). Opal suppressors do 
not suppress either amber or ochre codons.
Brenner et a l . (19 65) deduced the primary sequence of 
the amber and ochre codons by studying the production and 
reversion of rll amber and ochre mutants using the 
transition mutagens hydroxylamine and 2-aminopurine.
Analysis of amber mutants of the head protein of the rlI 
mutants of phage T4 defined the amino acids whose codons 
could be mutated to the amber triplet and comparison of the 
results with known amino acid codons helped to deduce the 
structures of the amber and ochre triplets. However, the 
normal termination triplets do not always have the same 
function. For example, in animal mitochondria the codon UGA 
is used as a Trp codon. In addition, the codons AGA and AGG 
(Arg) are stop signals in human mitochondrial DNA.
At a nonsense codon, in the absence of a suppressor, 
peptide chain termination occurs on the ribosome, and 
requires soluble protein factors in both prokaryotic and 
eukaryotic systems. Both mammalian and bacterial cells 
utilize the same terminator codons. In bacterial cells 
these codons are recognized by protein release factors (RFs) 
which are codon specific (Scolnick et a l . , 1968); RF-1 is 
specific for the codons UAA or UGA and RF-2 is specific for 
the codons UAG or UGA. In mammalian cells however, a single 
release factor recognizes all three terminator codons 
(Goldstein et a l , 1970). A third protein factor, RF-3 
identified in bacterial extracts (Milman et a l ., 1969) has 
the capacity to facilitate the binding of release factor to 
ribosomes (Goldstein and Caskey, 19 70) and interacts with 
GDP and GTP. Since mammalian RF alone is stimulated by GTP, 
a separate RF-3 equivalent may not be involved. The 
hydrolysis of peptidyl-tRNA at chain teminators also 
requires the ribosomal enzyme peptidyl transferase.
41. (a ) .2 POLARITY
Bacterial operons encode polycistronic messengers 
which are translated sequentially into proteins. Because of 
this, a nonsense mutation in an early gene of an operon will 
affect not only the gene in which it resides but also the 
subsequent cistrons. Ames and Hartmann (1963) reported the 
existence of point mutations which as well as inactivating 
the enzyme encoded by the gene (by premature termination at 
the nonsense codon) also caused a reduction in the amount of 
protein produced from cistrons distal to the mutation. This 
phenomenon was termed polarity.
Newton et a l . (19 65) examined the effect of the 
position of nonsense mutations within the lactose operon of 
E. coli. They observed that mutations which were operator 
proximal were completely polar allowing virtually no 
synthesis of the subsequent proteins whereas mutations which 
were operator distal displayed little polarity. Yanofsky et 
a l . (19 71) found that deletion of a large part of the 
operator proximal gene between the site of mutation and the 
end of the gene restored activity of the neighbouring genes 
to previously strongly polar mutants. This provided 
evidence that it is the distance between the nonsense 
mutation and the following initiation site that is crucial 
in polarity. Thus double mutations constructed in 
consecutive cistrons reduce proportionally the synthesis of 
proteins distal to them.
Yanofsky and Ito (19 66) observed that when two 
nonsense mutations reside in the same gene, the second 
mutation has no effect on the polarity resulting from the 
presence of the first mutation. This, however, is not 
always the case since if the first mutation is very close to 
the operator then there is a possibility that reinitiation 
may occur and the second mutation can then act as a chain 
terminator.
The strong coupling between transcription and 
translation in prokaryotic systems led to the proposal that 
the polar effects of a nonsense mutation are caused by the 
RNA polymerase encountering previously latent sites for 
termination of transcription that become active due to the
lack of translation (de Crorabrugghe et a l . 1973; Shimizu and 
Hayashi, 1974). This model for polarity includes two major 
premises: (1) that there are rho (transcription termination
factor) dependent sites of transcription termination within 
operons, and (2) these sites are not susceptible to the 
influence of rho as long as the mRNA is concurrently 
translated (Adhya and Gottesman, 1978). Support for these 
features was provided by the discovery of a class of 
polarity suppressors that do not restore translation, and 
these mutations have been shown to affect rho factor 
(Ratner, 1976; Das et a l ., 1977)
1 . (a ) .3 NONSENSE MUTATIONS IN HIGHER EUKARYOTES 
AND THEIR VIRUSES
An important property of nonsense mutations lies in 
their observed stringency, with a few exceptions, in both 
prokaryotes and eukaryotes. This is especially so since the 
application of traditional conditional lethal genetics 
(temperature-sensitive mutations) to mammalian cell genetics 
has not been without difficulty. The versatility of ts 
mutants has been limited because mammalian cells cannot be 
grown over as wide a temperature range as either bacteria or 
yeast. As a result, many ts mutants are 'leaky1 - that is, 
they exhibit measurable activity at the non-pemissive 
temperature.
Some peripheral use of nonsense mutants has been made 
in animal virus genetics and in mammalian cell genetics (an 
account of these mutants is given below) but without access 
to suppressing host cells these mutations have all been in 
non-essential genes.
Several nonsense mutations in non-essential genes of 
eukaryotic viruses have been isolated. Cremer et a l . (1979) 
showed that certain thymidine kinase (TK) deficient mutants 
of herpes simplex virus (HSV) were nonsense mutants. The 
mRNA f**om cells infected with the TK deficient mutants was 
in vitro translated in the presence of yeast nonsense 
suppressors. One of the mutants (TK4~) was found to be an 
amber nonsense mutant since a serine inserting amber 
suppressor tRNA restored both the synthesis of normal length
protein and TK activity in vitro. Another TK nonsense 
mutant (TK43“ ) could be suppressed by both leucine and 
serine opal suppressor tRNAs to produce normal length 
protein. However, neither succeeded in restoring an active 
gene product. Thus the insertion of leucine at the TK4 3- 
locus is presumably incompatible with TK function. More 
recently, Summers et a l . (1983) showed, using a transient 
suppression system developed by Laski et al. (19 82b and 
described in section l.(b).6 below), in which a Xenopus 
laevis amber suppressor tRNATy r gene is inserted into an 
SV40 vector, that when cells are infected with this SV40 
vector and subsequently infected with the TK deficient 
mutants described above, that the amber mutation in TK4- 
(but not the opal mutation in TK4 3“ ) is suppressed to give a 
functional product.
Grodzicker et a l . (19 76) isolated nonsense mutants 
within the genome of the adenovirus type 2 (Ad2)-SV4 0 hybrid 
virus Ad2+ND1 (see Lewis et a l ., 1969, 1973 for a 
description of the virus). This hybrid allows efficient 
growth of adenovirus in monkey cells (a non-pemissive host) 
by insertion of the necessary SV4 0 helper sequences into the 
adenovirus genome. Unlike Ad2, which grows 1000 fold less 
well in African Green Monkey (AGMK) cells than in human 
cells, AD2+NDl grows equally well in both human and AGMK 
cells (Lewis et a l ., 1969) presumably by providing a helper 
function required for efficient adenovirus growth. This 
hybrid virus synthesizes a 30000 dalton (30K) protein 
encoded by both Ad2 and SV40 sequences. Host range mutants 
were generated, by nitrous acid mutagenesis, which were 
defective in growth on AGMK cells but which still retained 
the ability to grow on human cells. The mutants with the 
greatest host range restriction did not produce the Ad2+NDl 
hybrid 3 OK protein but instead they synthesized a novel 
fragment of this protein. Three of these host range mutants 
(140, 167 and 71) isolated by Grodzicker et a l . (1976), 
which gave rise to a truncated 30K gene product, were shown 
to be nonsense mutants by Gesteland et a l . (19 77). In the 
presence of a yeast amber suppressor tRNA it was shown that 
two of the host range mutants (140 and 167) synthesized a
7full-length 30K protein, as well as the fragment usually 
associated with these mutants, in vitro. The remaining host 
range mutant 71 yielded full length 30K protein only in the 
presence of an ochre suppressor tRNA in vitro.
Rawlins and Muzyczka (1980) described the 
construction of an amber mutation within the SV40 genome by 
site-specific mutagenesis. Nucleotide sequence analysis of 
the mutagenized region confirmed a C to T transition, 
resulting in the conversion of a glutamine codon to an amber 
stop codon. The position of this mutation within the SV40 
genome should result in a T-antigen 24% shorter than the wt 
protein. It was suggested by the authors that the presence 
of nonsense mutations within what is a multfunctional 
protein should help identify the functional regions of the 
T-antigen.
More recently, Robertson et a l . (1983) described the
characterization of a ts mutant (ts 47) of fowl plague virus 
which contained a t£ lesion in segment 8 (which encodes both 
the NSi and NS 2 proteins from overlapping reading frames) 
and which synthesized a NS^ protein of higher 
electrophoretic mobility than that of the wt protein (Almond 
et a l ., 1977). Nucleic acid sequence analysis of a 540 
nucleotide portion from the 3 1 end of the message of 
segment 8 of ts 47 revealed a G to A change in the NSj 
reading frame. This resulted in the conversion of a UGG 
(Trp) codon to (UGA) opal stop codon resulting in premature 
termination of translation and the loss of 28 amino acid 
residues. This single base change was located in the 
overlapping coding region of the mRNA encoding the NS^ and 
NS2 proteins. The G to A base change in the NS 2 mRNA 
results in the conversion of a GGA (Gly) to a GAA (Glu) 
codon resulting in an increased negative charge of t£ 47 
NS2 .
Capecchi et a l . (1977) isolated nonsense mutations 
within the mammalian cell gene which encodes the enzyme 
hypoxanthine guanine phosphoribosyl transferase (HGPRT) 
which is non-essential for growth in tissue culture. This 
was accomplished by isolating a large number of mouse L 
cells deficient for this enzyme using the purine analogues
8-azaguanine and 6-thioguanine. Cell lines containing the 
enzyme HGPRT are killed by these compounds and thus select 
for HGPRT- cell lines. An HGPRT- cell line was isolated in 
which the HGPRT molecule was shown by tryptic peptide 
analysis to have a carboxy terminal tryptic peptide shorter 
than the corresponding wt peptide. After microinjection of 
a yeast ochre suppressor tRNA into this HGPRT- cell line, 
the mutant cells regained HGPRT activity. Microinjection of 
an amber suppressor tRNA did not restore this activity.
Amber and ochre nonsense codons have also been 
isolated in the human/^-globin gene, from human patients 
w i t h fi-thalassaemia (Chang and Kan, 1979). Nucleotide 
sequence analysis of the non-functional mRNA from a patient 
with /^-thalassaemia revealed that the lesion resulted from 
the mutation of an adenine to a uracil altering the lysine 
coding triplet AAG in the normal /^-globin gene to an amber 
termination codon UAG.
1.(b) THE PHENOMENON OF SUPPRESSION
A nonsense mutation generates an in-phase polypeptide 
chain termination codon within the coding region of a gene, 
and as a consequence of a nonsense mutation an amino 
terminal polypeptide fragment, rather than the completed 
polypeptide chain, is synthesized (Sarabhai et a l ., 1964).
A second mutation may occur, which results in the 
production of a tRNA which can insert an amino acid at the 
point of mutation so suppressing the mutant phenotype by 
allowing completion of the protein (Hawthorne and Mortimer, 
1963; Capecchi and Gussin, 1965; Engelhardt et a l ., 1965; 
Andoh and Ozeki, 1968; Goodman et a l ., 1968; Hawthorne and 
Mortimer, 1968; Gilmore et a l ., 1971; Sherman et a l ., 1973; 
Hawthorne and Leupold, 1974; Capecchi et a l ., 1975; Liebman 
et a l ., 1975; Gesteland et a l ., 1976; Piper et a l ., 1976; 
Brandriss et a l ., 1976).
Suppressor tRNAs with altered codon recognition might
result in principle from two classes of mutation. The
suppressor gene might code for a modifying enzyme so that 
the mutant enzyme fails to make some modification essential
for proper codon recognition (e.g. a methylase). Such
9mutations should be recessive. Alternatively, the 
suppressor locus may comprise a structural gene for the 
tRNA, in which case the mutation alters one of the bases in 
the anticodon. These mutations should be dominant. Base 
substitutions in the tRNA anticodon alter tRNA codon 
recognition so that the mutant suppressor tRNA can no longer 
translate its original codon. The amino acid inserted by 
the suppressor tRNA at the site of mutation must be 
compatible with the requirements of protein functionality to 
restore an active gene product.
In E. coli the majority of codons are translated by 
more than one tRNA species or by tRNAs coded by multiple 
identical genes so that a suppressor mutation in any one of 
these does not prove lethal by virtue of preventing the 
synthesis of any proteins which rely upon the translation of 
these codons. An anticodon change in a tRNA uniquely 
responsible for a coding function would be lethal to the 
cell. Such mutations are recessive lethals, since if the wt 
gene is lost the cell loses its capacity to respond to some 
codons and will die. This particular class of suppressor can 
only be isolated where the tRNA gene has been duplicated. 
Recessive lethal mutations have been isolated by Soil and 
Berg (1969a, 1969b) - Su7, a high efficiency glutamine 
inserter, and Su8, a much lower efficiency suppressor. In 
Salmonella typhimurium, Miller and Roth (1971) isolated 
recessive lethal UAG and UGA suppressors.
Most of the classical nonsense suppressors in E. coli 
result from mutations in tRNA genes. However a notable 
exception was characterized by Hirsh in 1971. He described 
a UGA suppressor (Su9) which turned out to be a mutant form 
of tRNATrP and it contained the normal anticodon (CCA) 
corresponding to the Trp codon UGG. The structural 
alteration of this tRNA was found in the stem of the 
dihydrouraci1 loop where a G is replaced by an A. This 
implies a mechanism whereby the UGA triplet is read by a CCA 
anticodon and suggests A-C pairing in the third position. 
This result provided a striking indication that 
conformational aspects of tRNA structure may play a role in 
codon recognition. However, Yarus (19 82) proposed that the
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base change in the dihydrouraci1 stem leads to a change in 
translational specificity of the tRNA by increasing 
post-transcriptional modification of cytosine C34 in the 
anticodon wobble position. The enzyme postulated to do this 
normally modifies C34 of a minor lie tRNA specific for AUA 
codons. This modification whould reduce reading of G in the 
third codon position, allowing the Hirsh suppressor to read 
UGA codons. Delamarche and Buckingham (1985), however, 
could not substantiate this theory and therefore found in 
favour of the former hypothesis.
In prokaryotes and eukaryotes all amber suppressors 
were found to translate exclusively the codon UAG and those 
sequenced have the anticodon CUA. Unlike the yeast and 
mammalian ochre suppressors, which are UAA specific, E. coli 
and phage T4 ochre suppressors translate both UAA and UAG 
codons. This is caused by reading imprecision (wobble) in 
the pairing of the third base of the codon (Crick, 1966)
1.( b ) . 1 THE EFFECTS OF CODON CONTEXT ON SUPPRESSION
Apparent differences in the efficiency of suppression 
of a suppressor acting at different sites have been 
identified in a number of systems (Salser, 1969; Salser et 
a l ., 1969; Yahata et a l ., 1970; Akaboshi et a l ., 1976;
Fluck et a l ., 1977; Feinstein and Altman, 1977, 1978; Fluck 
and Epstein, 1980; Bossi, 1983; Miller and Albertini, 1983). 
These reports have suggested that the reading of a given 
codon may be influenced by mRNA sequences external to this 
codon. This influence has been described as the effect of 
reading context on translation. Bossi and Roth (1980) 
studied the effect of the surrounding sequence on efficiency 
of suppression of the amber suppressor sup E at a particular 
amber site. The nucleotide adjacent to the 3' side of the 
nonsense codon was implicated in the observed alteration in 
suppression efficiency. The presence of an adenine residue 
(as opposed to a cytosine residue) at this position resulted 
in a tenfold increase of sup E efficiency in reading UAG. 
More recently Miller and Albertini (1983) and Bossi (1983) 
compared the surrounding sequence and resulting suppression 
efficiencies for a large number of nonsense codons in the
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lac I gene of E. coli. A lac I-Z gene fusion permitted 
direct measurement of the suppressed levels of nonsense 
mutations in the lac I gene by assaying the /?-galactosidase 
activity. This was possible since the lac I-Z gene fusion 
synthesized a hybrid repressor-/5-galactosidase molecule 
which had normal /J-galactosidase activity. Suppression 
efficiencies were shown to vary by 3 5 fold for amber 
suppression and 170 fold for UGA suppression. They observed 
that when the codon at the 3' side of the nonsense codon 
began with A or G the suppression efficiencies were high, 
whereas when the codon began with U or C suppression was 
low. Salser (1969) and Fluck et a l . (1977) suggested that 
context effects result from variation in efficiency of 
termination at the nonsense site. However Bossi (1983) and 
Miller and Albertini (1983) argued that context effect 
results from variations in the efficiency of suppression. 
Several models were invoked to explain this phenomenon and 
are described here:
(1) The residue adjacent to the nonsense codon could 
form a fourth base pair with the suppressor tRNA. The 
presence of an invariant uracil residue (U33) at the 
relevant position in all known tRNAs and its proposed 
ability to form a fourth base pair would explain the 
observations that the presence of an A or a G on the 3 1 side 
of the nonsense codon resulted in efficient suppression 
whereas the presence of a U or C resulted in inefficient 
suppression. This explanation, however, does not fit with 
the observation that nonsense codons which were immediately 
followed by either the codons CUC and CUG were efficiently 
suppressed:
(2) Alternatively, the codon adjacent to the 
nonsense codon could be implicated in context effects. This 
hypothesis involves an interaction between the tRNA at the 
ribosomal P site and the tRNA at the ribosomal A site. Thus 
tRNAs that read codons starting with A or G might interact 
strongly with all amber suppressor tRNAs whereas tRNAs 
reading codons starting with C or U might interfere with the 
suppressor tRNA. The observation by Nishimura (19 72) that 
tRNAs that read codons beginning with the same base have
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similar modified bases on the 3 1 side of the anticodon 
reinforces this hypothesis.
(3) mRNA secondary structure has also been shown to 
affect efficiency of suppression. A potential secondary 
structure involving the amber site A2 6 was proposed by 
Miller and Albertini. It was conjectured that this 
secondary structure could possibly inhibit release factor 
action on nonsense sites, leading to elevated suppresssion 
levels noted at amber site A 2 6 by the amber suppressors Su3 
and Su6.
The results of Raftery et a l . (1984), where the 
effect of context on a set of cloned termination suppressors 
was studied, also suggested that not only was the presence 
of a codon beginning with A following the stop codon a good 
context, but that features of the tRNA structure are 
important as well.
1.(b).2 THE EFFECT OF AMINOGLYCOSIDES ON SUPPRESSION
Aminoglycosides (in particular streptomycin) have 
been shown to cause non-genetic phenotypic suppression of 
auxotrophic mutants in bacteria (Gorini, 1974; Davies et 
a l ., 1964). Singh et a l . (1979) reported the phenotypic 
suppression of all three nonsense codons in Saccharomyces 
cerevisiae by several aminoglycosides (including hygromycin 
B, paramomycin and neomycin). Palmer et a l . (19 79) also
reported that paramomycin phenotypically suppressed all 
three types of nonsense codon in S. cerevisiae. In addition 
Roberts et a l . (1979) and Martinelli and Roberts (1983) 
described the suppression of nonsense mutations in A . 
nidulans by aminoglycosides. The aminoglycosides have been 
shown to affect the fidelity of translation in vitro using 
E. coli ribosomes (Davies et a l ., 1965) and eukaryotic 
ribosomes (Palmer and Wilhelm, 19 78; Wilhelm et a l . 19 78a, 
1978b) and in vivo in E. coli (Edelmann and Gallant, 1977). 
Martinelli (1984) examined the effect of five ribosomal 
antibiotics on strains of A. nidulans containing 
informational suppressors. Strains carrying dominant 
(presumed tRNA) suppressors were only slightly sensitive to 
the effect of aminoglycosides whereas those carrying
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recessive mutations (presumed ribosomal mutations) proved to 
be hypersensitive to the antibiotics. Burke and Mogg (19 85) 
reported suppression of a nonsense mutation in mammalian 
cells by the aminoglycosides G418 (a neomycin derivative) 
and paromomycin. Both aminoglycosides promoted readthrough 
of an amber mutation in the chloramphenicol acetyl 
transferase (CAT) gene of the mammalian cell transfection 
vector p R S V c a t a m k 3 8  monkey cells (COS-7). The maximum 
level of suppression achieved by G418 was 19.6% and for 
paromomycin 5.4%. The observed difference in drug 
concentration needed to achieve maximum suppression was 
thought to reflect either a difference in permeability 
between the two drugs or different mechanisms of action on 
the ribosomes.
1.(b ).3 CODON SPECIFIC AND NON-SPECIFIC SUPPRESSORS IN YEAST
Yeast nonsense suppressors were first isolated 
through their ability to reverse simultaneously the 
phenotype of as many as five mutations residing within the 
iso-1-cytochrome c gene (Hawthorne and Mortimer, 19 63; 
Gilmore, 1967). These mutants designated cycl mutants were 
easily identified since they were deficient in lactate 
metabolism and thus failed to metabolise the toxic analogue 
chlorolactate. Revertants of the cycl mutants were selected 
by growth on lactate medium. Nonsense suppressors of the 
yeast S. cerevisiae have been divided into two groups, codon 
specific and codon non-specific.
The majority of suppressors in the former group arise 
by anticodon mutations of tRNA genes (Hawthorne and Leopold, 
1974; Capecchi et a l ., 1975; Gesteland et a l ., 1976; Piper 
et a l ., 1976; Olson et a l ., 1977; Piper, 1978; Ono et a l ., 
1979a, 1979b, 1981; Liebman et a l ., 1984). These 
suppressors have been shown to suppress defined UAA and UAG 
mutations in the iso-1-cytochrome c gene. The majority of 
UAG suppressors insert a tyrosine residue at the site of 
mutation in haploid strains (Liebman et a l ., 1976). They 
restored production of iso-1-cytochrome c to approximately 
50% of the wt activity. Leucine inserting UAA suppressors 
were isolated which suppressed the same set of amber
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mutations as the tyrosine suppressors but at a much lower 
efficiency. These suppressors were distinguished from the 
tyrosine inserting amber suppressors by their reduced action 
on a specific amber allele cycl-179 (about 15-20%, Liebman 
et a l ., 1977 and Ono et a l ., 1979b). Liebman et a l . (1984) 
described the isolation and mapping of leucine inserting UAG 
suppressors. Genetic mapping placed them into nine 
complementation groups some of which were found not to be 
linked to the previously mapped leucine inserting ochre 
suppressors. Brandriss et a l . (1975) examined suppression 
of amber mutations in diploid strains. Most of the 
suppressors isolated which suppressed two specific markers 
(trp-1 and aro-7 ) , although stable in the heterozygous 
state, proved lethal in the homozygous condition. This 
suggested that the suppressors were coded for by a single 
gene in the haploid genome. One of the suppressors was 
shown to restore iso-l-cy tochrome c levels to about 5 0% of 
the wt (Brandriss et a l ., 1976; Ono et a l ., 1981 and 
Etcheverry et a l ., 1982). Eight loci were identified which 
gave rise to suppressors which suppressed a set of UAA 
markers (Gilmore, 19 67; Hawthorne and Mortimer, 19 68; Ono et. 
a l ., 1979a) by inserting a tyrosine residue. In contrast to 
the amber tyrosine inserters the ochre tyrosine suppressors 
restored cytochrome c levels to only about 5-10% of the wt.
The efficiency of suppression of UAA stop codons can 
be increased substantially by the presence of an 
extrachrosomal factor psi. Psi factor is probably a DNA 
plasmid. It enhances several fold the efficiency of tRNA 
ochre and some frameshift suppressors but is without effect 
on UAG or UGA suppressors. Psi factor is itself a weak UAA 
suppressor (Liebman and Sherman, 1979) rendering the 
tyrosine inserting ochre suppressors so efficient as to make 
them lethal to the cell. Its mode of action is unknown but 
Dujardin et a l . (1985) suggested that psi is or affects a 
component of the translation machinery. Ono et a l . (1979a) 
detected lower efficiency suppressors in psi+ strains (the 
tyrosine inserters were isolated in psi~ strains) which 
could be mapped to two loci. These suppressors were shown 
to insert a serine residue in response to an ochre stop
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codon. Additional serine inserting UAA suppressors were 
isolated in a study by Ono et al. (1981). These suppressors 
could be assigned to one or other of four different loci. In 
the study by Ono et a l . (19 79a) a minority class of UAA 
suppressors were discovered which were distinguished by a 
very low efficiency of suppression and their ability to 
suppress a marker (ura-4-1) which was not suppressed by the 
serine inserting suppressors. In addition, they did not 
suppress a marker (lysl-1) which was suppressed by both the 
tyrosine and serine inserting suppressors. This class of 
suppressor (SUP26) was shown to insert a leucine residue.
Ono et a l . ( 1979b) isolated additional examples of this 
class of suppressor and assigned them to six unlinked loci. 
Three of these suppressor loci were mapped to specific 
chromosomal locations. The remaining three were mapped by 
Ono et a l . (1985).
Suppressors acting solely on UAG codons have been 
isolated in both yeast and bacteria. Piper et a l . (1976) 
demonstrated that a modified base in the anticodon 
(pseudouridine) prevents wobble pairing - this is consistent 
with the situation in prokaryotes. However, although UAA 
suppressors have been observed to suppress both UAA and UAG 
nonsense codons in bacteria, UAA suppressors act solely on 
UAA nonsense codons in yeast. This was thought to result 
from a modification of the anticodon from UUA to SUA. The S 
could represent either a 2-thio-5-carboxymethyluridine 
derivative or a 5-carboxymethyluridine derivative (Yoshida 
et a l . , 1971; Kuntzel et a l . , 1975).
UGA specific suppressor tRNAs were first identified 
through reversion of the allele ade5,7-14 3. Hawthorne 
(19 76) observed that this allele was not suppressible by 
either amber or ochre specific suppressors and that it was 
suppressed by a new class of allele specific suppressor.
The ade5,7-143 allele could mutate to an ochre allele in the 
presence of an ochre suppressor. Conversely, ochre alleles 
can mutate to UGA suppressible alleles which are no longer 
susceptible to ochre specific suppressors. Hawthorne (1981) 
described the isolation of additional UGA suppressors and 
although the tRNA species involved was not identified there
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appeared to be close linkages with either the serine 
inserting or leucine inserting UAA suppressors (Hawthorne, 
1981) .
Codon non-specific suppressors are not thought to be 
mutations in a tRNA gene since they lack codon specificity. 
They are generally recessive and capable of suppressing 
amber, ochre and opal termination codons and fall into two 
complementation groups. Dominant omnipotent suppressors 
have been identified which are thought to map to a separate 
locus from the recessive suppressors (Ono et a l ., 1981,
1984). They are thought to be ribosomal mutations (Smirnov 
et a l ., 1978 and Surguchov et a l ., 1980). Liebman and 
Allrobyn (19 84) demonstrated that an extrachromosomal 
element eta+ causes recessive omnipotent suppressors to 
become lethal genes. Unlike psi+ which has a weak UAA 
suppresor activity, eta+ has no such activity. In addition 
eta+ does not act on UAA codons. Song and Liebman (19 85) 
investigated the interaction of UAG tRNA suppressors and 
omnipotent suppressors in yeast. Previously, Liebman and 
Cavanagh (1980) had suggested that the strain lethality 
observed when dominant UAA suppressors and recessive 
omnipotent suppressors interacted in haploids was caused by 
excessive suppression. Song and Liebman, however, observed 
that only in some combinations did lethality occur and that 
in some combinations the interaction actually reduced the 
efficiency of suppression. This suggested that suppression 
in these cases involved some previously unsuspected type of 
interaction between the suppressor tRNA and the ribosome.
1.(b).4 SUPPRESSION IN ASPERGILLUS NIDULANS
Bal et a l . (1978) described the reversion of two 
mutations at two different A. nidulans loci by informational 
suppressors. The first detailed report of suppressors in A. 
nidulans was by Roberts et a l . ( 1979 ). They described the 
isolation of seven suppressor mutations by coreversion of 
alleles in the structural gene for allantoinase (a l X ), the 
sulphate permease gene (sB) and alcohol dehydrogenase 
(a l c A ) . Two classes of suppressor were characterized: 
suaBlll, suaDl03 and D108 were semidominant in diploids and
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did not have any pleiotropic effects. They were thus 
suggested to be informational suppressors with the mutation 
residing in the tRNA gene. Recessive suppressor mutations 
were also isolated which did have pleiotropic effects. 
Strains carrying these mutations exhibited slow growth, 
changes in colony morphology and, rarely, cold sensitivity. 
The recessive mutations probably map in genes coding for 
translation termination or in essential ribosomal genes. 
Martinelli (1984) investigated the effects of ribosomal 
antibiotics on informational suppressors in A. nidulans. As 
expected they observed that the antibiotics had a much 
greater effect on strains carrying the recessive suppressor 
mutations than those carrying dominant suppressors.
1. (b).5 SUPPRESSION IN CAENORHABDITIS ELEGANS
Two amber suppressor tRNA loci (SUP5 and SUP7) were 
initially identified in the nematode C. elegans (Waterson 
and Brenner, 1978; Waterson, 1981). Waterson (1981) 
isolated 2 5 suppressor mutations and mapped 19 to the SUP5 
locus and 6 to the sex-linked locus SUP7. Nematodes which 
were homozygous for SUP7 (and to an extent SUP5) were found 
to be inviable at 15°C (Waterson, 1981). This is known as 
cold sensitive lethality. Suppression efficiency was found 
to be elevated at this temperature. The SUP7 suppressor 
alleles were shown by Kimble et a l . (19 82) to suppress a 
nonsense mutation in the tra-3 allele which affects sex 
determination in the nematode. In the nematode sex is 
determined by the Xrautosome ratio. Thus XX animals are 
hermaphrodites and XO animals are males (there are no 
females). A recessive mutation in any of the three 
autosomal transformer genes (tral, tra2 and tra3) results in 
the generation of pseudomales (phenotypic males) instead of 
hermaphrodi tes.
SUP7 DNA was microinjected into the gonads of an 
animal bearing the tra-3 allele (e!107) and the offspring 
(FI) inspected for phenotypic suppression. 60% of the 
offspring gave rise to hermaphrodite offspring (F 2 ).
However, only a small number of the total offspring from 
each animal (FI) were hermaphrodites. This was thought to
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be a result of few oocytes actually receiving the suppressor 
tRNA. As further proof that the hermaphrodite offspring 
arose as a direct result of suppression it was observed that 
no hermaphrodite offspring were detected when animals 
bearing the non-amber allele of tra-3 (e!767 ) were used.
Wills et a l . (1983) attempted to determine the
specificity and to define the nature of the SUP-5 and SUP-7 
suppressors. In the 'allele first' approach they examined 6 
null mutants of the unc54 gene in C. elegans. Macleod et 
a l . (19 77) had previously shown that these mutations were
suppressible by SUP5 and SUP7 suppressors. The unc54 gene 
specifies a major myosin heavy chain present only in body 
wall muscle cells. Sequence analysis of the region 
containing the mutation in one of these mutants revealed a C 
to T substitution which resulted in the alteration of a 
glutamine codon to an amber terminator.
In the 'suppressor first1 approach, extracted tRNA 
from suppressor carrying animals was added to a wheat germ 
translation system along with brome mosaic virus (BMV) RNA 
which contained a characterized suppressible amber stop 
codon at the 5' end of the coat protein gene (Dasgupta e_t 
a l ., 1980). Suppressor activity was detected as judged by 
the production of full length protein. There was no 
detectable suppressor activity when the BMV RNA was 
substituted byo<-globin RNA which contained an ochre 
terminator. The DNA sequence of SUP7 was obtained (Bolten 
et a l ., 19 84 ) and shown to be a tryptophan tRNA gene 
containing an alteration at the anticodon (CCA to C U A ) which 
permitted the tRNA to read amber codons.
Hodgkin (1985) identified three additional amber 
suppressor tRNAs (SUP21, SUP22 and SUP23) in C. elegans by 
isolating revertants of amber mutants of the tra-3 gene.
The efficiency of suppression of a variety of amber alleles 
in the nematode was measured for comparison. A marked 
heterogeneity in the suppression level of alleles from the 
SUP21 and SUP22 loci was discovered. Thus, it was suggested 
that the different isolates could represent tRNA genes from 
different families or tRNA genes from the same family 
expressed at different levels. An allele of SUP21 (el957)
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was found to be a good suppressor of hypodermal (dpy) amber 
mutations, a poor suppressor of amber mutations in muscle 
genes (unc-54) and a very poor suppressor of amber mutations 
in neuronal genes (unc- 1 3 ). This suggested tissue 
specificity for this allele. In addition, the suppressor 
loci SUP21 encoded a weaker suppressor than either SUP5 or 
SUP7. This meant that animals homozygous for this allele 
were viable at 15°C unlike SUP5 or SUP7 homozygotes.
1.(b).6 SUPPRESSOR tRNAs IN MAMMALIAN CELLS
The first account of suppressor tRNAs in a mammalian 
cell system was reported by Laski et a l . (1982b). Prior to
this, Laski et a l . (1982a) had described the cloning of a 
Xenopus laevis tRNA^-Y1" gene into an SV4 0 vector and its 
subsequent introduction into a mammalian cell line (CV-1). 
The mature tRNA^yr was found to be overproduced by 
transcription of high copy numbers of the SV40-tRNATY r 
recombinant. The RNA was also fully processed and modified. 
This involved removal of a 13 bp intervening sequence and 
appropriate modification of some of the nucleotides. They 
then described the generation of an amber suppressor tRNA 
from this t R N A ^ r gene by site specific mutagenesis using a 
synthetic oligonucleotide containing a single base pair 
mismatch in the anticodon region of the tRNATY r gene (Laski 
et a l ., 1982b). This changed the anticodon sequence of the 
tRNA gene from GTA to CTA. The suppressor tRNATY r gene was 
then inserted into the late region of an SV40 vector. After 
infection of CV-1 cells by the SV40-suppressor tRNATY r 
recombinant the su+ tRNA was found to be produced at only 
20% of the level of the wt tRNA^Yr. This was thought to be 
due to inefficient splicing of the intervening sequence - 
thought to be essential for suppressor tRNA gene expression 
(Johnson and Abelson, 1983). However, the su+ tRNATY r was 
shown to promote readthrough of amber mutations in the 
hybrid virus Ad2+ NDl (see section l.(a).3 above) which 
apparently yielded suppressed levels of the protein 
comparable to wt Ad2+ NDl.
Hudziak et a l . (1982) reported the first description
of mammalian cell lines to express a suppressor tRNA. Mouse
L cell lines were isolated which could suppress an amber 
mutation in three conditional lethal genes. This
was accomplished initially by isolating nonsense mutations 
in the HSV TK gene, the E. coli xanthine-guanine 
phosphoribosyl transferase (eco-gpt) gene and the 
aminoglycoside 3' phosphotransferase (npt-11) gene, in E . 
coli. These mutations were then transferred into cultured 
mammalian cells. It was important to isolate mutations in 
these genes and to subsequently transfer them into mammalian 
cells because their gene products confer a selectable 
phenotype on the cell. Thus the acquisition of an 
integrated amber suppressor tRNA would allow the cell to 
grow in the appropriate selection medium. The amber 
suppressor tRNATy r gene (described by Laski et a l ., 1982b) 
was then introduced into the cell lines containing the 
multiple amber mutations. Transformants expressing 
thymidine kinase activity were selected on HAT medium and 
those expressing npt-11 on G418 medium. Transformants were 
isolated and shown to have phenotypically suppressed the 
nonsense mutations, presumably by acquisition of the amber 
suppressor tRNATY r gene. Three of the transformed cell 
lines were maintained for over 70 generations in their 
respective selection medium without loss of suppressor 
activity. One of the transformants characterized 
(designated L 3 9 ) is the suppressor cell line used in this 
Ph.D. project report. Young et a l . (19 83) measured the 
suppression level of both the L39 suppressor cell line and 
the SV40-su+tRNATy r recombinant. They made use of a field 
isolate of influenza virus (A/CAM/46) which proved to have a 
suppressible NS1 gene amber termination codon. This 
phenomenon is not restricted to this field isolate. Parvin 
et a l . (1983) reported several field isolates of influenza 
virus with a possible suppressible NS1 mRNA. The 
suppression level could be estimated from the amount of 
radiolabelled suppressed readthrough product detected by 
polyacrylamide gel electrophoresis. The L39 cells were 
found to suppress the NS1 amber codon at a low level (about 
3.5%) whereas the SV4 0-su.+tRNATY r recombinant suppressed the 
nonsense codon relatively efficiently (about 22.5%). The
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low level of suppression observed for the L39 cell line may­
be the maximum that a cell line constitutively expressing a 
suppressor tRNA can tolerate.
Laski et a l . (1984) generated an ochre suppressor
tRNA gene by site specific mutagenesis of a X. laevis 
tRNATy r gene. This was the same tyrosine tRNA gene that had 
been used previously to produce an amber tRNATV'r gene (Laski 
et a l ., 1982b). The suppressor gene is efficiently 
expressed as mature spliced tRNA after introduction into the 
cell as part of a replicating SV40 recombinant. However, 
the ochre suppressor tRNA was produced at only 20% of the 
level of the wt tRNATy r . The amber tRNATy r was also 
produced at this low level (Laski et a l ., 1982b) possibly as 
a result of inefficient splicing. An ochre codon separating 
the Ad2 hexon gene from a 2 3kd downstream gene was 
successfully suppressed as was an ochre termination codon in 
the NS1 gene of the influenza isolate A/TEX/1/68. The ochre 
suppressor did not suppress the amber termination codon of 
the A/CAM/46 isolate. This is in direct contrast to ochre 
suppressors in prokaryotes which suppress both amber and 
ochre suppressors. Ochre suppressors in yeast are also 
specific for ochre codons only. A modification of the U in 
the first position of the UAA anticodon to a base 
(pseudouridine) which cannot recognise amber codons by 
’wobble' pairing was thought to be responsible for the 
observed specificity in yeast and mammalian cells.
Unless tyrosine inserting suppressors act on a 
nonsense site which contained a tyrosine codon in the wt it 
is possible that the insertion of a tyrosine could be 
incompatible with the structure or function of the 
suppressed protein. It should be noted however that 
tyrosine inserting suppressors are the most efficient 
suppressors yet isolated in yeast (Liebman et a l ., 1976).
Capone et a l . (1985 ) generated amber, ochre and opal 
suppressor tRNA genes from a human serine tRNA gene by 
oligonucleotide directed site specific mutagenesis to change 
one or two bases in the anticodon. After infection of CV-1 
cells as part of an SV40 recombinant both the amber and 
ochre suppressor tRNAs were produced at almost the same
level as wt serine tRNA. In contrast to the tyrosine 
inserting amber and ochre suppressor tRNAs described by 
Laski et a l . (1982b, 1984 ) which were present at only 20% of 
the wt tRNATy r level in CV-1 cells. This was attributed to 
a lower rate of splicing of the su+ gene in these cells.
The human serine tRNA gene does not contain an intron and as 
such its behaviour is consistent with this hypothesis 
(Capone et a l . , 1985). The amber and ochre suppressors were 
shown to promote readthrough of their respective nonsense 
codons. The amber suppressor promoted readthrough of the 
amber termination codon of the A/CAM/46 isolate at a level 
comparable to the tyrosine inserting suppressor (about 
25-30%). The ochre suppressor suppressed the termination 
codon of the Ad2 hexon gene at a 1.5 fold higher efficiency 
than that achieved by the ochre tyrosine suppressor used by 
Laski et a l . (19 84). Attempts to produce an opal serine 
inserting suppressor tRNA were unsuccessful. It was 
suggested that possibly the presence of an opal suppressor 
is deleterious to CV-1 cellular metabolism and/or SV40 
propagation. The major capsid protein VPl of SV40 
terminates with an opal codon. Readthrough of this 
termination codon results in a VPl protein 4 0 amino acids 
longer than normal. The authors suggested that since Tooze 
(1981) had shown that mutants in VPl were defective in virus 
assembly it was possible that the presence of an opal 
suppressor interfered with virus assembly. Capone et a l .
(19 86) constructed amber, ochre and opal mutations in the 
CAT gene of the mammalian cell transfection vector pRSVCAT 
by oligonucleotide-directed site specific mutagenesis, to 
facilitate rapid and sensitive testing of the level of 
suppression of cell lines containing su+ tRNA genes. 
Significantly, they tested the opal suppressor (as well as 
the amber and ochre suppressors) derived from a human serine 
tRNA gene (Capone et a l ., 1985). This opal suppressor had 
been found previously (Capone et a l ., 19 85) not to function 
in mammalian cells for some reason. However, in this case 
pronounced readthrough of the opal termination codon within 
the CAT gene was found resulting in the production of active 
enzyme. Thus, the opal suppressor was shown to be effective
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in short term transfection experiments. Their results also 
showed that in mammalian cells, as in bacteria and yeast, 
opal suppressor tRNAs are specific for UGA termination 
codons.
Recently Ho et a l . (1986) described the establishment 
of permanent cell lines (derived from CHO cells) containing 
different copies of amber suppressor tRNAL¥ s genes 
(constructed by Temple et a l . (1982). The suppressor tRNA 
gene was linked to the dihydrofolate reductase (DHFR) gene 
and the resulting recombinant plasmid was used to transform 
(CH0-K1) DHFR- cells. This was especially useful since 
genes linked to DHFR can be coamplified during the selection 
of methotrexate (MTX) resistance after transforming them 
into DHFR- cells. Transformants were exposed to increasing 
concentrations of methotrexate to select resistant colonies. 
The level of suppression in the CHO cell lines was 
determined by measuring the readthrough NS1 protein after 
infecting them with the influenza isolate A/CAM/46 
(described above) and was found to be only 3.6% in cells 
isolated at the highest concentration of MTX, in spite of 
the increase in the tRNA level as the gene copy number 
increased with increasing concentration of MTX. This is 
comparable to the level observed by Hudziak et a l . (19 82) 
for the L39 cells. This low level of suppression was 
thought to be caused by the low level of aminoacylated 
tRNALys found in vivo.
1.(b ).7 NATURAL SUPPRESSION IN EUKARYOTES
Suppressor activity can be of two types: (1)
naturally occurring and (2) induced through mutagenesis. It 
has been suggested that natural suppression may be a 
mechanism for producing proteins which, while related to 
other proteins, nonetheless perform distinct and essential 
functions. Naturally ocurring suppressors have been largely 
associated with viral infection in prokaryotic as well as 
eukaryotic systems. It appears that natural suppression 
does not affect each of the three termination codons 
equally. In fact Geller and Rich (1980) went as far as to 
suggest that the termination codons may have different
24
meanings in the cell; namely, that perhaps the ochre codon 
(UAA) means that translation must always stop and that the 
codons UGA and UAG may mean it should usually stop. This 
interpretation resulted from the observation that, in 
several systems, natural suppression of UGA and UAG stop 
codons (especially UGA in phage and bacteria) has been 
found. For instance, Pelham (1978) showed for tobacco 
mosaic virus (T M V ) that a 160000 (160K) dalton protein is 
generated by partial readthrough of the amber termination 
codon of a 110000 (110K) dalton protein gene. After 
addition of an amber suppressor tRNA the in vitro synthesis 
of the 160K protein is increased whereas the yield of the 
110K protein is diminished. Bienz and Kubli (1981) purified 
a tRNATy r (anticodon G-pseudo U-A) that stimulated this 
readthrough in Xenopus oocytes which apparently translated 
UAG using a G/G wobble base pair.
Natural suppression has also been documented in the 
case of the retroviruses Moloney murine leukaemia virus and 
Rous sarcoma virus. It has been known for some time 
(Philipson et a l ., 1978) that although an amber nonsense 
codon separates the gag and pol genes of MuLV, translation 
of the genome size mRNA, results in the synthesis of a 
gag-pol polyprotein as well as the gag protein (at a much 
reduced level). Yoshinaka et a l . (1985) purified the
protease comprising the gag proximal product of the pol 
gene, and carried out partial amino acid sequence analysis. 
They found that the first four amino acids are encoded by 
the end of the gag gene and that the fifth is glutamine 
which is inserted by suppression of the UAG termination 
codon at the gag-pol junction, presumably by misreading by 
the normal tRNA^-^-n .
In Mo-MuLV the gag and pol genes are in the same 
reading frame, however this is not the case in other 
retroviruses such as Rous sarcoma virus. The actual 
mechanism responsible for suppression in Rous sarcoma virus- 
was reported by Jacks and Varmus (19 85). They found that 
translation of an mRNA produced in vitro gave a level of 
gag-pol polyprotein, relative to the gag protein, similar to 
that found in vivo. The authors concluded that ribosomal
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frameshifting was responsible for the synthesis of the 
gag-pol polyprotein.
More recently, Chambers et a l . (1986) reported an 
intriguing example of natural suppression in which the 
selenocysteine residue in the active site of the mouse 
glutathione peroxidase protein was shown to be encoded by 
the triplet UGA (normally the opal stop codon). In 
addition, it had been shown previously that selenocysteine 
was introduced into the enzyme during translation (as 
opposed to post-translationally), and that a specific 
selenocysteyl-aminoacyl-tRNA had been identified (see 
Chambers and Harrison, 1987). This result suggested that, 
since UGA evidently has more than one function, some other 
unspecified factor was responsible for its different usage.
Possible uses for natural readthrough were provided 
by Geller and Rich (19 80). They suggested that natural 
suppression could provide a system with an additional 
control of gene expression at the level of translation and 
more speculatively, that perhaps natural suppression was a 
less complex a 1te rna t ive toanother method of joining 
proteins; namely RNA splicing.
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CHAPTER 2 THE GENETICS OF VESICULOVIRUSES
The aim of this chapter is to provide a review of the 
more relevant (to this study) areas of vesiculovirus 
virology. This chapter will include topics such as VSV 
taxonomy, virion structure, genome structure, growth cycle 
and genetics. Due to the confines in space, important 
topics including pathogenesis, persistent infection and 
virus cell interactions are not covered.
2 . (a) TAXONOMY
Rhabdoviruses are widely distributed among 
vertebrates and are also found in invertebrates and plants. 
They are grouped into the Lyssavirus and the Vesiculovirus 
genera. However, only a few of more than 7 5 named 
rhabdovi ruses are included in the two recognized genera 
(Brown et a l ., 19 79). The prototype Vesiculovirus is 
vesicular stomatitis virus (VSV) of which various strains 
have been isolated from cattle and horses as well as flies 
and mosquitoes (Brown and Crick, 1979). The prototype 
Lyssavirus is rabies virus - a virus which still represents 
a major health hazard.
VSV is predominantly a disease of the New World, but 
it also exists in Europe and possibly South Africa. The 
clinical manifestation of VSV infection is similar to foot 
and mouth disease, though it is much milder. In man, VSV 
infection may be inapparent or resemble influenza (Howatson, 
1970; Andrewes et a l ., 19 78).
The genus Vesiculovirus comprises nine viruses.
These are VSV Indiana, VSV New Jersey, Chandipura virus, 
Isfahan virus, Piry virus, Jurona virus, Keuraliba virus, La 
Joya virus and Yug Bugdanovac virus. The Indiana serotype 
comprises the subtypes Indiana, Cocal, Argentina and Brazil. 
The New Jersey serotype comprises the Concan and Hazelhurst 
subtypes.
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2.(b ). VIRION STRUCTURE AND COMPOSITION
2 . ( b) . 1 MORPHOLOGY
The family Rhabdovi ridae are typified by a bullet 
shaped or bacilliform morphology (figure 1). The virus 
particles range in size from 130-380nm in length and 60-75nm 
in diameter (Brown et a l ., 19 79). The major constituents of 
the virus particle are a surface projection layer, a 
membrane envelope layer and a helically wound nucleocapsid. 
The mass of the native virion was calculated, by dark field 
scanning transmission electron microscopy, to be 
256.6i 13.3 MDa (Thomas et a l ., 1985).
2.(b ).2 PROTEINS
The five recognized VSV proteins are the L (large), N 
(nucleoprotein), NS (non-structural), G (glycoprotein) and M 
(matrix) proteins. The N, L and NS proteins associate to 
form the internal ribonucleoprotein core (RNP) along with 
the genomic RNA. The G and M proteins associate with the 
outer membrane of the virus (Kang and Prevec, 19 69; Wagner 
et a l ., 1969; Cartwright et a l ., 1970b; Bishop and Roy,
1972; Emerson and Wagner, 1972).
Until recently, the weight of the available evidence 
suggested that, in infected cells, there was no virus 
encoded protein which was not present in the mature virion 
(Mudd and Summers, 19 70; Kang and Prevec, 19 71; Wagner et 
a l ., 1972; Wunner and Pringle, 1972a,1972b). However, a 
recent report by Herman (1986) suggested the existence of a 
small non-structural polypeptide present in the cytoplasm of 
cells infected with the Indiana serotype of VSV, encoded by 
the 3' one-third of the NS gene. It has also been suggested 
that a small protein could be encoded by the second open 
reading frame of both the New Jersey and Indiana serotypes 
(Hudson et a l ., 1986).
A quantitative analysis of the structure and assembly 
of the VS virion of the Indiana serotype was undertaken by 
Thomas et a l . (1985). They determined the molecular 
composition of the virion using a scanning transmission 
electron microscope. The results of this study are included
Figure 1
(a) Schematic model of an idealized rhabdovirus particle.
Illustrated features include the surface projection 
layer (sp), the membrane envelope (m), the helical 
nucleoprotein (np) and an invagination giving rise to an 
axial channel (ac).
(b) Purified preparation of VSV Indiana serotype negative 
stained with sodium silico tungstate.
The characteristic bullet shape is clearly evident 
well as the helical nucleoprotein (np). The membrane laye 
(ml) and an axial channel (ac) are also visible. 
(Magnification x 150,000)
Negative kindly provided by Jim Aitken.
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within the detailed description of each virion protein.
2 .(b ).2 .1 . THE G PROTEIN
The G protein is the third most abundant virion 
protein (in terms of the number of molecules per virion) 
comprising 33.8% of the total protein (estimated to 
represent 1205 molecules per virion). The G gene is 1665 
nucleotides (excluding polyadenylic acid) in length (1565 
nucleotides in the New Jersey serotype; Gallione and Rose, 
1983) and encodes a polypeptide of 511 amino acids including 
a signal peptide of 16 amino acids that does not appear in 
the mature virion (Rose and Gallione, 1981). The G protein 
forms the spikes which protrude from the virion envelope 
(Cartwright et a l ., 1970a, b; McSharry et a l ., 1971). The G 
protein is the major antigenic determinant and is 
responsible for neutralization by antibody and for type 
specificity of the virus (Cartwright et a l ., 1970a; 
Cartwright and Brown, 19 72; Kelley et a l ., 19 72). The 
glycoprotein can be removed from the surface of the virion 
by proteolytic enzymes, resulting in a loss of infectivity 
(Cartwright et a l ., 1970b; McSharry et a l ., 1971; Bishop et 
a l . , 19 75). It has also been shown to mediate cell fusion 
in vitro (Florkiewicz and Rose, 1984).
The G protein is synthesized on membrane bound 
ribosomes (Morrison and Lodish, 1975) and is inserted as a 
nascent chain into the membrane of the rough endoplasmic 
reticulum (RER) (Rothman and Lodish, 1977; Toneguzzo and 
Ghosh, 1978). A hydrophobic signal sequence is cleaved from 
the N-terminus of the growing polypeptide chain (Rose, 19 77; 
Lingappa et a l ., 1978; Irving et a l ., 1979). After 
synthesis, the G protein remains anchored in the membrane of 
the RER by a carboxy terminal hydrophobic segment (Chatis 
and Morrison, 1979; Rose et a l ., 1980; Rose and Gallione,
1981). It is subsequently transported to the Golgi 
apparatus (Bergmann et a l ., 1981) where fatty acid acylation 
takes place (Capone et a l ., 19 82). The fatty acid chain 
(palmitate) is linked to the single cysteine residue in the 
cytoplasmic domain in the Indiana serotype but not in the 
New Jersey serotype (Rose et a l ., 1984). G is then
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transported to the plasma membrane, where it facilitates the 
assembly of the mature virion.
The Indiana serotype contains two identical 
asparagine linked complex oligosaccharides (Reading et al.,
1978). The exact positions of these glycosylation sites 
were determined by Rose and Gallione (19 81) by sequence 
analysis. From the sequence analysis it has been suggested 
that the protein could ba divided into four domains. These 
are the signal sequence (16 amino acids), the main body of 
the protein (446 amino acids), the transmembrane domain (20 
amino acids) and the cytoplasmic domain of 2 9 amino acids 
(Rose and Gallione, 1981).
Several authors have reported that a derivative of G 
protein can be identified in the culture medium from VSV 
infected cells as one of the major soluble antigens (Kang 
and Prevec, 1970; Little and Huang, 1977). This Gs protein 
is thought to arise from the viral G protein by proteolytic 
cleavage at the cell surface (Little and Huang, 19 78; Chatis 
and Morrison, 1982; Irving and Ghosh, 1982). Little and 
Huang (1978) suggested a role for this protein in viral 
pathogenesis - the Gs protein could serve to neutralize 
antibody.
Garreis-Wabnitz and Kruppa (19 84) demonstrated that 
after VSV infection of BHK cells, a short form of the viral 
glycoprotein (Gsi) is formed intracellularly which lacks a 
carboxy terminus region. As already mentioned, the carboxy 
terminal region of the G protein contains the hydrophobic 
sequence which is essential for membrane integration. This 
Gsi protein is missing the membrane anchoring sequence and 
is therefore secreted into the culture medium.
2.(b).2.2. THE M PROTEIN
The M (matrix) protein is the most abundant virion 
protein which represents 24% of total protein per virion 
(estimated to be 1826 molecules per virion; Thomas et a l ., 
1985). The M gene is 833 nucleotides in length (excluding 
polyadenylic acid) and encodes a protein of M r 26064 (Rose 
and Gallione, 1981). M is the most basic of the VSV 
proteins (Rose and Gallione, 1981). It lines the inner
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surface of the lipid bilayer in close association with the 
RNP core (Newcomb et a l ., 1982). The M protein appears to 
be synthesized as a soluble protein, but is then directly 
incorporated into membranous structures. It was found to 
enter extracellular virus very quickly, as though it moved 
directly from a soluble state into budding virus (Knipe et 
a l ., 1977a ).
The M protein is thought to play a regulatory role in 
virus directed RNA synthesis in infected cells and to be an 
inhibitor in vitro of viral transcription (Carroll and 
Wagner, 1979; Wilson and Lenard, 1981; De et a l ., 1982; 
Pinney and Emerson, 1982). Pal et a l . (1985) investigated 
the effects of monoclonal antibodies directed against three 
epitopes on the M protein on the capacity of the M protein 
to regulate transcription of VSV RNP cores. Antibody 
directed against epitope 1 greatly enhanced transcription by 
the inhibited RNP/M core complex. Antibodies to epitopes 2 
and 3 had the opposite effect of considerably enhancing the 
inhibitory effect of the M protein. The ts mutant ts_ 023, 
which was defective in inhibition, did not bind antibody 
against epitope 1. A revertant which had fully recovered 
its inhibitory properties did bind antibody against epitope 
1 whereas three revertants which had not recovered any 
inhibitory properties did not bind antibody against epitope
1. This suggested that exposure of epitope 1 on the surface 
of M protein is essential for inhibition of transcription by 
VSV RNP cores.
2.(b).2.3. THE N PROTEIN
The N protein is the second most abundant virion 
protein contributing 30.1% of the total protein (estimated 
to represent 1258 molecules per virion; Thomas et a l ., 1985) 
and is the group specific antigen (Cartwright and Brown, 
1972). The N gene is 1326 nucleotides in length (excluding 
polyadenylic acid) and encodes a polypeptide of M r 47355 
(Gallione et a l , 1981).
The N protein is found closely associated with the 
virion RNA and also with the replicative intermediate and 
mRNA species in infected cells (Soria et a l ., 19 74; Grubman
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and Shafritz, 1977; Rubio et a l .,19 80; Naeve and Summers,
19 80; Adam et a l ., 19 86). As a result of the close 
association of the N protein and virion RNA, the virion RNA 
is rendered resistant to ribonuclease digestion (Cartwright 
et a l . , 19 70a).
2.(b).2.4. THE NS PROTEIN
The NS protein of VSV in association with the L 
protein constitutes the RNA polymerase complex (Emerson and 
Yu, 1975; Naito and Ishihama, 1976). The NS gene of the 
Indiana serotype is 814 nucleotides long (excluding 
polyadenylic acid) and encodes a 2 65 amino acid polypeptide 
of M r 30000, while the NS gene of the New Jersey serotype is 
856 nucleotides long encoding a 2 74 amino acid polypeptide 
(Gallione et al., 1981; Gill and Banerjee, 1985; Hudson et 
al ., 1986). It contributes 5.9% of the total protein 
(estimated to be 466 molecules per virion) and is therefore 
only a minor component of the virion (Thomas et a l . , 1985). 
Several reports have suggested that the degree of 
phosphorylation of the NS protein both in vitro and in vivo 
plays a regulating role in the transcription process 
(Clinton et a l ., 1978; Hsu et a l ., 1982; Kingsford and 
Emerson, 1980; Testa et a l ., 1980; Kingsbury et a l ., 1981; 
Sinacore and Lucas-Lenard, 1982).
Isoelectric focusing, electrophoresis and 
chromatography have revealed a variety of phosphorylated 
forms of the NS protein which can be separated into two 
classes (NS1 and N S 2 ) which, in addition to differing 
markedly in their degree of phosphorylation, have different 
transcriptase activating ability (Clinton et a l ., 1979; 
Kingsford and Emerson, 1980; Kingsbury et a l ., 1981; Hsu and 
Kingsbury, 1982).
Comparison of the location of the phosphorylated
regions by chymotryptic cleavage in both NS1 and NS2 has
revealed a conserved group of phosphorylated residues, which
may be required for a basal level of activity. Hsu and
s
Kingsbury (19 82) defined the contitutively phosphorylated 
regions close to the amino terminus and suggested that they 
may be embedded within the tertiary structure of the
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protein. The amino acids which are phosphorylated 
secondarily, and which make NS more active in RNA synthesis, 
reside in a more exposed region of the protein molecule.
The NS protein is alone (amongst VSV proteins) in its 
ability to withstand mutations. Unlike the N, M and G 
proteins of the two serotypes (Indiana and New Jersey), 
which are highly conserved in amino acid sequence, the NS 
proteins of these two serotypes exhibit only 3 0% homology 
(Gill and Banerjee, 1985). Nevertheless, the NS proteins 
share certain structural features: a negatively charged 
N-terminal region, 18 conserved potential phosphorylation 
sites (serine and threonine) spanning the polypeptide (Rae 
and Elliott, 1986) and a highly conserved (90%) 21 amino 
acids at the C terminus.
2.(b).2.5. THE L PROTEIN
The L protein is the largest VSV protein. Its gene 
is 6380 nucleotides in length and codes for a basic 2109 
amino acid protein with a M r 241012 (Schubert et a l ., 1984). 
Thomas et a l . (1985) observed that the L protein is the 
least abundant protein in the virion contributing only 6.1% 
of the total protein (estimated to represent 5 0 
copies/virion). The L protein is known to be located in the 
nucleocapsid in the virion and to form at least part of the 
transcription complex (Emerson and Wagner, 19 73; Emerson and 
Yu, 1975; Szilagyi et a l ., 1977; Naito and Ishihama, 1976; 
Mellon and Emerson, 1978). Ongradi et a l . (1985b) however 
conjectured that L is the transcriptase itself. Sanchez et_ 
al. (1985) described a protein kinase activity associated 
with the purified L protein that preferentially 
phosphorylates the NS protein on serine residues in vitro. 
Blocking NS phosphorylation resulted in the cessation of RNA 
synthesis indicating that the phosphorylation of the NS 
protein by the L-protein-associated kinase plays a direct 
role in transcription. Thus the L protein is not only the 
polymerase but also mediates auxiliary reactions essential 
for transcription (and conceivably replication) and in 
addition L i s  thought to perform functions such as capping, 
methylation and polyadenylation of the messages. Attempts
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to identify domains within the L protein and relate them to 
specific functions using recombinant DNA technology have 
been hampered by the large size and instability of the L 
protein.
2.(c). THE ORGANIZATION OF THE VSV GENOME
2.(c ).1. GENERAL
The genome of VSV Indiana consists of the leader 
region (Colonno and Banerjee, 1978a; Rose et a l ., 1980; 
McGeoch and Dolan, 19 79; Rowlands, 19 79), the leader-N 
intertranscript region (McGeoch and Dolan, 1979), the five 
VSV genes; N, NS (Gallione et al., 1981), M, G (Rose and 
Gallione, 1981) and L (Schubert et al., 1984) and the 5 ! 
terminal trailer region (Schubert and Lazzarini, 1981b).
The genome including the leader region, the five genes, the 
four intercistronic regions and the terminal tail region 
comprises 11162 nucleotides (Figure 2). The genes are 
transcribed sequentially in the order 3 1-N-NS-M-G-L-51. 
Villarreal et a l . (1976) observed that the five mRNA's are 
not present in equimolar amounts in vivo and that they are 
present in a decreasing order of abundance which is 
inversely related to their distance from the 3' terminus. N 
mRNA is thus the most abundant mRNA and L mRNA is the least 
abundant. This abundance gradient is thought to be a result 
of partial termination of transcription (attenuation) at or 
near the intergenic boundaries (Iverson and Rose, 1981) 
since both the. efficiency of translation and the rate of 
degradation are similar for each mRNA (Pennica et a l ., 19 79; 
Lodish and Froshauer 1977; Villarreal et a l ., 1976).
Until recently, there was no evidence of any 
polycistronic mRNA in VSV, although the occurrence of small 
non-structural polypeptides encoded both in the same reading 
frame and in overlapping reading frames of the viral P 
protein (a phosphoprotein thought to correspond to NS) have 
been reported for other non-segmented negative strand 
viruses such as Newcastle disease virus (Collins et a l .,
1982), mumps virus (Simpson et al ., 1984), simian virus 5 
(Paterson e t a l ., 1984), measles virus (Bellini et a l .,
Figure 2
A schematic diagram of the VSV genome constructed
from the nucleotide sequence data.
The coding regions of each gene are marked by filled 
boxes. The terminal trailer region is denoted ' t' and the 
leader region 'I1. The four two-nucleotide intercistronic 
regions are also shown. The sizes of the mRNAs without 
poly(A) tails and the sizes of the terminal untranslated 
regions of each mRNA are indicated above and below.
Adapted from Schubert et a l . (19 84 )
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1985) and Sendai virus (Giorgi et a l . , 1983). The report by 
Herman (1986) of a small polypeptide encoded in the same 
open reading frame as the NS protein of VSV New Jersey was 
the first of a possibly bicistronic message in VSV. The 
additional protein was shown to be synthesized both in an in 
vitro translation system and in vivo in intracellular 
infected cell extracts. Immunoprecipitation with monoclonal 
antisera directed against the NS protein showed that the 
additional protein was encoded in the same open reading 
frame as the NS protein. Translational mapping of the NS 
mRNA indicated that the additional polypeptide was encoded 
by the 3' one-third of the sequence probably by initiation 
at an internal AUG.
The five mRNAs are capped and methylated at the 5' 
terminus and polyadenylated at the 3 1 terminus (Abraham et 
a l ., 1975b; Rose, 1975; Rose and Knipe, 1975).
2.(c ).2 THE LEADER RNA
The leader RNA is 4 7-4 8 nucleotides in length and 
unlike the viral mRNAs is not capped, polyadenylated or 
translated (Colonno and Banerjee, 1976, 1978a, 1978b). It 
is transcribed from the exact 3' end of the genome. Leppert 
et a l . (19 79) have shown the presence of both plus and minus 
leader RNAs in VSV infected cells, the minus strand leader 
being transcribed from the 3' end of the plus strand 
antigenomic RNA. The plus strand leader has been implicated 
in the inhibition of host RNA synthesis (Week and Wagner, 
1978, 1979; McGowan et a l ., 1982; Grinnell and Wagner,
19 84). Blumberg et al . (19 83) noted the existence of a five 
times repeating array of adenine residues in nascent plus 
and minus leader RNA and proposed that this sequence 
repetition constitutes at least part of the specific 
assembly sequence of VSV. Kurilla et a l . (19 82) observed 
that the leader RNA is transiently associated with the 
nucleus. In addition Leppert et a l . (19 79) and Blumberg et
al. (19 81) proposed that the plus and minus leader RNAs may 
function as decision points for switching between 
transcription and replication.
Kurilla and Keene (19 83) proposed that the plus
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strand leader RNA could be divided into three domains;
(1) the 3' terminus: This region is conserved between 
both VSV serotypes and at the 3' end of D I 1s (Keene et a l .,
1979). It has been suggested that this region is probably 
essential for polymerase initiation on the template and for 
N protein nucleation on the leader RNA transcript (Blumberg 
et_al, 19 83).
(2) the middle 1/3: This region contains a TATA like 
sequence (Rose and Iverson, 19 79) and it has been shown that 
the viral RNA polymerase interacts with this region on the 
template (Keene et al., 1981) and it therefore may function 
as part of a promoter sequence for recognition by virion 
polymerase components (Keene et a l ., 19 81).
(3) the terminal 1/3: Kurilla and Keene (1983) 
proposed that the interaction of this region of the leader 
RNA with the cellular La protein raises the possibility of 
the involvement of La protein in the viral inhibition of 
host macromolecular synthesis. La protein is normally found 
transiently bound to unprocessed cellular RNAs that are 
products of RNA polymerase III. It has also been suggested 
that the binding of La protein to plus and minus leader may 
serve as a modulator of virus transcription versus 
replication (Kurilla and Keene, 1983; Wilusz et a l ., 1983).
2 . (c).3 INTERGENIC REGIONS
VSV has four intergenic junctions. They are similar 
in structure and contain the conserved sequence 
3 '-AUAC(U)7*-5 ' . There is a further poly(A) addition site 
downstream of the distal L gene (McGeoch, 1979; Schubert et 
a l ., 19 80; Rose, 19 80). The above sequence is thought to 
represent the signal for polyadenylation by 'slippage 
polymerization'. The sequence is followed by the 
dinucleotide S'-GA-S', or 3'-CA-5' in the case of the NS:M 
junction (Rose, 1980) which is not transcribed and marks the 
true intergenic junction. This dinucleotide is followed by 
sequence with the general form 3 '-UUGUCNNUAG-51 (where N 
represents a variable site) which is complementary to the 5' 
end of the mRNA (McGeoch, 19 79; McGeoch et al ., 19 80).
There is no evidence of any potential secondary structure at
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the intergenic junctions that might correlate with the 
observed partial termination of transcription, thought to 
occur at or near the intergenic boundaries (Iverson and 
Rose, 19 81).
2 . (d ) . THE REPLICATIVE CYCLE
Virus entering the cell is uncoated and releases its 
nucleocapsid into the cytoplasm. This incoming nucleocapsid 
contains the negative polarity RNA strand which serves as a 
template for the five subgenomic mRNAs (Morrison et a l ., 
1974; Both et al ., 1975), the leader RNA (Leppert et a l ., 
1979; Blumberg et a l ., 1981; Kurilla et a l ., 1982) and a 
sequence complementary to the 5' terminal region (Schubert 
and Lazzarini, 1981a).
Primary transcription of the incoming genome utilises 
the relevant proteins present in the virion particle
including the proteins necessary for replication (N, NS, L).
The polymerase has a single entry site at the 3 1 end of the 
genome (Emerson, 1982). In the replication mode, the 
polymerase proceeds to the 5' end, ignoring all internal 
termination and polyadenylation signals along the RNA. The 
resulting plus strand antigenome then serves as the template 
for full length negative strand genomes which in turn take 
part in secondary transcription to generate more mRNAs.
The remainder of this section will concentrate on a
more detailed description of the entry of virus into the
cell, the viral proteins involved in transcription, and the 
mechanisms of transcription and replication.
2. (d).1 VIRUS ATTACHMENT AND PENETRATION
VSV infects host cells via adsorptive endocytosis 
(Dahlberg, 1974; Matlin et a l . , 1982; Schlegel et a l . , 1981,
1983). This process involves the interaction of the VSV G 
protein with specific receptors on the plasma membrane of 
the cell. VSV binds preferentially to the acidic 
phospholipid phosphatidyl serine (Schlegel et a l ., 19 83). 
After binding VSV is rapidly translocated into plasma 
membrane 'coated pits' and then transferred to intracellular 
vesicles (endosomes).
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Evidence for the involvement of G protein in this 
process was provided by Kelley et a l . (19 72) and Bussereau 
et a l . (19 75) who effectively prevented any G mediated 
interaction by proteolytic hydrolysis of the external spikes 
(Kelley et a l . , 19 72 ) and by specific neutralization of the 
G protein by antibody (Bussereau et a l . , 19 75). More 
recently, several reports have demonstrated the direct 
involvement of the G protein in membrane interactions. 
Firstly, White et a l . (1981) observed that mammalian cells 
can be fused by exogenous VSV at low pH. Secondly, 
Florkiewicz and Rose (1984) and Riedel et a l . ( 1984) 
demonstrated that cells expressing cloned G protein are 
fusogenic at low pH. Thirdly, Eidelman et a l . (1984) and 
Bailey et a l . (19 84) observed that G protein can promote 
liposome membrane fusion. Finally, Schlegel and Wade (19 84, 
19 85) demonstrated that G protein can haemolyse erythrocytes 
at low pH and that the haemolytic domain resides within the 
terminal six amino acids at the mature NH 2 terminus.
Schlegel et a l . (19 82) reported the existence of 
specific receptors for VSV on Vero cells. Approximately 
4000 sites were detected per cell. In addition to these so 
called 'saturated sites', 'non-saturated sites' were also 
found which bound VSV at low multiplicities and which were 
thought to possibly represent a route of infectivity.
2.(d ).2 VSV PROTEINS INVOLVED IN TRANSCRIPTION
The transcribing ribonucleoprotein (R N P ) of VSV 
consists of linear, single stranded genome RNA of negative 
polarity closely associated with approximately 1258 
molecules of nucleocapsid protein (N), 50 molecules of L 
protein and 466 molecules of NS protein (Thomas et al .,
1985). In the presence of the four NTPs, this RNP 
synthesizes the five VSV mRNAs in vitro.
Using in vitro reconstitution experiments Schubert et 
al . (19 82) and Patton et a l . (19 84) demonstrated a 
requirement for both L and NS protein for mRNA synthesis. 
Because of the lability of the L protein, investigations 
into the roles played by both L and NS proteins in the 
transcription process have met with some difficulty. In
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addition, there is still some controversy as to the exact 
roles of the L and NS proteins in both the initiation and 
elongation steps of transcription. However, it has been 
established that the requirement for L protein, for optimal 
RNA synthesis, is catalytic whereas the requirement for NS 
protein is stoichiometric (De and Banerjee, 1985; Schubert 
et a l ., 19 85).
The results of De and Banerjee (1984, 1985) with VSV 
Indiana suggest that while L protein is involved in the 
initiation step, the NS protein is involved in the RNA chain 
elongation step. However, Ongradi et a l . (1985a, 1985b) in
their studies of transcription using transcriptase negative 
ts mutants of VSV New Jersey, proposed that polypeptide L i s  
the transcriptase itself and that the NS protein exerts some 
control over transcription. More recently, Banerjee (1987) 
suggested that the NS protein comprises three distinct 
functional regions directly involved in transcription.
Domain I contains the negatively charged N-terminal half of 
the protein which it is thought may interact with the N 
protein, thereby making the template RNA accessible to the L 
protein transcriptase. Domain II has been shown by deletion 
mapping experiments and by use of an in vitro transcription 
and translation system (Gill et a l ., 1986) to contain a 34 
amino acid stretch (residues 213-247) that is involved in 
binding NS protein to the L protein. The L protein in turn 
interacts with the N-RNA complex to initiate RNA chains. In 
addition, Chattopadhyay and Banerjee (19 87) showed, in an 
investigation of the functional significance of 
phosphoserine residues in Domain II, that site directed 
substitution of serine residues at positions 236 and 232 
(which are conserved between the Indiana and New Jersey 
serotypes) by alanine abolished RNA synthesis catalysed by 
the NS-L complex in vitro. It was suggested therefore that 
phosphorylation of these two serine residues regulates NS 
binding to L protein and the N-RNA template and that it is 
essential for activation of viral RNA synthesis 
(Chattopadhyay and Banerjee, 1987). Domain III comprises 
the 21 amino acids at the C-terminus. This domain is not 
required for transcription but since it is the most
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conserved between the two VSV serotypes, it was suggested 
that it might interact with the N protein that is associated 
with the genomic RNA template.
2 .(d) . 3 TRANSCRIPTION
Studies on the mechanism of transcription in vitro by 
the RNP of VSV have demonstrated that RNA synthesis is 
sequential and takes place in the order leader-N-NS-M-G-L 
(Abraham and Banerjee, 1976a, 1976b; Ball and White, 1976; 
Iverson and Rose, 1981, 1982). Two models have been 
proposed for this sequential mode of VSV mRNA transcription 
in vitro.
In the single initiation model, it is suggested that 
the transcriptase begins transcription at the 3' end of the 
genome and that the leader plus five mRNAs are produced by 
sequential transcription followed by sequential cleavage of 
the growing precursor chain. Evidence for such a model is 
provided by the detection both in vitro (Rose et a l ., 1977; 
Herman et a l ., 1978, 1980) and in vivo (Masters and Samuel,
1984) of polycistronic transcripts. However, there appears 
to be a major difference between in vivo and in vitro 
synthesized polycistronic messenger. The in vitro 
synthesized mRNAs are polyadenylated at intercistronic 
junctions (Masters and Samuel, 1984) whereas the in vivo 
synthesized polycistronic messengers are only polyadenylated 
at the 3' molecular termini (Herman et a l . , 1978, 1980).
In the multiple initiation model, it is suggested 
that the RNA polymerase initiates transcription at multiple 
promoter sites, but that chain elongation from a given site 
only occurs after transcription of its upstream gene. 
Thornton et a l . (19 84) provided evidence for this model 
using a uv irradiated template reconstituted with soluble 
transcriptase. They showed that the synthesis of leader RNA 
and other small initiated mRNA sequences continued while 
full length mRNA synthesis decreased by 90%. Also, under 
partial reaction conditions phosphorylated oligonucleotides 
which represent 5 ' terminal sequences transcribed from the 
leader template and genes coding for mRNAs were detected. In 
addition, in the presence of arabinosyl ATP (an inhibitor of
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RNA synthesis in vitro) the synthesis of leader RNA was 
found to be initiated considerably more than other small 
initiated RNA sequences but under conditions in which leader 
RNA synthesis is abolished initiation at the N gene 
continued demonstrating that an internal site is available 
for binding of transcriptase.
With a view to addressing the respective roles of the 
L and NS proteins in the transcription process Banerjee 
(1987) proposed a model for VSV transcription in vitro based 
on the structure and function of the L and NS proteins 
(figure 3). It had previously been established that the 
requirement for L protein for optimal RNA synthesis is 
catalytic whereas the requirement for NS protein is 
stoichiometric (De and Banerjee, 1985; Schubert et a l .,
1985). Banerjee proposed that NS protein is bound uniformly 
along the RNP, whereas the L protein is located at specific 
sites on the template (to be able to initiate transcription 
of individual genes) and is also probably associated with a 
subset of NS molecules. During transcription as the L 
protein associates with previously bound NS protein, it 
displaces the tightly bound N protein, allowing access to 
the template by the L protein transcriptase.
2.(d ).4 CAPPING AND POLYADENYLATION OF mRNAs
The in vitro synthesized mRNA species, in common with 
typical eukaryotic mRNAs, contain a 5 '-terminal cap 
structure (GpppA) (Abraham et al ., 1975b; Hefti and Bishop, 
1976) and a 3 '-polyadenylic acid [poly(A)] tract (Banerjee 
and Rhodes, 1973; Galet and Prevec, 1973; Villarreal and 
Holland, 19 73: Ehrenfeld, 19 74). In the presence in vitro 
of the methyl donor S-adenosyl-L-methionine, specific 
methylation of the 5 ' cap structure occurs with the 
formation of the dimethylated cap 5'-m GpppAm (where m G 
represents 7-methyl guanine and Am represents 2-O-methyl 
adenine; Abraham et al., 19 75a). In contrast, the mRNAs 
isolated from infected cells contain, in addition to 
methylated G, a doubly methylated penultimate A and variable 
degrees of methylation at the second A residue (Rose, 1975; 
Moyer and Banerjee, 1976). In addition, uncapped full
Figure 5
A possible model for VSV transcription.
The top half of the model shows the proposed 
positions of the N and NS proteins when the 
ribonucleoprotein is in an inactive state. NS is bound 
uniformly along the RNP whereas L protein is located at 
specific sites on the template, to be able to initiate 
transcription of individual genes, and is probably 
associated with a subset of NS molecules.
During active transcription (bottom half of model), '
as the L protein moves to each new region of the template, $
I;
it binds to NS protein already bound so displacing tightly |
I
bound N protein and allowing access to the template by the L 
protein transcriptase.
From Banerjee (19 87).
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length transcripts containing 5 '-triphosphate A and G have 
been found in low levels in vivo (Rose, 1975) and in vitro 
(Hefti and Bishop, 1976; Toneguzzo and Ghosh, 1976). The 
unique feature of the cap structure of the VSV mRNAs is that 
the oi. and phosphates of the blocking GTP and the oL 
phosphate of the penultimate A are incorporated into the 
5'-5'-triphosphate moiety G (5 ' )°$/*( 5 1 ) AA (Abraham et a l . , 
1975a, 1975b). This feature is quite different from those 
of other viral systems (such as reovirus and vaccinia) where 
the ©C phosphate of the blocking GTP and both ot and 
phosphates of the penultimate base are incorporated into the 
triphosphate bridge (Banerjee, 1980).
The in vitro synthesized mRNAs contain approximately 
200 adenine residues at their 3' end, indicating that 
post-transcriptional polyadenylation is carried out by one 
or more virus specified proteins (Banerjee and Rhodes, 1973; 
Galet and Prevec, 1973; Villarreal and Holland, 1973; 
Ehrenfeld, 1974). Curiously, S-adenosyl-L-homocysteine, an 
inhibitor of methylation, greatly increases the length of 
the poly(A) tails made in vitro (Rose et a l ., 1977).
Although the role of S-adenosyl-L-homocysteine has not been 
elucidated, the results seem to indicate that methylation 
and polyadenylation are interdependent and both may have 
roles in the transcription process.
2.(d ).5 REPLICATION OF VSV RNA
VSV nucleocapsids serve as templates for both 
transcription and replication (figure 4). The negative 
sense RNP serves as the template for the synthesis of full 
length negative strand RNA. This plus strand complexed with 
N protein serves as the template for the synthesis of 
negative sense RNP's which are employed in secondary 
transcription and progeny virus assembly. The synthesis of 
both full length genomic and antigenomic RNA is thought to 
be catalysed by the same replicase (Emerson and Yu, 19 75; 
Perlman and Huang, 1973; Pringle, 1978), perhaps in 
conjunction with unidentified host factors (Simpson et a l ., 
1979; Morrongiello and Simpson, 1979; Mukherjee and Simpson, 
1984).
Figure 4
A schematic diagram of the replication cycle of VSV
Replication of rhabdoviruses takes place in two 
stages. Primary transcription involves transcription of the 
negative sense genomic RNA from the extreme 3 ' end to 
generate the five viral mRNAs wich are subsequently 
translated. Plus sense RNA is synthesized when viral 
protein synthesis decreases. The plus sense RNA then acts 
as a template for synthesis of full length negative sense 
RNA which is packaged into budding virions or used as a 
template for subsequent mRNA synthesis (secondary 
transcription).
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Using a coupled transcription/translation system, 
Patton et a l . (1984) employed both intracellular and virion 
derived nucleocapsids in conjunction with purified 
individual mRNAs to examine the protein synthesis 
requirements for VSV RNA replication. Their results showed 
that VSV replication required only a new source of N protein 
and that it did not require the synthesis of new L or NS 
prote in.
Arnheiter et a l . (1985) suggested that specific 
binding of the nucleocapsid protein to the 5 ' end of the 
leader RNA, so initiating encapsidation of the growing RNA 
strand (Blumberg et a l . , 19 83), might posibly serve to 
protect the RNA from processing or cause the readthrough of 
the transcriptional signals thus allowing synthesis of 
genome size RNA. Arnheiter et a l . (1985) investigated the 
role of the N protein in the regulation of VSV RNA synthesis 
using two monoclonal antibodies directed against different 
epitopes of the N protein. Antibody 1 bound to 
nucleocapsids and possibly the pool of cytoplasmic free N 
protein. It interfered with both the transcriptional and 
replicative activity of the nucleocapsid - possibly by 
arresting the progress of the polymerase. Antibody 2 did 
not inhibit transcription and bound only poorly to 
nucleocapsids. However, it did inhibit replication and it 
bound to the free pool of cytoplasmic N protein. They 
suggested that this antibody inhibited replication by 
neutralizing the pool of free N protein. The results 
obtained using these antibodies suggest a mechanism of 
regulation in which the availability of free N protein 
determines the balance between replicative and 
transcriptional RNA synthesis in VSV infected cells 
(Arnheiter et a l ., 1985).
2.(d ) . 6 VIRAL PROTEIN SYNTHESIS
All newly synthesized viral proteins can be detected 
by 1-2 h post infection in VSV infected cells (Mudd and 
Summers, 1970; Wunner and Pringle, 1972a, 1972b). The first 
viral protein to be detected is the N protein, which can be 
detected about 30 minutes before the other four viral
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proteins. Later in infection, N protein is found associated 
with a large number of nucleocapsids (Hsu et al ., 1979). N 
is synthesized on free ribosomes (as are the rest of the VSV 
proteins except G protein) and is first detected as a 
soluble protein before it is incorporated into the 
nucleocapsid (Knipe et a l ., 19 77a; Hsu et a l ., 1979). NS 
protein is found in abundance in the cytoplasm of infected 
cells (Wagner et al ., 1976). L protein is also found free 
in the cytoplasm after synthesis as well as becoming 
associated with the plasma membrane.
Early in infection M protein is distributed diffusely 
throughout the cytoplasm of infected cells. Later however, 
N, NS and M accumulate close to the membrane and it is 
thought that M only interacts with the nucleocapsid close to 
the assembly site at the membrane.
G protein is synthesized on membrane bound ribosomes. 
The nascent protein is inserted into the membrane of the 
rough endoplasmic reticulum where the 16 amino acid signal 
sequence is proteolytically cleaved (Chatis and Morrison, 
1979; Irving et a l ., 1979). The co- and post-translation 
glycosylation and transport of G protein to the cell surface 
have been well documented (Rothman and Lodish, 19 77; Rothman 
and Fine, 1980; Lodish and Rothman, 1979; Etchison and 
Summers, 1979; Morrison, 1980; Bergmann et al ., 1981; Rose 
and Bergmann, 1982; Wehland et a l ., 1982; Guan et al ., 1985; 
Puddington et al., 1986). Additional post-translational 
modification occurs before or when G arrives at the plasma 
membrane in VSV Indiana, but not in VSV New Jersey. This 
consists of the addition of fatty acids which are thought to 
act as an auxiliary lipophilic anchor of G protein to the 
membrane (Schmidt and Schlesinger, 19 79; Capone et a l ., 
1982). The fatty acid chain (palmitate) is linked to the 
single cysteine residue in the cytoplasmic domain (Rose et 
a l ., 1984). The findings of Villarreal et al . (1976) and 
Lodish and Froshauer (1977), which revealed that the VSV 
mRNAs are all translated with equal efficiencies and that 
the molar ratios of the proteins reflect the molar ratios of 
the mRNAs, suggest that control of viral protein synthesis 
in vivo occurs at the level of transcription.
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2 .(d ). 7 VIRUS MATURATION AND BUDDING
The ultimate step in the replicative cycle of VSV is 
the assembly of the virus, which involves the interaction of 
the nucleocapsid with virus modified host membranes at the 
site of budding. The respective roles of the G and M 
proteins in promoting attachment of the nucleocapsid to the 
membrane have been long debated. Several observations 
support the role of the G protein in virus assembly and 
budding. Exposure of VSV infected cells to monensin (which 
stops the transport of G protein to the cell surface) 
prevents virus budding at the cell surface (Johnson and 
Schlesinger, 1980). In differentiated epithelial cells, G 
protein is transported mainly to the basal pole, and VSV 
buds predominantly from this domain (Rodriguez-Boulan and 
Prendergast 1980; Rodr iguez-Boulan and Sabatini, 1978).
Roth et a l . ( 1979 ) and Roth and 'Compans (1980) observed that 
the polarity of budding is maintained after tunicamycin 
treatment, suggesting that glycosylation of G protein is not 
a major determining factor in the site of virus budding. 
However, several reports have concluded that the G protein 
does not have an essential role in budding, in particular 
the observation that spikeless virions were formed at a 
relatively high yield from cells infected by the G mutant ts_ 
045. The ts^  045 glycoprotein is retarded in the rough 
endoplasmic reticulum (RER) due to a transport block and no 
protein is found at the cell surface (Knipe et a l . , 19 77a; 
Zilberstein et a l . , 1980). However, more recently a report 
by Metsikko and Simons (1986) showed that the spikeless 
virions formed from ts 045 infected cells contain a full 
complement of membrane anchors derived from the C-teminus 
of the G protein. This clearly favours the idea that an 
interaction between the G protein carboxy terminal domain 
with the (M-protein coated) nucleocapsid is an essential 
event in viral assembly.
Zakowski and Wagner (19 80) suggested that since the M 
protein is located on the inside of the envelope, it may 
form a bridge between the G protein and the nucleocapsid. 
Evidence for this association was provided by Newcomb and
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Brown (19 81) who demonstrated that M protein remains 
complexed with the tightly coiled nucleocapsid skeleton 
after removal of both G protein and the viral membrane from 
virions by treatment with the detergent octyl glucoside. 
Odenwold et a l . (1986) examined the role of the M protein in 
the budding process by stereo electron microscopy. From 
their results they postulated that the process of budding 
starts with the attachment of nucleocapsids to the cell 
membrane (presumably by interacting with G protein on the 
cytoplasmic side of the membrane) so resulting in the 
initiation of nucleocapsid coiling. This conformational 
change allows M protein to specifically bind to the 
nucleocapsid and induce a conformation favourable for 
coiling or cross link adjacent turns in the tight coil or 
both (Odenwold et al . , 1986) . Moreover, Ono et a l . (1987) 
have recently reported that no nucleocapsid coiling is seen 
in cells infected by the M mutant ts_ G33, supporting this 
view of VSV assembly.
2.(e). GENETICS
2.(e).1 MUTANTS
Mutants of VSV can be divided into two general 
categories (Pringle, 1977). These categories consist of;
(1 ) mutants which have a specific phenotype.
Examples of this type of mutant are the plaque morphology 
mutants described by Wagner et a l . (1963) and the Rif+ 
mutants (Moreau, 1974).
(2) mutants which are conditionally lethal. Mutants 
which fall into this category can be of three distinct 
forms. They can be temperature sensitive (ts_), temperature 
dependent host range (tdCE) or host restricted (hr) mutants. 
A fourth class of conditional lethal mutant can now be 
included in this category. These are suppressible nonsense 
mutants, which were isolated from mutagenized VSV and are 
the subject of this thesis.
Of the mutants described above, ts_ mutations have 
been used more extensively in VSV genetic analysis than any 
other type of mutant because of the ease with which they can
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be isolated from mutagenized virus and also because of the 
ease with which they can be assayed.
The mutagen which has been most effective in the 
generation of ts_ mutants of VSV is the base analogue 
5-fluorouracil (5-FU; Pringle, 1970). Several other 
mutagens have been used, such as ethyl methane sulfonate 
(EMS) (Pringle, 1970; Holloway et a l ., 1970), 5-azacytidine 
(ACR) (Pringle, 1970), and nitrous acid (NA) (Holloway et 
a l ., 1970; Rettenmeier et al ., 1975) but with considerably 
less success. In a comparison of the mutagenic abilities of 
different mutagens (EMS, 5-FU and ACR), Pringle (1970) 
reported that 5-FU was the most potent mutagen of the three 
tested. However, Flamand (19 70) reported the isolation of 
ts mutants from an unmutagenized stock of VSV Indiana. This 
must surely reflect the low fidelity of RNA genome 
replication resulting from the lack of any proofreading 
mechanisms.
Ts mutants of VSV Indiana and New Jersey have been 
classified into six complementation groups. In the case of 
the New Jersey serotype the six groups are designated A-F 
and in the case of the Indiana serotype I-VI. The anomaly 
of six complementation groups and only five gene products is 
thought to result from intragenic complementation. Although 
no intragenic recombination was observed between the 5-FU 
induced mutants of the Glasgow strain of VSV Indiana, 
intragenic complementation has been detected in group Chi 
(polymerase gene) of Chandipura virus (Gadkari and Pringle, 
1980). The extent of the intragenic complementation in 
Chandipura virus was thought to suggest that the virion 
polymerase exists in a multimeric form (Gadkari and Pringle, 
1980).
No direct evidence of recombination has been observed 
for complete VSV genomes, although the structures of fusion 
defective interfering particles (DI's, which are described 
in a separate section) suggest the presence of a RNA 
breakage-reunion process in VSV infected cells. In 
addition, no recombination has been detected for any other 
negative strand RNA virus with an unsegmented genome.
Genome rearrangements have been detected within negative
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strand RNA viruses with segmented genomes, however this is 
more correctly reassortment and not recombination. Although 
the possibility that recombination occurs cannot be 
excluded, it must be an extremely rare event if it does 
occur.
Complementation however, has been observed widely 
within vesiculoviruses and classification of ts mutants into 
complementation groups has proven an effective method of 
examining the functional properties of the genome of these 
vi ruses.
Host range (hr) mutants of VSV Indiana have been 
isolated which were restricted in Hela cells, but not in CE 
cells (Obijeski and Simpson, 1974; Simpson and Obijeski, 
1974). In a comparison of thirty cell types Simpson et a l . 
(19 79) reported a gradient in permissiveness of these 
mutants in which cells of human origin were the least 
permissive. In addition a difference in permissiveness was 
observed between individual sublines of Hela cells (Simpson 
et al . , 19 79 ) and it was concluded that host factors were 
involved in viral replication.
Conditional (tdCE) and non-conditional (hrCE) host 
range mutants of VSV New Jersey, Indiana and Cocal have also 
been described (Szilagyi and Pringle, 1975; Pringle 1977, 
1978). The tdCE mutants are conditionally ts mutants which 
grow normally in BHK21 (clone 13) cells at either 31°C or 
39°C, but only at 31°C in CE cells. A reversible inhibition 
of in vitro polymerase activity at 39°C was exhibited by 
several of these mutants (Szilagyi and Pringle, 1975). 
Dissociation and reconstitution experiments revealed that 
the mutation in these mutants lay in the L protein (Szilagyi 
et a l , 1977). Szilagyi and Pringle (1975) observed that 
this phenotype was expressed irrespective of the cells in 
which the virus had been grown. The host range involvement 
in the phenotype of these cells suggested that host factors, 
absent in CE cells, were involved with the polymerase in 
some way maintaining it in an active conformation at the 
non-permissive temperature (Szilagyi and Pringle, 19 75; 
Pringle, 1978).
In a study involving different cell types (picked
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because they represented cell types from different stages in 
differentiation) Pringle (1978) suggested that the putative 
host factors may not be expressed until the host cell has 
undergone an undefined degree of differentiation.
2.(e ). 2 GENE ASSIGNMENT OF VSV INDIANA
This section summarizes the data presently available 
linking complementation groups to specific genes. Some of 
the evidence is in fact quite weak but this probably does 
not affect the validity of the gene assignments derived from 
such data. The application of additional nucleotide 
sequence analysis promises to clarify this area.
2. (e ).2.1. COMPLEMENTATION GROUP I
The defect in complementation group I was identified 
by Hunt et a l . (1976) as residing in the L protein. Mutants 
in group I exhibit restricted RNA synthesis (RNA“ phenotype) 
at the non-pemissive temperature. Hunt and Wagner (19 74) 
demonstrated that the transcription defect in three group I 
mutants was due to thermosensitivity of the solubilized 
transcriptase enzyme. Hunt et a l . (19 76) distinguished 
between the two components of the transcriptase complex (L 
and NS) by demonstrating that the in vitro transcriptase 
activity of three group I mutants was restored by the
addition of L protein fractions derived from wt and not by
NS protein fractions.
2(e).2.2. COMPLEMENTATION GROUP II
The defect in complementation group II was localized 
both by partial proteolysis of wt and ts mutants of VSV 
(Metzel and Reichmann, 1981) and also by tryptic peptide 
mapping (Lafay and Benejean, 1981).
Metzel and Reichmann (19 81) compared the partial
digests of VSV proteins derived from wt and the group II ts
mutants by partial proteolysis with Staphylococcus aureus V 8 
protease. Mutants of complementation group II differed from 
the wt virion in peptide profiles of their NS protein.
Lafay and Benejean (1981) analysed tryptic digests by 
ion-exchange chromotography of NS protein from mutants and
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revertants of group II. Since a ts defect is correlated 
with a specific protein modification, it follows that 
revertants of this mutation should posess a new modification 
in the same protein. In the case of the group II mutant 
studied (ts 052) the modified peptide was found in the NS 
protein.
2. (e).2.3. COMPLEMENTATION GROUP III
The defect in mutants of complementation group III 
was also identified by Metzel and Reichmann (1981) and Lafay 
and Benejean (19 81) by the same method. Partial proteolysis 
revealed that a mutant of complementation group III (t£ G31) 
differed from wt in the peptide profile of its M gene 
(Metzel and Reichmann, 1981). Lafay and Benejean (1981) 
revealed by tryptic peptide mapping that the modified 
peptide in the group III mutant ts 02 3 was detected in the M 
protein. In addition, Freeman and Huang (1981) used 
heteroduplex mapping to identify the defect in group III 
mutants. The genomic RNA was annealed to small 
complementary mRNAs and trimmed with ribonucleases. Should 
a base mismatch occur between the mutant gene and mRNA 
isolated from revertant infected cells, the duplex 
containing the lesion would be expected to migrate 
differently on a polyacrylamide gel. Heteroduplex mapping 
of the mutant ts G31 assigned this mutation to the gene 
coding for the M protein. More recently Gopalakrishna and 
Lenard (1985) determined the nucleotide sequence of the M 
gene of four te M-protein mutants (ts G31, ts G33 of the 
Glagow strain and ts 023 and te 089 of the Orsay strain) and 
of their respective wt M-protein genes. It was found that 
the mutants differed from the wt by one or two point 
mutations in the M gene.
2. (e ) .2.4. COMPLEMENTATION GROUP IV
The defect in complementation group IV of VSV was 
determined in the same manner as mutants of complementation 
group II. Metzel and Reichmann (19 81) compared the partial 
digests, produced by partial proteolysis, of ts G41(IV) and 
wt virus. The peptide profile of ts_ G41(IV) differed from
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the wt in the peptide profile of the N protein. Lafay and 
Benejean (1981) identified the mutation in ts Oll(IV) by 
tryptic peptide analysis. The modified peptide was found in 
the N protein.
2.(e ) .2.5. COMPLEMENTATION GROUP V
Zavada (19 72) identified the defect in
complementation group V by rescuing the ts 0 45 phenotype by
pseudo type formation. The mutant jts 0 45 grown at 4 5°C
rapidly lost infectivity when plated for assay in chicken, L
or BHK-21 cells. When ts 045 was grown in avian
heated,
myeloblastosis virus (AMV) preinfected cells,^and then cultured 
in chick cells, the resultant virus had about 1 0 0  times 
higher activity. All thermostable chick specific virus was 
neutralized with anti-AMV serum. Thus pseudotype formation 
had rescued the ts 045 phenotype. In addition, Knipe et a l . 
(19 77b) showed that the mutant ts M501(V) did not undergo 
the final sialylation at 39°C resulting in a G protein with 
a slightly different electrophoretic mobility as detected on 
polyacryamide gels. Also the mutant could not be 
complemented by coinfection with virus strains coding for G 
protein that migrated normally (Knipe et a l ., 19 77b). 
Gallione and Rose (19 85) determined the site of the ts 0 45 
mutational lesion, responsible for the conditional transport 
of G protein, by determining the sequence of cloned cDNA 
copies of G protein mRNA of ts 045(V), a spontaneous 
revertant of ts 045(V) and wt virus. This revealed that any 
one of three mutations could be responsible for the 
temperature sensitivity of the mutant. Recombinant plasmids 
containing these mutations were transfected into COS-1 cells 
and the temperature sensitivity of each recombinant 
investigated. This revealed that the recombinant molecule 
containing a mutation which substituted phenylalanine by 
serine was sufficient to prevent transport of G protein to 
the cell surface at 39.5°C.
2.(e ) .2.6 . COMPLEMENTATION GROUP VI
The defect in complementation group VI was identified 
by Deutsch et al. (1979). The sole member of group VI,
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ts 0 82, was shown by uv inactivation studies to have similar 
rescue characteristics to group II (NS) mutants. This 
implies that the NS protein comprises two domains. 
Complementation observed between this mutant and a group II 
mutant (ts 052) would result therefore from intragenic 
complementation between two separate domains of the NS 
protein.
2.(f ) . DEFECTIVE INTERFERING PARTICLES
Defective interfering particles (DI's) are viral 
particles that contain only a portion of the genetic 
material of the parental virus and are equivalent to 
deletion mutants. They are presumed to arise from aberrant 
replicative events during which the polymerase changes 
template position without releasing the nascent strand.
They are constantly generated at low levels by infectious 
virus and can accumulate during' replication at high 
multiplicities of infection. They are unable to self 
replicate in host cells but can utilize the functions of a 
helper virus to multiply. This results in the phenomenon of 
autointerference when the replication of the helper virus is 
greatly suppressed. DI particles are thought to suppress 
replication of the helper virus by effectively competing for 
the L or N proteins supplied by the helper virus. DI 
particles need only cis-acting replication functions such as 
initiation sites at their 3' terminus, the complement of an 
initiation site at the 5' terminus and the nucleocapsid 
encapsidation site. Trans-acting functions are supplied by 
the helper virus.
DI's have been implicated in the establishment and/or 
maintenance of persistent infection in cell culture (Holland 
et a l . , 1980; Holland and Villarreal, 1974; Horodoyski and 
Holland, 1980). Other factors have been observed to play a 
role, such as interferon (Sekellick and Marcus, 1979) and ts 
mutants, but clearly not to the same extent as the 
attenuating properties of DI's in moderating an otherwise 
cytocidal infection. Interestingly, DI's appear to provide 
a selective pressure for rapid and extensive mutational 
drift of standard virus during long term persistent
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infections (Holland et a l ., 1979).
Four types of DI particle genome have been 
characterized and have been designated (1) fusion,
(2) panhandle (3) snapback and (4) compound (Lazzarini et 
al . , 1981; Perrault, 1981).
The first class (fusion) consists of simple deletion 
mutants, of which DI-LT is the prototype. They represent 
internal deletions of the L gene leaving the terminal 
regions intact (Leamnson and Reichmann, 1974; Perrault and 
Semler, 1979; Epstein et al ., 1980). This type of DI was 
observed to predominate in early passages and were 
subsequently replaced by genomes with compound complementary 
ends suggesting that the latter may have a selective 
advantage (Keene et a l ., 19 81). Fusion DI's can be 
transcribed both in vivo and in vitro and complement ts 
mutants because the parental 3 ' terminus along with the G,
M, NS and N genes are undeleted'(Colonno et a l ., 1977; 
Johnson et a l .,19 79).
The second class of DI particles (panhandle) have 
lost the entire N, NS, M and G coding regions in addition to 
the 3' end of the L gene and thus only contain information 
from the 5' half of the VSV parental genome. Unlike fusion 
DI's they can neither transcribe functional mRNA nor 
complement ts_ mutants from any of the VSV complementation 
groups.
The third class (snapback) also only contain 
sequences from the 5 ' half of the genome and have been shown 
to contain RNA with extensive self-complementarity (Perrault 
and Leavitt, 1977; Keene et al ., 1978; Schubert et a l .,
1978, 1979; Schubert and Lazzarini, 1981a). If DI-011 is 
deproteinized, the DI particle snaps into a perfect duplex 
of about lOOObp (Schubert and Lazzarini, 1981a).
The fourth class (compound) consists of DI particles 
with compound initiation sites at the 3' terminus of their 
RNAs and have about 6 000 nucleotides of the L mRNA coding 
region deleted. The prototype is DI-LT2 which was 
discovered in seed stocks of the simple deletion DI particle 
DI-LT, and it has been suggested that DI-LT2 may be derived 
from DI-LT (Perrault and Semler, 1979; Epstein et a l .,
5 3
1980). Unlike DI-LT, DI-LT2 is not transcriptionally active 
and the leader region (now located internally) is muted.
There are three major factors which influence the 
generation of DI particles:
(1) The host cell type; Holland et a l . (19 76) 
observed that different cell types varied in the amount of 
DI's they produced. In addition, when a mixed stock of DI's 
was used to infect different cell types, the predominant DI 
species amongst the progeny was shown to vary with cell 
type.
(2) The time of harvest; Khan and Lazzarini (1977) 
observed that harvesting virus shortly after infection 
results in a virus preparation which contains fewer DI's 
than virus harvested late in infection. The explanation for 
this observation is thought to be a consequence of the 
slower rate of release of DI particles in comparison to 
standard virus.
(3) Multiplicity of infection; Faulkner and Lazzarini 
(1980) showed that infecting cells at low multiplicity (i.e. 
less than 1 pfu/cell) resulted in fewer DI particles in the 
resulting virus preparation than infecting cells at high 
multiplicity.
MATERIALS AND METHODS
54
MATERIALS AND METHODS
CHAPTER 3. (a) MATERIALS
3 . (a ). 1 CELLS
Baby hamster kidney (BHK-21) clone 13 cells 
(Macpherson and Stoker, 1962) were provided by the cytology 
department, Institute of Virology.
LMTK- cells, a line derived from mouse fibroblasts 
were a gift from M. Capecchi of the Department of Biology, 
University of Utah, Salt Lake city, Utah.
(L39) cells, also obtained from M. Capecchi were 
derived from LMTK“ cells and carried an amber suppressor 
tRNATy r gene.
3.(a).2 VIRUS
Wild-type and ts stocks of vesicular stomatitis virus 
Indiana serotype were obtained from C.R. Pringle, Institute 
of Biological Sciences, University of Warwick, Coventry, 
England. (Pringle, 1970, Pringle et a l . , 1971).
3.(a).3 CHEMICALS
Chemicals and biochemicals were obtained from the 
following suppliers.
Acrylamide (BDH); agar (Difco); aminopterin (Sigma); 
ammonium persulphate (Bio-Rad); bovine serum albumin (BSA) 
(Sigma); caesium chloride (Koch-Light); 5-fluorouraci1 
(Sigma); Geneticin (G-418; Sigma); glutaraldehyde 2%
(Arbrook Products); glycerol (Koch-Light); hypoxanthine 
(Sigma); Lyovac Cosmegen (actinomycin-D; Merck, Sharpe and 
Dohme); N ,N 1-methylene bi sacrylamide (BDH); 
protein-A-sepharose (Sigma); trypsin (Difco).
All other chemicals were obtained, where possible, in 
Analar form, from BDH and Sigma.
3 . (a ).4 RADIOCHEMICALS
L - [3 5s]-methionine (1150-1500 Ci/m mol), and Nal25j 
were supplied by The Radiochemical Centre, Amersham. Na125I
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was used in the preparation of 125i_protein A, which was 
obtained from C. Maclean.
3.(a).5 TISSUE CULTURE MATERIALS
Flasks, petri dishes, and 24-well Linbro trays were 
manufactured by Nunc and were supplied by Gibco-Biocult 
Limited.
3.(a) . 6 TISSUE CULTURE REAGENTS
Tissue culture reagents were supplied by Flow 
Laboratories and Gibco-Biocult.
Calf serum, Giemsa, Neutral red, Eagle's overlay, 
trypsin and versene were all prepared in the Institute of 
Virology.
The various tissue culture reagents used are 
described below.
DMEM/10%FCS comprised 500 ml lx Dulbecco's minimal 
essential medium (Dulbecco and Freeman, 1959), supplemented 
with 5 mM L-glutamine and 10% calf serum.
MEM/10%CS comprised lOx Glasgow modification of 
Eagle's medium, diluted in distilled water and supplemented 
with 5 mM L-glutamine, 2.75 g/1 NaHCC>3 and 10% calf serum.
EC/2%CS low methionine comprised 140 ml Eagle's A,
15 ml Eagle's B without L-methionine, 5 ml Eagle's B, 
supplemented with 2 % calf serum.
PBS/2%CS comprised 8 parts PBS A, 1 part PBS B, 1 
part PBS C supplemented with 2% calf serum.
Agar overlay comprised 310 ml Eagles A, 6 0 ml 
Eagles B without phenol red, 125 ml 3.6% Difco agar, 7 ml 
calf serum.
Neutral red overlay comprised 310 ml Eagles A, 60 ml 
Eagles B without phenol red, 125 ml 3.6% Difco agar, 10 ml 
neutral red.
3.(a).7 MISCELLANEOUS MATERIALS
Miscellaneous materials were obtained from the 
following suppliers. E n h a n c e  (New England Nuclear); Kapton 
tape (R and J Wood); Kodak X-Omat S film (Kodak); 
Nitrocellulose paper (Schleicher and Schuell).
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3.(a) . 8 BUFFERS AND SOLUTIONS
PBS 170mM NaCl, 3.4mM KCl, ImM Na2 HPC>4 pH 7.2. 
NTE lOOmM NaCl, lOmM Tris HCl pH 7.5, ImM EDTA.
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3 . ( b ) METHODS
3.(b).1 GROWTH OF CELLS
BHK-21 C13 cells were grown in 2 litre glass or 
plastic burrler bottles containing 250 ml of Eagle's/10%CS 
in an atmosphere of 9 5% air and 5% CO2 . LMTfC (su~) and L39 
(su+ ) cells were grown in 175 cm2 tissue culture flasks 
containing 75 ml of DMEM/10%CS in an incubator containing 5% 
CO2 at 3 7°C. L39 cells were propagated in HAT medium 
(DMEM/10%FCS supplemented with 100 uM hypoxanthine, 0.4 uM 
aminopterin, 16 uM thymidine and 3 uM glycine). Cells were 
harvested by washing twice with versene and once with a 
trypsin/versene mix. 9 0 mm plates of su+ cells for use in 
plaque picking and plaque purification, were seeded as 
required - usually three from a large tissue culture flask. 
The plates were then incubated at 3 7°C until confluency was 
reached five days later. Linbro wells of su+ cells, used to 
titrate virus and for protein analysis, were prepared by 
seeding five, 2 4 well multiwells from a large tissue culture 
flask. The monolayers were incubated for 24 h at 3 7°C.
90 mm plates of su~ cells for use in isolating 
revertant plaques were prepared from large tissue culture 
flasks by seeding four plates per flask and incubating until 
confluency 48 h later. Eight 2 4 well multiwells, to be used 
for titration of virus and for protein analysis, could be 
seeded from a large tissue culture flask of su~ cells with 
confluency reached 16-24 h later. 25 cm^ tissue culture 
flasks were prepared for complementation analysis by seeding 
from a single large tissue culture flask of su~ cells and 
incubating for 24 h at 37°C.
3.(b).2 PURIFICATION OF VIRUS
VSV stocks were grown in monolayers of BHK-21 C13 
cells in 2 litre burrler bottles.
Monolayers were infected at low multiplicity with a 
10 ml inoculum containing 0.01 pfu/cell in PBS/2%CS. The 
virus was allowed to absorb for 6 0 min at 31°C and 4 0 ml of 
Eagle's/2%CS added. The cells were incubated at 3 1°C until 
extensive cpe was observed. The supernatant was decanted
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and clarified by centrifugation for 30 min in a Sorvall 
RC-5B superspeed centrifuge using a GSA rotor. Virus was 
pelleted from the clarified medium through a 9 ml cushion 
consisting of 30% (v/v) glycerol, 20 mM Tris-HCl pH8.0, 1 mM 
EDTA and 100 mM NaCl. Centrifugation was for 9 0 min at 
21000 rpm and 4°C using the Du Pont 10x100 rotor in the 
Sorvall OTD-50 ultracentrifuge. The pellet was resuspended 
in 1 ml NTE. Virus was further purified by banding the 
virus in a 15-45% sucrose gradient. The gradient was 
centrifuged for 9 0 min at 22000 rpm and at 4°C using the 
TST41 rotor in the Sorvall OTD50 ultracentrifuge. The band 
was collected, diluted to 10 ml with NTE, and pelleted 
through a 30% glycerol cushion as before. The final pellet 
was resuspended in 1 ml of NTE and stored at -7 0°C.
3.(b).3 5-FLUOROURACIL MUTAGENESIS
Confluent monolayers of su+ cells were infected in 
90 mm plates, with a 0.6 ml inoculum containing 
0.02 pfu/cell of wt VSV in PBS/2%CS. The virus was absorbed 
for 1 h at 31®C and 10 ml of DMEM/2%CS containing either 0, 
50, 100, or 2 00 ug/ml of the chemical mutagen 5-FU.
Infection was continued until cpe was observed in the cells 
infected in the absence of the mutagen. The supernatant was 
harvested and clarified by centrifugation as descibed above. 
The mutagenized virus preparation was aliquoted into bijoux 
and stored at -70°C.
3.(b).4 ISOLATION OF HOST RANGE MUTANTS
Confluent monolayers of the su+ cells in 90 mm 
plates, were infected with a 0 . 6  ml inoculum of 1 0  fold 
serial dilutions of the mutagenized virus in PBS/2%CS. The 
plates were incubated for 1 h at 31°C. The inoculum was 
removed and the plates washed twice with PBS/2%CS. 10 ml of 
agar overlay was then added. The plates were incubated for 
2 days at 31°C. The plates were overlayed again with 4 ml 
of neutral red overlay. The plates were then returned to 
31°C until plaques were clearly visible, usually 3-4 h 
later. Small plaques were picked and dispersed into vials 
containing 1.5 ml of Eagle's medium supplemented with 2 0%
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calf serum. The plaques were stored at -7 0°C.
3.(b).5 SCREENING PLAQUES
Confluent monolayers of su~ cells in Linbro wells 
were infected with 0.1 ml of the dispersed plaque 
preparation. The cells were incubated for 1 h at 31°C, the 
inoculum removed and the monolayers washed twice with 
PBS/2%CS. 1 ml of DMEM/2%CS was added and the infections 
continued at 31°C. The cell monolayers were examined twice 
daily for any sign of VSV infection, such as translucent 
areas on the cell sheet, rounding up of cells or cpe. This 
process was continued for 14 days after infection at which 
point any remaining monolayers were grossly overgrown.
Isolates which did not give rise to cpe in su~ cells 
after 14 days were used to infect monolayers of su+ cells in 
Linbro wells. Not all isolates then gave rise to cpe on su+ 
cells. This appeared to be caused by the occurrence of 
syncytia on the su+ cell monolayer. These syncytia do not 
stain as efficiently as normal cells and it was not always 
possible to distinguish them from small plaques.
3.(b).6 CLONAL PURIFICATION
In order to plaque purify the mutants isolated, the 
original isolate was plated by serial dilution to produce 
well isolated plaques on a monolayer of su+ cells in a 90 mm 
petri dish. 0.6 ml of the inoculum was plated on the su+ 
cells and the plates incubated at 31°C for 1 h. The 
inoculum was removed, 6 ml of agar overlay was added and the 
cells returned to 31°C for 2 days at 31°C. The plates were 
then overlayed again with 4 ml of agar overlay containing 
neutral red and returned to 31°C until plaques were visible. 
24 well isolated plaques were picked, dispersed into 1.5 ml 
of Eagle's/20%CS and stored at -70°C. Monolayers of su~ 
cells in Linbro wells were infected with 0.1 ml of the 
dispersed plaque preparation. The cells were incubated for 
1 h at 31°C after which the inoculum was removed and the 
monolayers washed twice with PBS. 1 ml of DMEM/2%CS was 
added and incubation continued at 31°C. The monolayers were 
inspected twice daily as before for any sign of viral
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infection. After 14 days none of the infections had given 
rise to cpe and in fact the monolayers were grossly 
overgrown indicating that each of the isolates had retained 
the host range phenotype of the original isolate. A single 
isolate was taken and used to infect monolayers of su+ cells 
in 90 mm petri dishes. 1 h post infection, the inoculum was 
removed and the monolayers washed twice with PBS. 10 ml of 
DMEM/2%CS was added and the infections returned to 31°C 
until advanced cpe was observed. The supernatant was 
decanted and clarified by centrifugation for 30 min at 
2,500 rpm in an MSE Ooolspin centrifuge. The virus was 
aliquoted and stored at -70°C. This virus was designated 
passage 1 and was used throughout.
3.(b).7 QUANTITATION OF HOST RANGE RESTRICTION
Passage 1 virus (see previous section) was used to 
quantify any restriction in host range between the su+ and 
su~ cell lines. Monolayers of both cell lines in Linbro 
wells were inoculated with 0.1 ml of a serial dilution of 
the virus preparation in PBS/2%CS. Absorption was carried 
out at 31°C for 1 h, the inoculum removed and the monolayers 
washed twice with PBS/2%CS and 1 ml of agar overlay added. 
The plates were incubated for 2 days at 31°C. The agar 
overlay was removed and the cells fixed with 10% Cidex in 
PBS for 2 h. Plaques were counted after staining with 
Giemsa for 3 0 min and the titre of the virus obtained for 
each cell line. Comparison of the titre attained by each 
isolate gave a measure of the restriction in host range.
3.(b ).8 ISOLATION OF REVERTANTS
Revertants of the host range mutants were isolated by 
plating 10 fold serial dilutions of the passage 1 stock of 
each mutant to produce isolated plaques on monolayers of su~ 
cells. 0.6 ml of virus in PBS/2%CS was added to confluent 
monolayers of su~ cells in 90 mm petri dishes. The virus 
was allowed to absorb for 1 h at 31°C. The inoculum was 
removed and the cell monolayer washed twice with PBS/2%CS 
and 6 ml of agar overlay added. The plates were incubated 
at 31°C for 2 days. 4 ml of agar overlay containing neutral
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red stain was added and the plates returned to 31°C for 
3-4 h. Well isolated plaques were picked and dispersed into 
glass vials containing 1.5 ml Eagle 1 s/20%CS.
3.(b )«9 SCREENING OF REVERTANTS
Confluent monolayers of su~ cells in Linbro wells 
were infected with 0.1 ml of the dispersed plaque 
preparation (see previous section) and incubated for 1 h at 
31°C. The inoculum was removed and the monolayers washed 
twice with PBS. 1 ml of DMEM/2%CS was added and the 
infected cells incubated at 31°C. When cpe was observed, 
usually within 4 8 h of infection, the supernatant medium was 
harvested, clarified by centrifugation at 1500 rpm for 
15 min. The supernatant was decanted and stored in bijoux 
at -70°C.
3.(b).10 PROTEIN SYNTHESIS IN ViRUS INFECTED CELLS
Monolayers of su+ and su~ cells were infected in 
Linbro wells with an inoculum consisting of 0.1 ml PBS/2%CS 
which also contained 10 ug/ml actinomycin-D and 10 pfu/cell 
virus (either wild-type, mutant or revertant virus). After 
1 h absorption at 31°C, the inoculum was removed and 
replaced with DMEM/2%CS containing 10 ug/ml actinomycin-D 
for either 7 h or 2 3 h at which point the medium was removed 
and 0.1 ml PBS containing 10 ug/ml actinomycin-D and 
100 uCi/ml 5§]-methionine was added to each well and
incubation continued at 31°C for 1 h.
After this period of incubation the supernatant 
medium was discarded and the monolayers washed once with 
cold PBS. 60 ul of protein dissociation mix (0.125 M 
Tris.HCl pH 6.8, 4% SDS, 10% mercaptoethanol, 20% glycerol, 
0.1% bromophenol blue) was added to each well. The cells 
were then scraped into the boiling mix with a piece of 
silicon tubing. The cells were then aspirated slowly by 
pasteur pipette into a 0.5 ml Eppendorf tube and heated at 
100°C for 2 min. The labelled cell extracts were either 
stored at -20°C or loaded directly on to a
SDS-polyacrylamide gel for fractionation. Labelled species 
were detected by autoradiography.
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3.(b).11 GROWTH OF RADIOLABELLED VIRUS
Confluent monolayers of su+ cells were infected in 
Linbro wells with a 0.1 ml inoculum containing 0.02 pfu/cell 
of either wild-type virus or one of the mutants. The cells 
were incubated for 1 h at 31°C after which the inoculum was 
removed and the monolayers washed twice with PBS. 1 ml of 
MEM/2%CS was added and the cells returned to 31°C for 6 h at 
which time the medium was decanted and replaced by EC/2%CS 
deficient in methionine containing 100 uCi/ml of 
[^^s]-methionine. 24 h post infection the supernatant was 
decanted and clarified by centrifugation for 30 min at 
2500 rpm in a MSE coolspin centrifuge. The labelled virus 
was pelleted through a 5 ml cushion consisting of 3 0% (v/v) 
glycerol, 20 mM Tris.HCl pH 8.0, 1 mM EDTA and lOOmM NaCl. 
Centrifugation was for 9 0 min at 21000 rpm and at 4°C using 
the Sorvall AH650 rotor in the Sorvall OTD-5 0 
ultracentrifuge. The pellet was resuspended in 200 ul of 
protein dissociation mix (0.125 M Tris.HCl pH 6.8, 4% SDS, 
10% mercaptoethanol, 20% glycerol, 0.1% bromophenol blue) 
and heated at 100°C for 2 min. The labelled proteins were 
analysed by polyacrylamide gel electrophoresis.
3.(b).12 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS
Vertical slab gels were cast in a sandwich consisting 
of two glass plates separated by 1.5 mm thick plastic 
spacers and sealed with Kapton tape. Single concentration 
gels were used throughout. The resolving gel contained 
acrylamide crosslinked with 1 part in 4 0 (w/w) 
N,N'-methylenebisacrylamide in 3 75 mM Tris pH 8.9, 0.4% SDS. 
The resolving gel was polymerised with the aid of 0.006% 
ammonium persulphate and 0.0 04% TEMED. In order to achieve 
a smooth interphase, a few ml of butan-2-ol was layered over 
the resolving gel.
Stacking gels were buffered with 122 mM Tris pH 6.7 
containing 0.4% SDS. They contained 5% acrylamide cross 
linked with N,N'-methylenebisacrylamide at the same ratio as 
was used in the resolving gel. The stacking gel was 
polymerized with ammonium persulphate and TEMED.
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After loading of samples the gels were 
electrophoresed at either 60 mA for 3-4 h at 4°C or 10 mA 
for 18 h at room temperature (RT) using a buffer containing 
52 mM Tris, 53 mM glycine and 0.1% SDS.
3.(b ).13 FLUOROGRAPHY
To increase the sensitivity of detection of
•35S]-methionine labelled proteins, gels were fixed in 45% 
methanol; 5% acetic acid for 4 5 mins, soaked and shaken in 
En^Hance for 60 mins and washed in water for 30 mins. The 
gels were then dried down under vacuum using a Bio-Rad gel 
drier, placed against Kodak X-Qmat-S film and stored at 
-7 0°C.
3.(b).14 COMPLEMENTATION ANALYSIS
Temperature sensitive mutants representing each of 
the five complementation groups were given by Professor C.R. 
Pringle, Department of Biological Sciences, University of 
Warwick, England. The ts mutants comprised ts 11 (group I), 
ts 22 (group II), ts_ 31 (group III), ts 41 (groupIV) and 
ts 04 5 (group V). The host range mutants comprised AmbLl, 
AmbL2, AmbL3, AmbL4, AmbL5, AmbG and hrTK“7.
Confluent monolayers of LMTK- cells in five 2 5 cm2
tissue culture flasks were infected with 0.2 ml of an
inoculum containing 5 pfu/cell of host range virus and
5 pfu/cell of ts virus in PBS/2%CS. Virus was allowed to
adsorb for 2 0 min at 4°C. The inoculum was removed and the
monolayer washed twice with PBS. 5 ml of prewarmed (39°C) 
DMEM/2%CS was added, the flasks were then sealed with Lasso 
tape and submerged in a Grant waterbath for 8 h at the 
non-permissive temperature (39°C). The supernatant was 
decanted into bijoux and stored at -7 0°C.
The supernatant was subsequently analysed for growth 
of the ts mutants by titrating the virus on su~ cells at the 
permissive temperature (31°C).
For singly infected controls, monolayers of su~ cells 
were infected with 0.2 ml of an inoculum containing
5 pfu/cell of either host range virus or ts^  virus in
PBS/2%CS. The protocol used for analysis of single
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infections was identical to that employed for mixed 
infections. Single and mixed infections were carried out in 
parallel using the same virus preparations and the same 
waterbath.
3.(b ).15 IMMUNOPRECIPITATION
Monospecific antisera raised in rabbits against the 
amino (N) and carboxy (C) termini of the VSV (Indiana) L 
protein were a gift from Dr. Manfred Schubert (Institute of 
Communicative Disorders and Stroke, National Institutes of 
Health, Bethesda, USA), and were desribed in Schubert et a l . 
(1985) .
Monolayers of su+ cells in Linbro wells were infected 
with 0.1 ml of an inoculum containing 10 pfu/cell of a group 
I mutant in PBS/2%CS. Virus was absorbed for 1 h at 31°C, 
the inoculum removed and the cells washed twice with PBS.
1 ml of DMEM/2%CS containing 10 ug/ml of actinomycin-D was 
added and incubation continued for 24 h at 31°C.
The supernatant was decanted and 0.1 ml of PBS/2%CS 
containing 250 uCi/ml of [ ^ ^S]-methionine and 10 ug/ml of 
actinomycin-D added. The cells were incubated for 1 h at 
31°C after which the supernatant was removed. The 
monolayers were washed twice with PBS/2%CS and then scraped 
into 1 ml of PBS/2%CS and transferred to a 1.5 ml Eppendorf 
tube. The cells were pelleted by a 1 min spin in an MSE 
microfuge. The pellet was resuspended in 100 ul of cell 
lysis buffer (015 M NaCl, 1% Na deoxycholate, 1% triton 
x-100, 0.1% SDS, 0.01 M tris.HCl pH 7.4 and 1 mM PMSF) and 
incubated on ice for 30 min. After brief vortexing, the 
nuclei and debris were pelleted with a 5 min spin.
A 50 ul aliquot was taken and 5 ul of either N or 
C-terminal specific antibody added. After incubation on ice 
for 3 h, 6 0 ul of protein-A-Sepharose beads was added. 
Incubation proceeded for 3 0 min and the immunecomplex 
pelleted by a 20 sec spin in an MSE microfuge. The pellet 
was washed three times in 200 ul 500 mM LiCl, 100 mM 
Tris.HCl pH 8.5 and dissolved in 50 ul protein dissociation 
mix. The samples were heated at 100°C for 2 min and stored 
at -20°C. Prior to loading on a polyacrylamide gel the
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samples were again heated at 100°C for 2 min, and 25 ul 
analysed on a 7.5% polyacrylamide gel.
3.(b ).16 IMMUNOBLOTTING
The immunoblotting technique was based on the method 
by Towbin et a l . (19 79), with several modifications.
[35g]-methionine labelled polypeptide extracts from su+ 
cells infected by wt virus or one of the five group I 
mutants were fractionated by gel electrophoresis on a 7.5% 
SDS-polyacrylamide gel. The separated proteins were 
transferred from the gel to a sheet of nitrocellulose using 
a BioRad 'transblot' apparatus. The gel was placed on a 
sheet of Whatman grade 182 filter paper on top of a foam 
pad- both presoaked in transfer buffer (2 5mM Tris HCl 
pH 8.3, 19 2mM glycine, 2 0% methanol). The sheets of 
nitrocellulose, also pre-soaked, were placed face down on 
the gel. A further sheet of pre-soaked filter paper and 
then another foam pad were placed over the gel and the 
sandwich was placed in the electrophoresis tank in a plastic 
holder. Proteins were transferred to the nitrocellulose 
sheets by electrophoresis in transfer buffer at 2 50 mA for 
3 h at RT.
Following transfer, the nitrocellulose sheets were
incubated overnight at 65°C in wash buffer (1 mM Tris.HCl
pH 7.4, 15.4 mM NaCl, 0.01% sodium azide) containing 0.05% 
Tween 20. The sheets were then immersed in approximately 
100 ml of appropriately diluted antiserum in plastic tubs. 
This was incubated for 2 h at 3 7°C. The sheets were then 
washed thoroughly in wash buffer containing 0.0 5% Tween 2 0 
by gently shaking at 3 7°C, with at least three changes of 
buffer over 2 h. To detect bound antibody, the sheets were 
covered with a solution of wash buffer containing 3% BSA and 
5x10^ cpm of iodinated protein A. This was gently shaken at 
37°C for 2 h, and the sheets removed and washed twice for 
1 h in wash buffer containing 1 M potassium iodide, followed 
by a 15 min wash in PBS. The sheets were placed on tissues 
to dry and taped to card prior to autoradiography.
To determine with which of the [35g]-methionine
labelled proteins the iodinated protein A had interacted,
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the sheets were exposed to three superimposed sheets of film 
with a sheet of black paper between the first and second 
sheets and with an image intensifying screen directly on top 
of all three films (Haarr et a l ., 1985). The first film 
detects the [35g]-methionine label with the black sheet 
preventing further penetration of this isotope. The high 
energy emission from the 125j passes through all the films 
with little absorption and interacts with the image 
intensifying screen producing photons which are detected 
only on the second and third films. -^C and 12 5j 
radioactive ink was spotted onto the card to allow the three 
films to be aligned.
3.(b).17 EXTRACTION OF TOTAL CELLULAR RNA
Confluent monolayers of su+ cells were infected at 
10 pfu/cell with mutant and wt virus as described previously 
for viral protein analysis. At '8 h post infection the cells 
were trypsinized and centrifuged at 1500 rpm for 15 min at 
4°C. The cell pellet was resuspended in cold PBS and 
pelleted at 1500 rpm for 15 min at 4°C. The cell pellet was 
lysed in 5 volumes of 6 M guanidinium isothiocyanate, 5 mM 
Na-citrate pH 7.0, 100 mM /?-mercaptoethanol, 0.5% sarcosyl. 
To each 2.5 ml of cell lysate, 1 g caesium chloride was 
added and dissolved by vortexing. The mixture was layered 
onto a 1.2 ml cushion of 5.7 M caesium chloride in 100 mM 
EDTA and centrifuged at 3 5000 rpm for 12 h at 2 0°C in an 
AH650 rotor. The supernatant was decanted and the RNA 
pellet resuspended in 10 mM Tris HCl pH 7.4, 5 mM EDTA, 1% 
v/v SDS and extracted once with an equal volume of a 4:1 
mixture of chloroform and 1-butanol. The organic phase was 
reextracted once more with an equal volume of the 
Tris/EDTA/SDS buffer. The aqueous phases were combined and 
the RNA precipitated in the presence of 0.3 M Na acetate and 
2.5 volumes of ethanol. After centrifugation at 12000 rpm 
for 10 min the RNA was resuspended in water and 
reprecipitated with ethanol. The RNA was stored at -70°C.
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3 .(b).18 IN VITRO TRANSLATION OF INFECTED CELL RNA
RNA prepared as described above was used to programme 
the following in vitro translation system (New England 
Nuclear). The reaction comprised: 2-4 ul RNA, 2.5 ul 
t35S] -methionine, 5 ul rabbit reticulocyte lysate, 2.75 ul 
in vitro translation cocktail (containing spermidine, 
creatine phosphate, dithiothreitol and GTP in concentrations 
optimized by the manufacturers), 1 ul 1 M potassium acetate, 
0.25 ul 50 mM magnesium acetate. The reactions were 
incubated for 1 h at 3 7°C and terminated by the addition of 
15 ul protein dissociation mix (0.125 M Tris-HCl pH 6.8, 4% 
SDS, 10% mercaptoethanol, 20% glycerol, 0.1% bromophenol 
blue). Samples were heated at 100°C for 2 min and stored at 
-20°C. Prior to loading onto the gel, samples were heated 
at 100°C for 5 min. The proteins were fractionated on a 
7.5% SDS-polyacrylamide gel, and the labelled species 
detected by autoradiography.
3.(b).19 ANALYSIS OF VIRAL PROTEIN SYNTHESIS IN THE 
PRESENCE OF G418 
Monolayers of su~ cells in Linbro wells were infected 
with 0.1 ml of PBS/2%CS containing 10 pfu/cell of virus,
10 ug/ml of actinomycin-D and 0, 50, 100 or 2 00 ug/ml of 
G418. The cells were incubated for 1 h at 3 1°C to allow 
virus to absorb. The inoculum was removed and the 
monolayers washed twice with PBS. DMEM/2%CS containing 
10 ug/ml of actinomycin-D and the same concentration of G418 
as the inoculum was then added and incubation continued for 
7 h at 31°C. 0.1 ml of PBS containing 100 uCi/ml of
[35g]-methionine, 10 ug/ml of actinomycin-D and the 
appropriate concentration of G418 was then added and the 
cells incubated for a further hour at 31°C. The label was 
removed and the monolayers washed twice with PBS. 5 0 ul of 
protein dissociation mix was added and the samples heated at 
100°C for 2 min. The proteins were fractionated on a 7.5% 
SDS-polyacrylamide gel, and the labelled species detected by 
autoradiography.
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3 .(b).20 INVESTIGATION OF VIRAL GROWTH IN THE PRESENCE 
OF G418
Monolayers of su~ cells were grown in Linbro wells 
and infected with 0.1 ml of PBS/2%CS containing 
0.02 pfu/cell of virus and 0 f 50, 100 or 200 ug/ml of G418. 
Virus was allowed to absorb for 1 h at 31°C. The inoculum 
was removed and DMEM/2%CS added which contained the same 
concentration of G418 as did the inoculum. The cells were 
incubated for 8 h at 31°C. The supernatant was removed and 
titrated in the usual way on the su+ cells.
RESULTS
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CHAPTER 4 RESULTS
4.(a) ISOLATION OF MUTANTS
4.(a).l VIRUS PURIFICATION
The wild-type strain of vesicular stomatitis virus 
(Indiana serotype) used was the attenuated derivative 
Indiana C (provided by C.R. Pringle). Virus was purified by 
infecting BHK (C-13) cells at a moi of 0.02 pfu/cell. When 
cpe was observed approximately 48 h later the supernatant 
was harvested and virus purified in a 14-45% sucrose 
gradient. The presence of a single band after 
centrifugation, as opposed to two separate bands, indicated 
an absence of defective interfering particles in the virus 
preparation.
The purified virus was then titrated on LMTK“ (su“ ) 
cells and a titre of l.lxlO10 pfu/ml obtained.
4 . (a).2 5-FLUOROURACIL MUTAGENESIS
Confluent monolayers of the suppressor carrying cell 
line (L39; su+ ) were infected by wt virus at a moi of 0.02 
pfu/cell in the presence of the chemical mutagen 
5-fluorouracil (5-FU). Virus was grown in the presence of 
0, 50, 100 and 200 ug/ml of 5-FU. The virus was harvested 
when cpe was observed (about 48 h later) in cells infected 
in the absence of 5-FU. The virus from each infection was 
then titrated on the su+ cells (Table 1). It was found that 
concentrations of 50 and 100 ug/ml of 5-FU reduced the titre 
three fold and five fold, while 2 00 ug/ml reduced it thirty 
fold. Virus treated with 100 ug/ml of 5-FU offered the best 
compromise between maximum mutagenesis and viability of the 
virus.
4. (a).3 ISOLATION OF MUTANTS
Mutagenized virus stocks were plated on su+ cells to 
give 50-60 plaques per 90 mm plate. These plaques were 
visualized 3 days post infection by neutral red staining. 
Plaques were then picked to screen for a mutation affecting 
host range. After mutagenesis the majority of plaques 
produced were 3-6 mm in diameter. In addition to these
Table 1
The effect of various concentrations of the mutagen 
5-FU on the titre of a wild-type stock of VSV.
Concentration of 5-FU (ug/ml) Titre (pfu/ml)
zero l . l x l o l O
50 3.4 x 109
100 2.2 x 109
200 4.0 x 108
Confluent monolayers of su+ cells were infected with 
wt virus in the presence of different concentrations of 
5-FU. Mutagenized virus was harvested when cpe was observed 
in the control plate (no mutagen) and then titrated on the 
su+ cells.
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plaques there was a small number of plaques (about 10% of 
all plaques) which were approximately 1 mm in diameter. To 
increase the possibility of picking up an amber mutant, only 
the small plaques were picked for screening. This selection 
strategy presumes that virus containing an amber mutant will 
not grow as well as wt in a weak suppressor system (about 4% 
suppression in the su+ cells; Young et a l ., 19 83). From a 
single 90 mm plate only 6-10 plaques were picked. In total 
2614 plaques were picked. Isolates were screened for a 
mutation affecting host range by infecting monolayers of su~ 
cells in Linbro wells and scoring the infections for the 
presence or absence of cpe. The majority of plaques which 
gave rise to cpe did so within 48 h. The remaining 
monolayers were examined twice daily until 7 days post 
infection for any evidence of virus growth. In the case of 
plaques which did not give rise to cpe after 7 days the 
monolayers were substantially overgrown, indicating that 
there was no virus growth. 8 2 plaques did not give rise to 
cpe on su“ cells. These isolates were then used to infect 
su+ cells to determine if there was any viable virus.
Growth of the su+ cells on plates resulted in the formation 
of syncytia. However these syncytia did not stain as 
efficiently as normal cells and it was not always possible 
to distinguish them from small plaques. Thirty isolates 
gave rise to productive infections after infection of the 
su+ cells, and the supernatant from each was then titrated 
on both the su+ and su~ cells to quantify any difference in 
host range. Of these, 13 revealed a difference in titre 
between the two cell lines of at least 2 0 fold (Table 2, and 
Figure 5). These isolates were thus considered to represent 
conditional lethal nonsense mutants. Subsequent analysis 
revealed that the mutations affect a specific gene product 
in 6 of the isolates and these were therefore named 
accordingly. The remainder of the mutants which could not 
be characterized were classified simply as host range 
mutants (hrTK“x, where x represents the number of the 
mutant).
The isolates which exhibited the most marked 
restriction were AmbL3 and AmbL4 which differed in titre 
between the su+ and su_ cells by a factor of 7.3x10^ and
Table 2
Plating efficiencies of the putative host range 
mutants on the su+ and su~ cells respectively.
Titre Titre
Mutant L39
Ind/AmbLl/84 1.0
Ind/AmbL2/85 1.7
Ind/AmbL3/85 2.2
Ind/AmbL4/85 3.0
Ind/AmbL5/85 3.0
In d/AmbG/85 1.0
hrTK“7 1.9
hrTK“8 2.0
hrTK“9 1.4
hrTK~10 5.4
hrTK~ll 7.0
hrTk“12 1.0
hrTK“13 1.0
(su+) LMTK- (su“ )
X 107 2.5 X 104
X 107 3.0 X 103
X 107 3.0 X 102
X 106 2.0 X 102
X 105 8.9 X
I—
1o 
1—
1
X 107 3.0 X 105
X 105 2.0 X 102
X 107 3.2 X 105
X
r-"or—1 4.0 X 105
X 105 2.4 X 104
X 107 4.0 X
VOor—(
X 106 2.4 X 103
X 104 5.0 X
1—
1 orH
Titres in pfu/ml of a passage 1 stock of each host 
range VSV mutant were measured on monolayers of su+ and su~ 
cells. Subsequent analysis has revealed that the mutations 
affect a specific gene product in six of the isolates and 
these were therefore named accordingly. The remainder of 
the mutants which could not be characterized were classified 
simply as host range mutants.
Figure 5
An example of the restricted host range exhibited by 
the group I mutant AmbL4.
Monolayers of su+ and su~ cells in Linbro wells were 
infected with a passage 1 stock of AmbL4 virus. The 
monolayers were fixed three days post infection and stained 
with Giemsa. In 5a plates 1 to 6 show 10 fold serial 
dilutions (10”3- to 10“®) of the virus stock on su+ cells.
In 5b plates 1 to 6 show the same dilutions plated on su~ 
cells.
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1.5x10^ respectively. The isolates AmbL2, AmbL5 and hrTK“7 
showed a 5.7x10^, 3.4x10^ and 1x10^ fold difference in 
titre. AmbLl and hrTK“13 exhibited a 400 and 200 fold 
difference in titre while the isolate AmbG exhibited a 30 
fold difference in titre between the two cell lines. The 
remaining isolates hrTK-8 to hrTK~12 gave rise to a 
difference ranging from 20 fold (hrTK”ll) to 60 fold 
(hrTK“8).
4.(a).4 CLONAL PURIFICATION OF THE MUTANTS
The stock used in the characterization of the mutant 
AmbLl was obtained by plating the original plaque to give 
well isolated plaques on a 90 mm plate. 24 well isolated 
plaques were picked. Each plaque was then checked for 
retention of its host range phenotype by infecting su~ cells 
in Linbro wells and scoring each infection for the presence 
or absence of cpe. None of the plaques gave rise to cpe 
after 7 days and in fact the cells in each Linbro well were 
substantially overgrown after this period. This indicated 
that all the plaques picked represented virus which had 
retained its host range restriction. A single plaque was 
used to infect monolayers of su+ cells. A single plaque 
from these plates was then taken and used to infect 9 0 mm 
plates of su+ cells. The supernatant was harvested when 
advanced cpe was observed in each of the plates. The virus 
was aliquoted and stored at -70°C. This passage (designated 
passage 1) was used throughout. This precaution was taken 
to ensure homogeneity of the virus preparation and to keep 
the level of revertants in a mutant stock to a minimum. The 
small plaque morphology exhibited by AmbLl (passage 1 stock) 
on the su+ cells, in comparison to the normal plaque
morphology of its revertants on the su~ cells, is shown in
Figure 6.
The identical procedure was performed for
purification of each of the twelve remaining isolates. In
each case the orginal isolate was used to plaque purify the 
mutant on su+ cells. The virus was plated to produce well 
isolated plaques on a 90 mm plate of the su+ cells. The 
resulting plaques all retained their small plaque morphology 
and 24 well isolated plaques were picked. Each plaque was
Figure 6
An example of the different plaque morphologies of 
tiie group I mutant AmbLl and its revertants.
Monolayers of su+ and su~ cells infected with serial 
dilutions of the same stock of the group I mutant AmbLl, 
fixed three days post infection and stained with Giemsa. 
Plates l r 2 and 3 show the small plaques produced by AmbLl 
on the su+ cells at the 10“^, 10“  ^ and 10”  ^ dilutions 
respectively. Plates 4 and 5 show the normal plaque 
morphology of revertants of AmbLl at the 10“^ and 10“  ^
dilutions respectively on su~cells.
*Oi
72
then screened on su~ cells in Linbro wells to check that all 
plaques represented mutant and not wt virus. For each 
mutant a single plaque was used to infect monolayers of su+ 
cells. The virus was harvested and aliquoted into ampoules 
and stored at -70°C. Only passage 1 virus was used 
throughout.
4.(b ) CHARACTERIZATION OF THE MUTANTS
4.(b ).1 VIRAL PROTEIN SYNTHESIS IN SU+ AND SU~ INFECTED 
CELLS
The object of this experiment was to examine viral 
protein synthesis in suppressor and non-suppressor cells 
infected with the host range mutants isolated, and to 
determine whether the mutation which caused the restriction 
in host range resulted in the generation of a novel 
polypeptide species representing a fragment of the complete 
polypeptide, produced by premature termination of 
translation at an amber codon.
Previously, in a study of amber head protein mutants 
of the rll collection of phage T4 mutants, Benzer and Champe 
(1961) showed that in su+ strains both the fragment and a 
completed polypeptide were detectable whereas only the 
fragment itself was detectable in su~ strains. This has 
also proved to be the case in a eukaryotic suppressor 
system. Young et al. (1983) studied the effect of 
suppression on a strain of influenza virus (A/CAM/46) which 
contained a characterized amber nonsense mutation within its 
NS1 gene. Although this resulted in a shorter than usual 
NS1 protein, it was stable and functional. Sequence 
analysis revealed an in-frame opal stop codon twenty amino 
acids downstream from the amber termination codon. 
Readthrough of the amber termination codon would therefore 
result in an NS1 protein equivalent in length to other 
influenza field isolates (see Parvin et al., 1983 for a 
description of A/CAM/46 and other influenza nonsense 
mutants). Using virus stocks of SV40 recombinants 
containing active amber su+tRNA^yr genes introduced into 
COS-1 cells, Laski et al., (1982b) showed that both the
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suppressed and non-suppressed forms of the NS1 protein were 
synthesized after superinfection with A/CAM/46. The 
suppressed form of the NS1 protein could be detected in 
significant amounts after polyacrylamide gel electrophoresis 
and the level of suppression was calculated by estimating 
the quantity of readthrough product. Significantly, they 
also examined suppression of the amber termination codon 
with the suppressor cells employed in this study (L39; su+ ) . 
This resulted in a relatively weak suppression of the amber 
codon, estimated at about 4% compared to 2 2.5% with the SV4 0 
system.
Synthesis of viral proteins by wt and the 13 mutants 
isolated was investigated by infecting su+ and su~ cells in 
the presence of Actinomycin D, labelling with 
[^5g]-methionine, then gel electrophoresing the extracted 
proteins and detecting labelled proteins by autoradiography.
4.(b).1.1 IN VIVO PROTEIN SYNTHESIS BY WILD-TYPE VIRUS
When su+ and su~ cells were infected by wt virus and 
the proteins analysed by the above procedure, the 
characteristic VSV protein profile was observed - host cell 
protein synthesis was reduced compared with mock infected 
cells, and labelled bands corresponding to the five VSV 
polypeptides L, G, NS, N and M were easily identified (refer 
to Figure 19).
4.(b ).1.2 IN VIVO PROTEIN SYNTHESIS BY IND/AMBLl/84
Viral protein synthesis by the mutant AmbLl in su+ 
and su~ cells was studied (Figure 7a). A comparison of the 
[^ ]-methionine labelled proteins synthesized in su+ cells 
by wt and AmbLl showed no detectable differences in the 
electrophoretic mobilities of the G, NS, N and M 
intracellular proteins. The L protein however, was not 
present in the mutant infected extract until late in 
infection (24 h post-infection). In addition, there was a 
novel viral specific polypeptide which migrated between the 
nucleocapsid protein (N) and the matrix protein (M). Since 
the mutant did not synthesize any full length L protein to a 
significant level up to 24 h post-infection, it was proposed
Figure 7
Comparison of the polypeptides synthesized in su'*' and 
su~ cells by wild-type and AmbLl virus.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 5 to 6 h post infection, 7 to 8 h post 
infection or 23 to 24 h post infection. Cells were 
harvested and the polypeptides analysed on a 7.5% 
polyacrylamide gel.
(a) su+ cells
The polypeptides synthesized in [33S ]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1), wt infected cells at 6, 8 and 24 h post infection 
(tracks 2, 3 and 4 respectively) and AmbLl infected cells at 
6, 8 and 24 h post infection (tracks 5, 6 and 7 
respectively). The L protein fragment is indicated by a 
closed arrowhead and named after the mutant, in this case 
ambLl. Full-length L protein is indicated by an open 
arrowhead.
(b) su~ cells
The polypeptides synthesized in [3 5S ]-methionine
labelled su~ cells are shown for mock infected cells (tracks
8h pi
1 and 3 ) , wt infected cells*(track 2) and AmbLl infected 
cells at 8 and 24 h post infection (tracks 4 and 5 
respectively). The bands are named and marked in the same 
way as above.
I II I
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that this new viral polypeptide is a truncated form of the L 
protein, produced by premature termination at an amber 
codon. The nucleocapsid gene encodes a polypeptide of 4 22 
amino acids with a M r of 47355 (Gallione et a l ., 1981) 
while the M protein encodes a polypeptide of 2 29 amino acids 
with a M r of 26064 (Rose and Gallione, 1981). The truncated 
form of the L protein migrated slightly closer to the N 
protein than it did to the M, consequently its M r could be 
estimated at approximately 3 7000 by comparing the observed 
mobility of the putative truncated L protein on 
polyacrylamide gels with the mobility and known M r of the N 
and M proteins.
The L (polymerase) protein is the least abundant 
protein in wild-type infected cells. However it was evident 
that the proposed shortened form of the L polypeptide was 
more abundant in su+ infected cells, than L protein present 
in wt infected cells. This apparent increase in the 
abundance of some parts of L protein may be the result of partial 
termination of transcription along the L RNA, resulting in 
an abundance of short L message over full length L message. 
Alternatively, translational attenuation could explain this 
result.
In contrast to infection of the su+ cells by this 
mutant, viral protein synthesis in su~ cells was found to be 
less prominent and 'switch-off1 of host-cell proteins was 
less marked (Figure 7b). This suggested that viral protein 
synthesis was itself much reduced. Negligible amounts of 
viral proteins were synthesized at the 8 h time point and 
only after 24 h were they clearly in evidence. The G, N, 
and M proteins were visible although no full length L 
protein could be identified. It was possible to identify 
the proposed shortened version of L after 2 4 h, although 
repeated analysis did not always reveal this polypeptide. 
Subsequent analysis has revealed that different preparations 
of the mutant contain differing proportions of revertants.
This was not unexpected since the proportion of revertants 
in a preparation is dependent upon the time during infection 
at.which the initial reversion event occurs. Mutant stocks 
containing higher numbers of revertants were associated with
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the detection of the novel polypeptide species after 
infection of the su~ cells. A possible interpretation of 
this result is that a high proportion of revertants present 
in the original inoculum could complement the mutant, late 
in infection, in cells multiply infected with mutant and 
revertant virus.
4.(b ).1.3 IN VIVO PROTEIN SYNTHESIS BY IND/AMBL2/85
Comparison of the polypeptides synthesized in su+ 
cells by wt and AmbL2 virus showed that although the G, NS,
N and M proteins were present, there appeared to be no L 
protein produced (Figure 8a). Also, the G, NS, N and M 
proteins synthesized by the mutant did not exhibit any 
anomalous electrophoretic mobility. A novel viral specific 
polypeptide could be identified which migrated between the 
full length L protein and the glycoprotein G. This 
polypeptide was thought to represent a truncated form of the 
L protein. The L protein has a M r of 2 41012 consisting of 
2109 amino acids (Schubert et a l ., 1984) while the G protein 
has a M r of 75416 encoded by 511 amino acids (Rose and 
Gallione, 1981). Thus, the M r of the putative truncated L 
polypeptide could be estimated at approximately 150000 by 
using the standard viral proteins as markers. On comparison 
of the observed abundance of the truncated L protein in su+ 
cells with the level of full length L protein in wt infected 
cells, it was evident that the shortened L i s  present 
intracellularly in significantly higher quantities.
The proteins synthesized by AmbL2 and wt virus in su~ 
cells are compared in Figure 8b. It can be seen that little 
or no viral proteins were synthesized in mutant infected 
cells in comparison to the wt result.
4.(b ).1.4 IN VIVO PROTEIN SYNTHESIS BY IND/AMBL3/85
Analysis of the polypeptides synthesized by AmbL3 in 
su+ cells (Figures 9a, b) showed that this mutant behaved in 
a similar fashion to the two host range mutants described 
previously; namely, the G, NS, N and M proteins migrated 
normally, no full length L protein could be detected and a 
novel polypeptide species was evident. However, in this
Figure 8
Comparison of the polypeptides synthesized in su+ and 
su~ cells by wild-type and AmbL2 virus.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h post infection in the case of mock 
and wt infected cells or 7 to 8 h and 2 3 to 2 4 h post 
infection in the case of AmbL2 infected cells. Cells were 
harvested and the polypeptides analysed on a 7.5% 
polyacrylamide gel.
(a) su+ cells
The polypeptides synthesized in [-^ ]-methionine
labelled su+ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL2 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively). The L protein fragment (ambL2) is marked by 
a closed arrowhead. Full-length L protein is indicated by 
an open arrowhead.
(b) su~ cells
The polypeptides synthesized in [35g]-methionine 
labelled su~ cells are shown for mock infected cells 
(track 1), wt infected cells (track 4) and AmbL2 infected 
cells at 8 and 24 h post infection (tracks 2 and 3 
respectively) . The bands are named and marked in the same 
way as above.
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Figure 9
Comparison of the polypeptides synthesized in su+ and 
su~ cells by wild-type and AmbL3 virus.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h in the case of mock and wt infected 
cells or from 7 to 8 h and 23 to 24 h post infection in the 
case of AmbL3 infected cells. Cells were harvested and the 
polypeptides analysed on a 7.5% polyacrylamide gel (a) and
(c) or a 4.5% polyacrylamide gel (b).
(a) su+ cells
The polypeptides synthesized in [ 3 ] -methionine 
labelled su+ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL3 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively). The L protein fragment (ambL3) is indicated 
by a closed arrowhead. Full-length L protein is indicated 
by an open arrowhead.
(b) su+ cells
The polypeptides synthesized in [35g]-m e thionine 
labelled su+ cells are shown for wt infected cells at 8 h 
post infection (track 1) and AmbL3 infected cells at 8 h 
post infection (track 2). The bands are named and marked in 
the same way as above.
(c) su~ cells
The polypeptides synthesized in [35g]-methionine 
labelled su~ cells are shown for mock infected cells 
(track 1), wt infected cells (track 4) and AmbL3 infected 
cells at 8 and 24 h post infection (tracks 2 and 3 
respectively) The bands are named and marked in the same 
way as above.
I '
(a) 
suppressor 
cells 
(b) 
suppressor 
cells 
non 
suppressor 
cells
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case, the putative truncated L protein migrated only 
slightly faster than the authentic wt L protein. Thus, if 
this faster migrating L polypeptide is a result of premature 
termination of translation then the mutation must reside 
close to the downstream end of the message. In contrast to 
the mutants AmbLl and AmbL2, the L protein fragment is 
present intracellularly at a level comparable to wild-type.
In Figure 9c, the proteins synthesized by AmbL3 and 
wt virus in su~ cells are compared. Although AmbL3 
synthesized viral protein in readily detectable amounts at 
8 h post infection in the su+ cells, there was little 
evidence of viral protein synthesis at this time point in 
the su~ cells. There was however, evidence of viral protein 
synthesis after 24 h. The G, N and M proteins were 
detectable as well as small quantities of the additional 
polypeptide species. This may have resulted from revertants 
in the original inoculum reaching a significant level and 
complementing the mutant in multiply infected cells late in 
infection.
4.(b ).1.5 IN VIVO PROTEIN SYNTHESIS BY IND/AMBL4/85
The [35g]_m e thionine labelled proteins synthesized by 
this mutant in su+ cells were studied. In Figure 10a the 
proteins synthesized in wt, AmbL4 and mock infected cells 
are compared. Each of the five viral proteins could be 
identified both at 8 h and at 24 h post infection. The L 
protein synthesized by AmbL4 migrated slightly faster than 
the full length protein and thus probably represents a 
truncated form of the L protein. The M r of the faster 
migrating L protein could be estimated to be about 227000 
using the standard viral proteins as markers. In addition, 
it appears that the proposed truncated version of the L 
protein may be more abundant than the full length protein, 
and in this respect, the mutant behaves similarly to AmbLl 
and AmbL2.
Examination of the proteins synthesized fcy AmbL4 in 
su~ cells is shown in Figure 10b. Inhibition of host cell 
protein synthesis, a characteristic of wt infection, was 
markedly reduced in su“ cells infected by the mutant. As a
Figure 10
Comparison of the polypeptides synthesized in su+ and 
su~ cells by wild-type and AmbL4 virus.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h in the case of mock and wt infected 
cells or 7 to 8 h and 2 3 to 24 h in the case of AmbL4 
infected cells. Cells were harvested and the polypeptides 
analysed on a 7.5% polyacrylamide gel.
(a) su+ cells
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL4 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively). The L protein fragments are indicated by a 
closed arrowhead and named after the mutant (ambL4). 
Full-length L protein is indicated by an open arrowhead.
(b) su~ cells
The polypeptides synthesized in [35g]_m e thionine 
labelled su~ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL4 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively) . The bands are marked and named in the same 
way as above. (■)signifies a host band which is present in 
AmbL4 infected cells at 8 h but not at 2 4 h post infection.
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result, the full extent of viral protein synthesis was 
somewhat obscured. However, some viral proteins were 
present, albeit at a reduced level. The M protein was 
detectable both at 8 h and 24 h post infection and probably 
the NS protein also. The truncated L protein could be 
identified at 24 h post infection although there was a high 
background of host proteins. One of these host proteins was 
absent at the 24 h time point, suggesting increased growth 
of the virus (Figure 10b). It is unclear whether this 
represented growth of mutant and/or revertant virus.
4.(b ).1.6 IN VIVO PROTEIN SYNTHESIS BY IND/AMBL5/85
A comparison of the [35S ]-methionine labelled 
proteins synthesized in mock, wt and AmbL5 infected cells is 
shown in figure 11a. After infection of su+ cells with 
AmbL5, the G, NS, N and M proteins were not observed to 
exhibit any anomalous migratory'properties. However, the 
mutant did not appear to synthesize any L protein. No full 
length L protein was detectable, nor was any detectable 
truncated form. Since inhibition of cellular protein 
synthesis by this mutant was incomplete, it is possible that 
a truncated version may co-migrate with a host protein, or 
even another viral protein.
Analysis of the proteins synthesized by this mutant 
after infection of su~ cells is shown in Figure lib. There 
was no apparent inhibition of host cell protein synthesis.
As a result viral specific proteins could not be identified 
easily. This observation in itself suggested that growth of 
the mutant in these cells was severely restricted. However 
the M and possibly NS proteins were detectable, particularly 
at the 24 h time point. Not unexpectedly, there was no 
evidence of either full length or truncated L protein. In 
accord with the result obtained with the mutant AmbL4 
(Figure 10b), one of the host proteins was absent at 24 h 
(Figure lib).
Figure 11
Comparison of the polypeptides synthesized in su+ and 
su~ cells by wild-type and AmbL5 virus.
Su+ and su" cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h post infection in the case of mock 
and wt infected cells or 7 to 8 and 2 3 to 2 4 h post 
infection in the case of AmbL5. Cells were harvested, 
extracts prepared and the polypeptides analysed on a 7.5% 
polyacrylamide gel.
(a) su+ cells
The polypeptides synthesized in [3 ]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL5 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively). Full length L protein is indicated by an 
open arrowhead.
(b) su~ cells
The polypeptides synthesized in [3 ]-methionine 
labelled su~ cells are shown for mock infected cells 
(track 1), wt infected cells (track 2) and AmbL5 infected 
cells at 8 and 24 h post infection (tracks 3 and 4 
respectively). Full length L protein is indicated by an 
open arrowhead, (-)signifies a host band present in AmbL5 
infected cells at 8 h but not at 24 h post-infection.
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4.(b).1.7 IN VIVO PROTEIN SYNTHESIS BY THE MUTANT 
IND/AMBG/85
The [^5s]-methionine labelled proteins synthesized by
this mutant as well as wt virus in su+ cells is shown in
Figure 12a. All five viral proteins were present, both at
8 h and 2 4 h post infection. The glycoprotein produced by
AmbG migrated slightly faster than wt G protein. The M r of
the mutant glycoprotein could be estimated at about 74500
from its mobility relative to the known M r of full length G
protein (75416; Rose and Gallione, 1981). The G protein
synthesized by AmbG may therefore represent the product of
premature termination, at an amber stop codon, close to the
downstream end of the G message. On comparing the
mobilities of the putative truncated G protein and
full-length G protein, it was calculated that approximately
10 amino acids were absent from the C-terminus of the AmbG
glycoprotein. If the change in mobility does indeed result
from an amber mutation, then the mutation probably resides
within the 29 amino acid cytoplasmic domain of G.
Examination of the amino acid sequence which encodes the
cytoplasmic domain of the G protein revealed four codons
which, by a single base change, could be mutated to an amber
stop codon. These codons lie, with respect to the
C-terminus of the G protein gene, at codon positions 11, 13, 
#  see diagram opposite . .
16 and 19. a Three involve transition mutations (13, 16 and
19) and one a transversion mutation (11). Interestingly, 
the base change at position 11 would result in the 
alteration of a tyrosine specifying codon to an amber codon. 
Suppression of an amber mutation at this position by this 
particular suppressor (tRNATY r ) would be expected to result 
in the production of an active gene product.
At 2 4h post infection two forms of the G protein were 
detectable, one of which probably represented full length G 
protein (synthesized by revertants), the other, the 
truncated form of G protein (synthesized by AmbG).
Viral protein synthesis in su~ cells infected either 
with mock, AmbG or wt virus is shown in Figure 12c. At 8 h 
there was little evidence of viral protein synthesis in 
mutant infected cells. However, after 24 h significant
Figure 12
Comparison of the polypeptides synthesized in su+ and 
su~ cells by wild-type, AmbG and hrTK~7 virus.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h post infection and from 23 to 24 h 
post infection. Cells were harvested, extracts prepared and 
the polypeptides analysed on a 7.5% polyacrylamide gel.
(a) su+ cells
The polypeptides synthesized in [35g]-methionine 
labelled cells are shown for mock infected, AmbG infected, 
hrTK”7 infected and wt infected cells at 8 h post infection 
(tracks 1, 2, 3 and 4 respectively). Tracks 5, 6 and 7 show 
the polypeptides from AmbG infected, hrTK“7 infected and wt 
infected cells at 24 h post infection respectively. In 
tracks 2 and 5, a closed arrowhead marks the position of the 
faster migrating G protein (named ambG). Normal G protein 
is indicated by an open arrowhead in track 4. In tracks 3 
and 6, the faster migrating NS protein is indicated by a 
closed arrow and the slower migrating N protein by an open 
arrowhead.
(b) su~ cells
The polypeptides synthesized in [- ^ ]-methionine 
labelled su~ cells are shown for mock and wt infected cells 
at 8 h post infection (tracks 1 and 4 respectively) and for 
hrTK~7 infected cells at 8 and 24 h post infection (tracks 2 
and 3 respectively).
(c) su~ cells
The polypeptides synthesized in [35g]-methionine 
labelled su~ cells are shown for mock and wt infected cells 
at 8 h post infection (tracks 1 and 2 respectively) and for 
AmbG infected cells at 8 and 24 h post infection (tracks 3 
and 4 respectively). Wt G protein is indicated by an open 
arrowhead and the faster migrating version (ambG) by a 
closed arrowhead.
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amounts of viral specific proteins were visible. The faster 
migrating G polypeptide was readily detectable as well as 
some full length protein. The observation that AmbG 
synthesizes the mutant G protein at such a high level in the 
su~ cells would suggest that AmbG is slightly 'leaky' in 
these cells. In addition, AmbG grew to a higher titre than 
any of the previously described mutants on su~ cells 
(Table 2) and, although some, if not all, of this may have 
represented growth of revertants, it is possible that this 
may have resulted from growth of the mutant itself.
Several studies have examined the effect of an 
altered cytoplasmic domain on transport of the VSV 
glycoprotein (Rose and Bergmann, 1983; Rose et a l ., 1984; 
Puddington et a l . , 1986). The most directly relevant study 
by Rose and Bergmann ( 19 83) examined the effect of deletions 
introduced into a cDNA clone encoding G protein. Three of 
the deletions lacked a portion of the cytoplasmic domain.
The deletion which resulted in a G protein nearest in size 
to the AmbG glycoprotein (lacking approximately 10 amino 
acids) lacked 16 terminal amino acids of its cytoplasmic 
domain. It was observed that this deleted G protein was 
transported to the Golgi apparatus at a markedly reduced 
rate in comparison to full length protein, although it was 
eventually transported to the cell surface. Thus, it is 
feasible that the shortened glycoprotein synthesized in su~ 
cells by AmbG, which is thought to lack 10 amino acids from 
its carboxy terminus, is also retarded, resulting in a 
decreased rate of transport of G to the cell surface, or 
even fewer G molecules on the cell surface at a given time.
From this model, one might conclude that an amber 
mutation, which resides within the cytoplasmic domain, and 
which results in the synthesis of a truncated version of G 
protein, as I propose is the case with AmbG, would have a 
deleterious but not lethal effect in the absence of the 
suppressor. This interpretation would explain why AmbG 
appears to be * leaky' on the su~ cells.
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4.(b).1.8 IN VIVO PROTEIN SYNTHESIS BY IND/HRTK~7/85
Analysis of the [35s]-methionine labelled proteins 
synthesized by hrTK~7 in su+ cells is shown in figure 12a. 
Comparison of the polypeptides synthesized after infection 
of SU+ cells by wt and hrTK~7 shows that the mutant produces 
an NS polypeptide which migrates faster than the wt 
polypeptide in polyacrylamide gels. The N protein also 
migrates anomalously, migrating slightly slower than wt N 
protein. Possibly the faster migrating NS polypeptide is a 
consequence of an amber mutation within the NS RNA.
However, the anomalous migratory properties of this 
phosphoprotein have been well documented (Wunner and 
Pringle, 1972; Obijeski et al ., 1974; Knipe et a l ., 1975; 
Kingsford and Emerson, 1980; Bell et a l ., 1984; Bell and 
Prevec, 1985). It has been reported that 5-FU induced 
mutants belonging to complementation group E (the NS gene) 
of VSV New Jersey (tsEl, tsE2 and tsE3) possess an NS 
protein with altered mobility in polyacrylamide gels (Evans 
et a l . , 1979). Nucleotide sequence analysis of a cDNA clone 
containing a full length copy of the NS gene revealed in 
each case that the basis of the mutant phenotype was a 
single nucleotide change, resulting in substitution of an 
amino acid of altered charge (Rae and Elliott, 1986b). 
Analysis of the predicted secondary structure of the wt and 
mutant NS proteins using the sequence data obtained 
indicated that the mutations might have a marked effect on 
the conformation of the protein. The authors postulated 
that the predicted alterations to the secondary structure of 
the NS protein were responsible for the observed 
electrophoretic mobility differences (Rae and Elliott, 
1986b). Thus, it is possible that the altered migration of 
the NS protein specified by hrTK~7 is the result of a point 
mutation possibly changing the charge of the affected amino 
acid so affecting the conformation of the protein. The 
reason for the slower migrating N protein is unknown, 
although it may also be caused by a point mutation altering 
the charge of the amino acid affected, possibly resulting in 
the altered mobility of the protein. Alternatively, the 
aberrant migration of the N protein could be the result of a
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mutation altering the normal stop codon to an amber codon. 
Readthrough of the amber codon in the su+ cells, followed by 
termination at an in—frame ochre or opal stop codon further 
downstream, would result in a higher molecular weight N 
protein. However, examination of the nucleotide sequence 
data for this region (Gallione et a l . , 1981) shows that 
there are no in-frame stop codons within 3 0 nucleotides of 
the termination codon.
Viral protein synthesis after infection of su~ cells 
by hrTK“7 was much reduced (Figure 12b) in comparison to the 
proteins synthesized by the mutant in su+ cells. No viral 
proteins were detectable 8 h post infection and the 8 h 
preparation was very similar to mock infected. At 2 4 h post 
infection, the L, N and M proteins were easily detecable.
The N protein migrated mormally and the faster migrating 
form of the NS protein could not be detected.
In conclusion, it is apparent that hrTK“7 growth is 
restricted in su~ cells. However, it is not clear whether 
the mutations affecting the mobilities of the N and NS 
proteins contribute singly or in conjunction towards the 
observed restriction. The NS protein specified by this 
mutant may possibly have a shorter chain length than normal 
and as such could conceivably be the product of a premature 
termination event. The N protein, on the other hand, 
appeared to possess a higher M r than the normal protein and 
as such is unlikely to result from premature termination of 
translation at an amber codon.
4.(b).1.9 IN VIVO PROTEIN SYNTHESIS BY THE HOST RANGE 
MUTANTS HRTK~8 TO HRTK~12
Examination of the [35S ]-methionine labelled proteins 
synthesized by these mutants after infection of su+ cells by 
polyacrylamide gel electrophoresis showed that each 
synthesized all five viral proteins normally. In addition, 
viral protein synthesis in su- cells infected by these 
mutants did not appear to be restricted. The mutant hrTK"13 
could only be grown to a titre of 104 and so any attempts at 
analysing the proteins synthesized intracellularly by this 
mutant would require concentration of the virus by
82
centrifugation. Although these mutants may merit further 
study it was decided to concentrate on a more complete 
characterization of the seven mutants described previously. 
Therefore, the remainder of this thesis relates only to 
these seven mutants.
4.(b ).2 COMPLEMENTATION ANALYSIS
4.(b ).2.1 INTERGENIC COMPLEMENTATION
Complementation analysis has been used extensively 
in the assignment of ts mutants of the Glasgow, 
Massachusetts, Orsay and Winnipeg strains of VSV Indiana 
(Flamand, 1970; Holloway et a l ., 1970; Pringle, 1970; 
Rettenmeier et a l . , 19 75), VSV Oocal (Pringle and Wunner, 
1973), VSV New Jersey, Hazelhurst subtype (Pringle et a l .,
19 71), Concan subtype (Byrd et al ., 19 84), and Chandipura 
virus (Gadkari and Pringle, 1980). However, ts mutants 
isolated from rabies virus have not exhibited convincing 
complementation, even though they have their own distinct 
phenotypic properties, and thus remain unclassified 
(Bussereau and Flamand, 1978).
Ts mutants of VSV Indiana were employed to assign the 
mutations specifying the restriction in host-range to a 
specific complementation group. The ts mutants used for 
this purpose were tsll (a group I mutant), ts22 (group II), 
ts31 (group III), ts41 (group IV) and ts04 5 (group V).
Initial attempts to assign the mutants were by a 
qualitative method. This consisted of infecting jsu cells 
in 50 mm dishes with an amber and a ts_ mutant, incubating 
the infections for 24 h at the non-permissive temperature 
and scoring each plate for the presence or absence of cpe. 
However, this method, although successfully employed in the 
assignment of tis mutations (Pringle et al . , 1971), 
consistently resulted in a failure to restrict growth of the 
singly infected tj3 controls.
A quantitative analysis was obtained by infecting 
monolayers of su" cells at the non-permissive temperature 
with pairs of mutants (a ts mutant plus an amber mutant) for 
a period equivalent to twice the latent period of the virus
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(8 h) and then titrating the supernatant on su~ cells to 
test for growth of the ts mutants. Attempts to test for 
growth of the amber mutants at the restrictive temperature 
on the su+ cells were unsuccessful due to the inviability of 
the su+ cells at this temperature.
Of the mutants tentatively assigned as L gene mutants 
from the results of the protein analysis, all five have been 
shown by means of negative complementation (Table 3) to have 
a mutation in complementation group I (the L cistron). The 
mutants ts2 2, ts31, ts41 and ts045 all successfully 
complemented AmbLl, AmbL2, AmbL3, AmbL4 and AmbL5 whereas 
the mutant tsll failed to do so. Thus this analysis is 
consistent with the results obtained from the protein 
analysis, assigning the mutations to complementation group I 
(the L cistron). As a control, the group I mutant (t£ 11) 
was tested in complementation with the four other ts 
mutants. Ts 11 was found to complement each of the 
representative ts mutants.
The mutant AmbG, which exhibited a slightly faster 
migrating glycoprotein in polyacrylamide gels after 
infection of the su+ cells (Figure 12a), appeared to 
complement all ts mutants apart from the mutant ts04 5, 
although the result was not completely convincing (Table 3). 
Since ts045 is a group V mutant this mutant can be 
tentatively assigned to complementation group V, the G gene.
The mutant hrTK“7 failed to complement any of the ts 
mutants and could not be allocated to a specific VSV 
complementation group. Thus this is probably a multiple 
mutant, and as a result it was classified simply as a host 
range (hr) mutant.
4.(b).2.2 INTRAGENIC COMPLEMENTATION
The occurrence of intragenic complementation has been 
observed in the analysis of _ts mutants of the Orsay 
collection of spontaneous bs mutants (Flamand, 1970) and bs 
mutants of the Winnipeg strain (Wong et al . , 1972) of VSV 
Indiana. Intragenic complementation has also been reported 
between ts mutants of VSV New Jersey (Pringle et a l . , 19 81) 
and Chandipura virus (Gadkari and Pringle, 1980a). However
Table 3
Complementation analysis of host range mutants.
(a) Ind/AmbLl
Singly infected Doubly infected
Titre Titre
AmbLl 2.0 X 104 AmbLl + ts 11 2.1 X 104
ts 11 1.8 X 103 AmbLl + ts 22 5.8 X 106
ts 2 2 1.6 X 103 AmbLl + ts 31 4.0 X 106
ts 31 1.8 X 103 AmbLl + ts 41 7.0 X 105
ts 41 2.0 X 103 AmbLl + ts 0/45 1.0 X 107
ts 0/45 2.1 X 103
(b) Ind/AmbL2
Singly infected Doubly infected
Titre Titre
AmbLl 1.5 X 102 AmbL2 + ts 11 2.0 X 102
ts 11 1.8 X 103 AmbL2 + ts 22 6.4 X 105
ts 22 2.0 X 103 AmbL2 + ts 31 5.0 X 105
ts 31 1.5 X 103 AmbL2 + ts 41 1.0 X 104
ts 41 1.5 X 103 AmbL2 + ts 0/45 2.0 X 106
ts 0/45 1.9 X 103
(c) Ind/AmbL3
Singly infected 
Titre
AmbL3 
ts 11 
ts 2 2 
ts 31 
ts 41 
ts 0/45
3.0 x 102 
1.2 x 102 
2.4 x 102
1.8 x 103
1.8 x 102
3.0 x 102
Doubly infected
Titre 
5.0 x 102AmbL3 + ts 11 
AmbL3 + ts 2 2 
AmbL3 + ts 31 
AmbL3 + ts 41 
AmbL3 + ts 0/45
7.1 x 105 
6.4 x 105
1.1 x 104 
2.0 x 106
(d) Ind/AmbL4
Singly infected Doubly infected
Titre Titre
AmbL4 2.8 X 102 AmbL4 + ts 11 7.2 x 102
ts 11 2.0 X 102 AmbL4 + ts 22 3.0 x 105
ts 2 2 1.0 X 103 AmbL4 + ts 31 4.6 x 105
ts 31 2.5 X 102 AmbL4 + ts 41 1.1 x 105
ts 41 2.7 X 102 AmbL4 + ts 0/45 4.1 x 106
ts 0/45 6.0 X 103
Ind/AmbL5
Singly infected Doubly infected
Titre Titre
AmbL5 1.6 X 102 AmbL5 + ts 11 2.4 x 102
ts 11 2.2 X 102 AmbL5 + ts 22 4.6 x 105
ts 2 2 8.4 X 102 AmbL5 + ts 31 1.0 x 105
ts 31 2.0 X 102 AmbL5 + ts 41 3.0 x 105
ts 41 1.0 X 103 AmbL5 + ts 0/45 2.1 x 106
ts 0/45 2.4 X 103
(f ) Ind/AmbG
Singly infected 
Titre
AmbG 
ts 11 
ts 2 2 
ts 31 
ts 41 
ts 0/45
3.2 x 103
1.0 x 102
2.1 x 102
1.8 x 102
2.0 x 102
1.8 x 103
Doubly infected
Titre 
3.0 x 104AmbG + ts 11 
AmbG + ts 2 2 
AmbG + ts 31 
AmbG + ts 41 
AmbG + ts 0/45
3.0 x 105
6.2 x 105
6.0 x 104
7.4 x 103
(q) hrTK~7
Singly infected Doubly infected
Titre Titre
hrTK“7 4.2 x 102 hrTK”7 + ts 11 5.2 x 102
ts 11 4.0 x 103 hrTK"7 + ts 22 4.0 x 103
ts 2 2 5.4 x 103 hrTK”7 + ts 31 8.2 x 103
ts 31 1.7 x 104 hrTK"7 + ts 41 3.4 x 103
ts 41 1.1 x 103 hrTK“7 + ts 0/45 2.2 x 104
ts 0/45 1.0 x 104
Monolayers of su~ cells were infected either singly 
or with a mixture of a host range mutant and a ts_ mutant. 
After 8 h at 39°C, the supernatants were recovered and the 
yield of virus titred of su~ cells at 31°C. Yields are 
given in pfu/ml.
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no such intragenic complementation was reported within the 
5-FU induced mutants of the Glasgow strain of VSV Indiana 
(Pringle, 1987). Its occurrence between ts mutants of
Chandipura virus resulted in the sub-division of
complementation group Chi (the L gene) into ChIA and ChIB 
(Gadkari and Pringle, 1980a). Thus it has been suggested 
that the gene product specified by this complementation 
group forms a multimeric protein (Gadkari and Pringle,
1980a) . For two mutations to complement, the conformation 
of the mutated region on one monomer must be corrected by 
the unmutated region of the other monomer. However, in 
cells multiply infected by two group I amber mutants, both 
viruses are defective in the same region since they all lack 
a portion of the carboxy terminus of their L protein.
The results of the intragenic complementation 
analysis are shown in Table 4. Of the ten possible pairwise 
combinations of these viruses none exhibit any significant 
complementation. These results are thus consistent with the
previous interpretation that each of the host range group I
mutants are defective in the same region, namely the C 
terminus of the L protein.
4.(b ).3 ISOLATION OF REVERTANTS
4.(b).3.1 PLAQUE PURIFICATION
Revertants of the host range mutants were isolated by 
plating the passage 1 stock of each isolate on the su~~ cell 
line to give well isolated plaques. In the case of four of 
the group I mutants (AmbLl to AmbL4) isolated plaques were 
produced at the 10“2 to 1 0 "2 dilution. The plaques 
exhibited a wt plaque morphology with plaques ranging in 
size from 3-6 mm. The plaques produced by these mutants on 
su+ cells were consistently about 1mm in diameter. 2 4 well 
isolated plaques were picked for each of the mutants and 
used to infect Linbro wells of su~ cells. without 
exception, each plaque gave rise to cpe within two days of 
infection. The virus was harvested and stored at -7 0°C.
Isolation of revertants of the group V mutant, AnbG, 
followed a slightly different pattern. Although plaques
Table 4
Intragenic complementation analysis of the 
group I mutants.
(a) AmbLl + AmbL2
Singly infected 
Titre
AmbLl 3.4 x 102
AmbL2 1.6 x 102
Doubly infected
Titre
5.4 x 102AmbLl + AmbL2
(b) AmbLl + AmbL3
Singly infected 
Titre
AmbLl 3.4 x 102
AmbL3 2.7 x 102
Doubly infected
Titre
4.1 x 102AmbLl + AmbL3
(c) AmbLl + AmbL4
Singly infected 
Titre
AmbLl 3.4 x 102
AmbL4 3.7 x 102
Doubly infected
Titre
5.0 x 102AmbLl + AmbL4
(d) AmbLl + AmbL5
Singly infected 
Titre
AmbLl 3.4 x 102
AmbL5 1.1 x 102
Doubly infected
Titre
7.3 x 102AmbLl + AmbL5
(e) AmbL2 + AmbL3
Singly infected 
Titre
AmbL2 1.6 x 102
AmbL3 2.7 x 102
Doubly infected
Titre 
2.0 x 102AmbL2 + AmbL3
(f) AmbL2 + AmbL4
Singly infected 
Titre
AmbL2 1.6 x 102
AmbL4 3.7 x 102
Doubly infected
Titre 
3.6 x 102AmbL2 + AmbL4
(g) AmbL2 + AmbL5
Singly infected 
Titre
AmbL2 1.6 x 102
AmbL5 1.1 x 102
Doubly infected
Titre 
4.0 x 102AmbL2 + AmbL5
(h) AmbL3 + AmbL4
Singly infected 
Titre
AmbL3 2.7 x 102
AmbL4 3.7 x 102
Doubly infected
Titre 
6.4 x 102AmbL2 + AmbL4
(i) AmbL3 + AmbL5
Singly infected 
Titre
AmbL3 2.7 x 102
AmbL5 1.1 x 102
Doubly infected
Titre 
4.3 x 102AmbL3 + AmbL5
(j ) AmbL4 + AmbL5
Singly infected 
Titre
AmbL4 3.7 x 102
AmbL5 1.1 x 102
Doubly infected
Titre 
6.0 x 102AmbL4 + AmbL5
Monolayers of su~ cells were infected either singly 
or with a mixture of two host range mutants. After 8 h at 
39°C, the supernatants were recovered and the yield of virus 
titred on su“ cells at 31°C. Yields are given in pfu/ml.
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were produced at the 10-4 dilution, they took 24 h longer to 
appear than revertant plaques of the group I mutants and 
were smaller in size (about 2-3mm in diameter). 24 well 
isolated plaques were picked and used to infect monolayers 
of su- cells in Limbro wells. 17 out of 2 4 plaques gave 
rise to cpe, but only after incubation for 3-4 days. This 
virus appeared to give rise to a less virulent infection of 
the su cells than either wt virus or revertants of the 
group I mutants.
When the mutants AmbL5 and hrTK~7 were used to infect 
su" cells only very small hazy plaques could be seen at the 
10-1 dilution on inspection, even after seven days post 
infection. A further incubation period of seven days failed 
to increase the size of the plaques appreciably. At this 
point 10 of the 'plaques' were picked, dispersed into 1.5 ml 
of MEM/20%CS and used to infect monolayers of su" cells in 
Linbro wells. However, none of the plaques gave rise to cpe 
even after seven days, although at two days post infection 
there was some evidence of viral infection, in that small 
areas of the cell monolayer appeared translucent. This 
usually occurred during a wt infection and invariably led to 
extensive cpe. However, in this case no cpe was forthcoming. 
This phenomenon was consistently reproducible. One possible 
interpretation of this is that the hazy plaques were simply 
the result of reasonably high titre virus being plated on 
cells (albeit non-pemissive cells) and not from actual 
growth of either mutant.
4.(b).3.2 IN VIVO PROTEIN SYNTHESIS OF REVERTANTS OF 
THE GROUP I AND GROUP V HOST RANGE MUTANTS
Revertants isolated for four (AmbLl to AmbL4) of the 
group I mutants and for the group V mutant (AmbG) were used 
to infect both su+ and su" cells, and the [3 5S ]-methionine 
labelled intracellular proteins were then analysed at 8 h 
post infection by fractionation on a polyacrylamide gel.
Examination of the proteins synthesized by revertants 
of the group I mutants AmbLl, AmbL2, AmbL3 and AmbL4 
(figures 13, 14, 15 and 16 respectively) showed that of the 
isolates examined, all exhibited a wt profile. In
Figure 13
Intracellular polypeptides synthesized in su+ and su~ 
cells by wt virus and revertants of AmbLl.
Su+ and su~ cells were infected at a moi of 
10 pfu/cell. Infected monolayers were incubated at 31°C and 
labelled from 7 to 8 h post infection. Cells were harvested 
and extracts prepared. The polypeptides were analysed by 
gel electrophoresis on a 7.5% polyacrylamide gel.
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected (track 1), wt 
infected (track 2) and three revertants of AmbLl (tracks 3,
4 and 5) .
The polypeptides synthesized in C 3 5S] -methionine 
labelled su" cells are shown for wt infected (track 6), 
three revertants (the same three as above) of AmbLl (tracks 
7, 8 and 9) and mock infected (track 10).
1 2 3 4  5 6 7 8  9 10
Figure 14
Intracellular polypeptides synthesized in su+ cells
by wt virus and revertants of AmbL2.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled from 
7 to 8 h post infection. Cells were harvested and extracts 
prepared. The polypeptides were analysed by gel 
elecrophoresis on a 7.5% polyacrylamide gel.
The polypeptides synthesized in [35s]-methionine 
labelled su+ cells are shown for mock infected (track 1), wt 
infected (track 2), AmbL2 infected (track 3) and five 
revertants of AmbL2 (tracks 4 to 8 respectively). The L 
protein fragment (ambL2) is indicated by a closed arrowhead. 
Full length L protein is indicated by an open arrowhead.
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Figure 15
Intracellular polypeptides synthesized in su+ cells
by wild-type virus and revertants of AmbL3.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled from 
7 to 8 h post infection. Cells were harvested and extracts 
prepared. The polypeptides were analysed by gel 
electrophoresis on a 7.5% polyacrylamide gel.
The polypeptides synthesized in [35s]-methionine 
labelled su+ cells are shown for mock infected (track 1), wt 
infected (track 2), AmbL3 infected (track 3) and five 
revertants of AmbL3 (tracks 4 to 8 respectively). The L 
protein fragment (ambL3) is indicated by a closed arrowhead. 
Full length L protein is indicated by an open arrowhead.
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Figure 16
Intracellular polypeptides synthesized in su+ cells
by wild-type virus and revertants of AmbL4.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled 
from 7 to 8 h post infection. Cells were harvested and 
extracts prepared. The polypeptides were analysed by gel 
electrophoresis on a 7.5% polyacrylamide gel.
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected (track 1), 
AmbL4 infected (track 2) and wt infected (track 3). The 
polypeptides synthesized in su+ cells infected by four 
revertants of AmbL4 are shown in tracks 4 to 7 respectively. 
The L protein fragment (ambL4) is indicated by a closed 
arrowhead. Full length L protein is indicated by an open 
arowhead.
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particular, the L protein band possessed both a normal 
mobility and a normal intensity. The characteristic novel 
polypeptide species observed after infection of su+ cells, 
and proposed to represent a truncated form of the L protein, 
were not present. This suggested that the revertants were 
all products of a back mutation in the same codon as the 
original mutation.
Comparison of the polypeptides synthesized in su+ 
cells by revertants of AmbG, wt virus and AmbG virus 
revealed that the putative revertants did not exhibit a wt 
protein profile (Figure 17). Instead, all synthesized a 
faster migrating glycoprotein similar in size to the faster 
migrating G protein synthesized by AmbG in the su+ cells. 
Thus, it appears that this so called 'revertant' virus does 
not represent true revertants of AmbG but instead the 
original AmbG inoculum. Evidence to support this 
interpretation was provided by titrating these 'revertants' 
on both the su+ and su" cells. Whereas revertants of the 
four group I mutants grew to a similar titre in both cell 
types, 'revertants' of AmbG exhibited the same restricted 
host range as the mutant itself. It seems likely that true 
revertants of AmbG are present in the passage 1 stock, but
that many more plaques need to be picked on the su" cells to
isolate any.
These results suggest that AmbG is a leaky mutant and 
will grow in the su" cells, albeit at a reduced level when 
compared to growth in the su+ cells. This is consistent with 
the results obtained in the analysis of AmbG viral protein 
synthesis in the su" cells. Here the mutant was observed to
synthesize significant amounts of the putative truncated G
protein in the su" cells (section 4.(b).1.7),. In 
conclusion, it appears that although AmbG probably contains 
an amber mutation within the cytoplasmic domain of its G 
protein, the mutant can still produce viable virus, albeit 
at a reduced level, in cells lacking the suppressor tRNA 
needed to allow production of full length protein.
Figure 17
Intracellular polypeptides synthesized in su* cells
by wild-type virus and revertants of AmbG.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled from 
7 to 8 h post infection. The cells were harvested and 
extracts prepared. The polypeptides were analysed by gel 
electrophoresis on a 7.5% polyacrylamide gel.
The polypeptides-synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected (track 1), wt 
infected (track 2), AmbG infected (track 3) and for five 
revertants of AmbG (tracks 4 to 8 respectively). Normal G 
protein is indicated by an open arrowhead. The faster 
migrating G protein (ambG) is indicated by a closed 
arrowhead.
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4.(b).4 ANALYSIS OF THE PROTEIN COMPOSITION OF THE VIRION
OF WILD-TYPE VIRUS AND THE FIVE GROUP I MUTANTS
In order to determine whether the truncated versions 
of the L protein were packaged, the protein compositions of 
the virion of the group I mutants were analysed. Su+ cells 
infected either with wt or one of the group I mutants were 
cultured in methionine-free medium containing 
[ 3 ] -methionine. The supernatant was removed and partially 
purified virions obtained by centrifugation through a 
glycerol cushion. Comparison of the virion protein 
composition of the five group I mutants with the wt result 
showed that none of the mutants packaged the truncated L 
protein (Figure 18). It was not possible to detect any full 
length L protein either hoewever, so it would be necessary to 
employ more sensitive methods before one could conclude that on! 
full length L is packaged. Possibly
further concentration of the virion preparation will allow 
detection of a readthrough product.
4.(b).5 IMMUNOPRECIPITATION STUDIES OF THE NOVEL POLYPEPTIDE 
SPECIES SYNTHESIZED BY THE GROUP I MUTANTS
It has been proposed from the analysis of the 
proteins synthesized in su+ cells by the group I mutants, 
that the observed aberrant migration of the L polypeptide 
resulted from premature termination of translation at an 
amber stop codon within the L mRNA. Premature termination 
at a nonsense codon results in the synthesis of a fragment 
of the complete polypeptide chain which contains an intact N 
terminus but lacks the C terminal portion present in the 
normal protein. The presence and/or absence of these 
regions in the L protein specified by these mutants 
(proposed to be the novel polypeptide) was examined by 
immunoprecipitation analysis using monospecific antisera 
which were directed against the N and C terminus of the wt L 
protein.
The monospecific antisera used in both this analysis 
and in the immunoblotting analysis were the gift of Manfred 
Schubert of the National Institute of Neurological diseases 
and Stroke, National Institutes of Health, Bethesda, USA.
Figure 18
Protein composition of the virion of the group I
mutants
Radiolabelled virus was prepared by growing su+ 
cells, infected at a moi of 0.02 pfu/cell by either wt virus 
or one of the group I mutants, in methionine-free medium 
containing [35g]-methionine. Labelled virus in the culture 
medium was partially purified by centrifugation through a 
glycerol cushion.
The [33s]-methionine labelled proteins present in the 
virion of wild-type virus is shown in track 1. The 
t35S] -methionine labelled proteins present in the virion of 
the five group I mutants (AmbLl to AmbL5 respectively) are 
shown in tracks 2 to 6 respectively. As a marker, the 
[3 ^s]-methionine labelled proteins synthesized by wt virus 
in su+ cells are shown in track 7. Full-length L protein is 
indicated by an open arrowhead. "

Schubert et a l . (1985) described the synthesis of these
antisera in rabbits by injection with oligopeptides which 
represented the sequences from the exact amino and carboxy 
termini of the wt VSV Indiana L protein.
Su+ cells were infected with wt virus or with one of 
the group I mutants. At 24 h post infection the cells were 
labelled with [35g]-methionine for 1 h and cell extracts 
prepared. Antibodies directed against the N and C termini 
of the L protein were added and the immunecomplexes isolated 
by binding to protein-A-Sepharose beads.
As shown in Figure 19, both antibodies specifically 
precipitated the L protein from cells infected with wt 
virus. Non-specific precipitation of other viral proteins 
was also observed, in particular the N and M proteins. 
However, subsequent analysis has shown that this 
non-specific binding was independent of the antibody or the 
cell extract used.
These antisera were then used to study the novel 
polypeptides produced by the group I mutants in the su+ 
cells. With cell extracts prepared from su+ cells infected 
with AmbLl, AmbL2, AmbL3 and AmbL4 the N terminal specific 
antiserum precipitated the novel polypeptide whereas the C 
terminal specific antiserum failed to do so (Figure 20a, b, 
c, and d respectively). Some non-specific binding of the G, 
NS and M proteins was again observed.
Immunoprecipitation of AmbL5 infected cell extract 
revealed a polypeptide species, where none had been observed 
before (see section 4.(b).1.6), of estimated M r 187000 which 
was specifically precipitated only by the N-terminal 
specific antiserum and not by the C-terminal specific 
antiserum (Figure 20e).
These results are consistent with my proposal that 
the novel polypeptide species synthesized by these mutants 
in su+ infected cells is a result of premature termination 
within the L mRNA at an amber codon.
Although the results obtained by immunoprecipitation 
analysis are reasonably convincing, it should be noted that 
it was difficult to get sufficient label into the L protein 
fragment. This resulted in the relatively weak
Figure 19
Immunoprecipitation of protein extracts from su+
cells infected by wt virus with monospecific antisera 
directed against the N or C termini of the VSV L protein.
Su+ cells were infected at a moi of 10 pfu/cell.
Infected monolayers were incubated at 31°C and labelled from 
23 to 2 4 h post infection. Cell extracts were prepared and 
reacted with either the N-terminal specific antisera or the 
C-terminal specific antisera. Immunecomplexes were isolated 
by binding to protein-A-Sepharose beads. The precipitated 
proteins were analysed on a 7.5% polyacrylamide gel.
The polypeptides synthesized in su+ cells infected by 
wt virus are shown in track 1. Tracks 2 and 3 show the 
polypeptides precipitated from the wt extract by the 
N-terminal and C-terminal specific antisera respectively.
L protein is indicated by an open arrowhead.
extracts from mock-infected cells gave rise to no specific bands 
after immunoprecipitation with either the N or C-terminal 
specific antisera. ™
w ild-type
u a'KISa
Figure 2 0
Immunoprecipitation of protein extracts from su+ 
cells infected by the mutants AmbLl, AmbL2 and AmbL3 with 
monospecific antisera directed against the N or C-termini of 
the L protein.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled from 
23 to 24 h post infection. Cell extracts were prepared and 
reacted with either the N or C-terminal specific antiserum. 
Immunecomplexes were isolated by binding to 
protein-A-Sepharose beads and the precipitated proteins 
analysed on a 7.5% polyacrylamide gel.
(a) ind/ambLl
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells infected by AmbLl are shown in track 1. 
Tracks 2 and 3 show the polypeptides precipitated from the 
AmbLl infected cells extract by the N-terminal and 
C-terminal specific antisera respectively. The L protein 
fragment (ambLl) is indicated by a closed arrowhead.
(b) ind/ambL2
The polypeptides synthesized in [35S]-methionine 
labelled su+ cells infected by AmbL2 are shown in track 1. 
Tracks 2 and 3 show the polypeptides precipitated from the 
AmbL2 infected cell extract by the N-terminal and C-terminal 
specific antisera respectively. The L protein fragment 
(ambL2 ) is indicated by a closed arrowhead.
(c) ind/ambL3
The polypeptides synthesized in [35s]-methionine 
labelled su+ cells infected by wt virus and AmbL3 are shown 
in tracks 1 and 2 respectively. Tracks 3 and 4 show the 
polypeptides precipitated from the AmbL3 extract by the 
N-terminal and C-terminal specific antisera respectively.
The L protein fragment (ambL3) is indicated by a closed 
arrowhead. Full length L protein is indicated by an open 
arrowhead.
(a) 
ind/am
bL1 
(b)ind/am
bL2 
(c)ind/am
bL3
Figure 20 (continued)
Immunoprecipitation of protein extracts from su+ 
cells infected by the mutants ind/ambL4 and ind/ambL5 with 
monospecific antisera directed against the N or C-termini of 
the L protein.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated at 31°C and labelled from 
23 to 24 h post infection. The cells were harvested, 
extracts prepared and reacted with either the N or 
C-terminal specific antiserum. Immunecomplexes were 
isolated by binding to protein-A-Sepharose beads and the 
precipitated proteins analysed on a 7.5% polyacrylamide gel.
(d) ind/ambL4
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells infected by AmbL4 are shown in track 1. 
Tracks 2 and 3 show the polypeptides precipitated from the 
AmbL4 extract by the N-terminal and C-terminal specific 
antisera respectively. The L protein fragment (ambL4) is 
indicated by a closed arrowhead.
(e) ind/ambL5
The polypeptides synthesized in [^ ]-methionine 
labelled su+ cells infected by AmbL5 are shown in track 1. 
Tracks 2 and 3 show the polypeptides precipitated from the 
AmbL5 extract by the N-terminal and C-terminal specific 
antisera respectively. The L protein fragment (ambL5) is 
indicated by a closed arrowhead.
(d) ind/ambL4 (e) ind/ambL5
a m b L 4
a m b L 5
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precipitation of the L protein fragment with the N- t e m i n a l  
specific antisera in comparison to the wt result.
4.(b ).6 WESTERN BLOT ANALYSIS OF THE TRUNCATED VERSION 
OF L PROTEIN SYNTHESIZED BY THE GROUP I MUTANTS
In order to confirm the results obtained by 
immunoprecipitation analysis, [3 5S ]-methionine labelled 
extracts of sii+ cells infected with each of the group I 
mutants were electrophoretically transferred from an 
SDS-polyacrylamide gel to nitrocellulose (Figure 21). 
Proteins which contained L protein N or C specific sequences 
were detected by autoradiography after reaction with the 
relevant antibody and iodinated protein-A (Figure 22). 
Firstly, the L protein synthesized by wt virus was shown to 
contain N and C specific sequences. The shortened version 
of the L protein produced by AmbLl, AmbL2, AmbL3 and AmbL4 
were then shown to contain N but not C specific sequences. 
With respect to the AmbL3 result, although the original 
autoradiograph does show the presence of a band representing 
the AmbL3 protein fragment, the processes of duplication and 
photography have almost eliminated it.
These results provide further proof that the novel 
polypeptide species synthesized by the group I mutants AmbLl 
to AmbL4 represent a fragment of the full length protein, 
produced by premature termination of translation.
The putative truncation product synthesized by AmbL5 
and detected only by immunoprecipitation analysis could not 
be identified. However, inspection of the AmbL5 result 
showed that an additional protein, present in AmbL5 infected 
cells, is bound strongly by the N-terminal specific 
antiserum only. Thus, it is even conceivable that there are 
two versions of the L protein synthesized in AmbL5 infected 
cells, one which has an M r of about 187000 detected by 
immunoprecipitation and another with an estimated M r of 
about 4 8000 detectable by immunoblotting. It is probably 
significant that AmbL5 appears to be a double mutant since 
it is not known to revert. However, a corresponding band is 
present in each of the remaining tracks (if at a reduced 
level) which appears to represent non-specific binding to
Figure 21
Immunoblotting analysis of the polypeptides 
synthesized in su.+ cells by wild-type virus and the five 
group I mutants with monospecific antisera directed against 
the N and C-termini of the L protein.
Su+ cells were infected at a moi of 10 pfu/cell.
[33s ]-methionine labelled cell extracts were prepared and 
fractionated by gel electrophoresis. The separated proteins 
were transferred to nitrocellulose sheets by 
electrophoresis. The blotted proteins were then reacted 
with either the N or C-terminal specific antiserum.
Immune complexes were detected by binding to iodinated 
protein-A.
The polypeptides synthesized in [ 3 5s]-methionine 
labelled su+ cells, after transfer to nitrocellulose sheets 
are shown for AmbLl, AmbL2, AmbL3, AmbL5, AmbL4 and wt virus 
(tracks 1 to 6 respectively) in Figure 21(a) and 21(b).
Wt L protein is indicated by an open arrowhead. The 
shortened versions of L (named ambLl to ambL4) are indicated 
by a closed arrowhead.

Figure 22
Immunoblotting analysis of the polypeptides 
synthesized in su+ cells by wt virus and the five group I 
mutants with the monospecific antisera directed against the 
N and C-termini of the L protein.
Su+ cells were infected at a moi of 10 pfu/cell.
[3 ]_m e thionine labelled infected cell extracts from wt and 
the group I mutants were blotted onto nitrocellulose sheets 
(Figure 21). The blotted proteins were then reacted with 
either the N (Figure 2 2a) or C-terminal (Figure 22b) 
specific antiserum. Immunecomplexes were detected by 
binding to iodinated protein-A. The 12Sj-iabeXXed proteins 
are shown for AmbLl, AmbL2, AmbL3, AmbL5, AmbL4 and wt 
(tracks 1 to 6 respectively) in Figure 22(a) and 22(b). Wt 
L protein is indicated by an open arrowhead. The shortened 
versions of the L protein (named ambLl to ambL4) are 
indicated by a closed arrowhead. A possible candidate for 
an AmbL5 truncation protein is indicated by a (o).
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the cellular actin protein and, because of this, any 
conclusions drawn based on the specificity of the N-terminal 
antisera to this 45000 dalton protein in AmbL5 infected cell 
extracts, must remain speculative.
In summary, a schematic diagram has been constructed 
showing the proposed approximate positions for each of the 
group I mutations within the L gene (Figure 23).
4.(b ).7 ISOLATION AND IN VITRO TRANSLATION OF RNA FROM 
WILD-TYPE AND MUTANT INFECTED CELLS
With a view to precisely mapping the position of the 
mutations and as final proof of their nature, it would be of 
interest to determine the nucleic acid sequence of the RNA 
segment containing the mutation.
As a preparatory step RNA was isolated from su+ cells 
infected either by wt virus or one of the mutants. Su+ 
cells were infected by 10 pfu/cell of virus and the cells 
harvested 8 h post infection. RNA was isolated using the 
guanidinium isothiocyanate method. RNA isolated from 
infected cells was used to prime an in vitro translation 
system. The [35g]_methionine labelled proteins were then 
fractionated by polyacrylamide gel electrophoresis and 
detected by autoradiography.
In vitro translation of wt, AmbLl and AmbL2 RNA is 
shown in Figures 2 4a and 2 4b respectively. In vitro 
translation of wt RNA showed that the G, NS, N and M 
proteins were translated but not the L protein. The same 
pattern of proteins was seen after in vitro translation of 
AmbL3, AmbL4 and AmbL5 RNA. The inability to translate L 
message is well documented (Preston and Szilagyi, 1977), and 
it is thought to be the result of RNase degradation. L RNA 
would be more sensitive than the RNAs encoding the G, NS, N 
and M proteins because of its considerably greater length.
In vitro translation of the RNA isolated from AmbLl and 
AmbL2 infected cells showed that, in addition to G, NS, N 
and M proteins, the additional polypeptide species 
synthesized by these mutants were also present.
In vitro translation of RNA isolated from cells 
infected with wt and AmbG viruses is shown in Figure 24c.
Figure 23
A schematic diagram of the approximate position of 
the amber mutations within the L mRNA of the group I 
mutants.
The approximate positions of the amber mutations
within the L mRNA of the group I mutants were calculated
using the VSV proteins as known molecular weight markers on 
SDS-polyacrylamide gels. The position of each mutation in 
the L mRNA is shown by an arrow.
In the case of the mutant AmbL5, the solid arrow
shows the position of a mutation that would give rise to the
truncated protein which was detected by immunoprecipitation 
analysis. The broken arrow shows the position of a mutation 
that would give rise to the truncated protein which was 
detected by immunoblotting analysis (Figure 2 2a).
The coding region is shown by an open box.
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Figure 24
In vitro translation of RNA isolated from su+ cells 
infected by the group I mutants AmbLl and AmbL2 and the 
group V mutant AmbG.
Su+ cells were infected at a moi of 10 pfu/cell. 
Infected monolayers were incubated for 8 h at 31°C. The 
cells were harvested and RNA isolated using the guanidinium 
isothiocyanate method. RNA was used to prime a reticulocyte 
lysate in vitro translation system. The proteins were 
analysed on a 7.5% polyacrylamide gel.
(a) in vitro translation of RNA isolated from AmbLl 
infected cells.
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1) and wt infected cells (track 2). The 
[ 3 ] -methionine labelled polypeptides synthesized in vitro 
using RNA isolated from AmbLl infected su+ cells are shown 
in track 3. The L protein fragment (ambLl) is indicated by 
a closed arrowhead.
(b) in vitro translation of RNA isolated from AmbL2 
infected cells.
The polypeptides synthesized in [35S]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1) and AmbL2 infected cells (track 2). The 
[ 3 ] -methionine labelled polypeptides synthesized in vitro 
using RNA isolated from AmbL2 infected su+ cells are shown 
in track 3. The L protein fragment (ambL2) is indicated by 
a closed arrowhead.
(c) in vitro translation of RNA isolated from AmbG 
infected cells.
The polypeptides synthesized in [35g]-methionine 
labelled su+ cells are shown for mock infected cells 
(track 1) and wt infected cells (track 2). The 
[35g]-methionine labelled polypeptides synthesized in vitro 
using RNA isolated from AmbL2 infected cells are shown in 
track 3, from AmbG infected cells in track 4 and from wt 
infected cells in track 5. The faster migrating pre-G (named 
ambp-G) is indicated by a closed arrowhead.
(a)ind/ambL1 
(b)ind/ambL2 
(c)ind/ambG
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The M r of the pre-G protein synthesized by wt and AmbG 
viruses could be estimated (by comparing their mobility to 
the known Mr of other VSV proteins, in this case the G and 
NS proteins) as approximately 71000 and 70000 respectively. 
This is consistent with the results obtained in the analysis 
of the viral proteins synthesized in su+ cells infected with 
either AmbG or wt virus (section 4.(b).1.7) and confirms 
that the difference in migration between the two G 
polypeptides is not simply the result of a difference in 
glycosylation.
4.(b ).8 THE EFFECT OF THE AMINOGLYCOSIDE G418 ON THE MUTANT 
AMBL1
Aminoglycosides have been shown to suppress nonsense 
mutations in bacteria (Gorini, 1974), yeast (Singh et a l ., 
1979; Palmer et a l ., 1979), and A. nidulans (Roberts et a l ., 
1979; Martinelli and Roberts, 1983) and have been shown to 
facilitate suppression by affecting the fidelity of 
translation (Davies et a l ., 1965; Palmer and Wilhelm, 1978; 
Wilhelm et a l ., 1978a, 1978b).
Burke and Mogg (19 85) reported the suppression of an 
amber mutation in the chloramphenicol acetyl transferase 
gene of the mammalian cell transfection vector pRSVCAT311^ ^ ^  
Readthrough of the nonsense mutation was assayed by the 
appearance of active enzyme. The optimum concentration 
required to facilitate suppression was found to be 50ug/ml. 
The efficiency of suppression by G418 was estimated to be 
approximately 19.6% (Burke and Mogg, 19 85). If the proposed 
amber mutation in the L gene of AmbLl was suppressed at such 
an efficiency, one might expect that AmbLl grown in the 
presence of the optimum concentration of G418 would grow to 
a higher titre than it might normally do on su- cells. In 
addition, it would be of interest to see if analysis of the 
proteins synthesized by AmbLl in su" cells with G418 present 
revealed any viral protein synthesis which might be 
associated with suppression of the amber mutation. 
Accordingly, two experiments were carried out: (1) su"
cells in Linbro wells were infected with either wt or AmbLl 
in the presence of 0, 25, 50, 100 and 200 ug/ml of G418. >
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8 h post infection the virus was harvested and titrated on 
su+ cells for growth of the mutant. (2) monolayers of su~ 
cells in Linbro wells were infected with wt or AmbLl and 
with either 0, 25, 50, 100 or 200 ug/ml of G418 present.
8 h post infection the intracellular proteins were labelled 
with [35g]_m e thionine for 1 h, then extracted into protein 
dissociation mix and fractionated by polyacrylamide gel 
electrophoresis.
In both cases there was no evidence of suppression of 
the amber mutation. In fact, the yield of virus decreased 
with increasing concentration of G418 and the presence of 
G418 had no appreciable effect on the proteins synthesized 
by AmbLl in infected su~ cells.
In conclusion, it is likely that the deleterious 
effect that G418 had on growth of the virus negated any 
possible effects of readthrough of the amber codon and, as 
such, this failure should not conflict with the previous 
interpretation that AmbLl is an amber mutant.
DISCUSSION
CHAPTER 5 DISCUSSION
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5.(a) DISCUSSION
The object of this study has been to investigate the 
use of suppressor cell lines in the isolation of nonsense 
mutations within an animal virus genome. The suppressor 
cell line used contained a X. laevis tyrosine transfer RNA 
gene altered by site specific mutagenesis within the 
anticodon to read amber codons. The suppression level of 
this suppressor cell line was estimated to be about 4%
(Young et a l ., 1983).
The use of vesicular stomatitis virus as a model 
has clearly contributed to the success of this work, in the 
following ways: VSV has a very broad host range and the
virus readily grows to high titre on a large number of cell 
lines. (The only documented mammalian cell types in which 
VSV will not grow include some types of human lymphoblastoid 
cells, rabbit kidney (DRK3) cells and rabbit corneal (RC60) 
cells). Thus there is a greater possibility that virus 
containing a nonsense mutation may, in spite of the low 
level of suppression exhibited by the suppressor cells used 
in this study, still produce enough virus to permit 
analysis. In addition, VSV has been reasonably well 
characterized genetically and ts mutants representing each 
of the VSV complementation groups are readily available. 
Finally, determination of the nucleotide sequence of the 
mRNAs of VSV Indiana has shown that the five natural 
translation terminators are either ochre (UAA) or opal (UGA) 
codons (Gallione et al ., 1981; Rose and Gallione, 1981; 
Schubert et a l ., 1984), thus the presence of an amber 
suppressor tRNA should not adversely affect natural 
termination by suppressing the natural stop codons.
A stock of wt VSV Indiana was mutagenized by the 
chemical mutagen 5-fluorouraci1, which favours transition 
mutations. This had been shown by the work of Pringle 
(19 70) to be a potent mutagen of VSV. However, there were 
serious limitations to this strategy of mutagenesis.
Ideally, to ensure that an active gene product is restored 
after suppression of the mutation, the amino acid inserted
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at the point of mutation by the suppressor tRNA should be
identical to the amino acid present in the wt protein. To
mutate a tyrosine codon (UAU and UAC) to an amber stop codon 
(UAG) requires a transversion mutagen. However, as far as I 
am aware, no applicable transversion mutagen is available. 
Thus suppression by the tyrosine inserting suppressor tRNA 
present in the L39 cell line will not result in replacement 
of the wt amino acid at any nonsense codon produced by 5-FU.
However, the production of amber codons by mutation from
other, non-tyrosine specifying codons should be increased.
In addition, it has been established that the frequency of 
spontaneous mutations in laboratory stocks of 
vesiculoviruses is high suggesting an inherent genetic 
instability. Thus, there is the additional possibility that 
the mutants described in this study arose spontaneously.
Because the L39 cell line was observed to suppress 
amber nonsense mutations at a low level, it might be 
expected that virus containing a nonsense mutation would not 
grow as well as wt virus in su+ cells. Thus the potential 
phenotypes of prospective nonsense mutants were limited by 
selecting only small plaque variants to screen for a 
mutation in host range. Whether or not this selection 
strategy excludes any class of viable mutant in practice is 
not known although it does seem unlikely.
Thirteen suppressible host range mutants were 
isolated using this method, of which seven have been 
partially characterized. Five were assigned by 
complementation analysis using ts mutants, representing the 
five VSV complementation groups, to complementation group I 
of VSV, representing the L gene. Another mutant was 
tentatively assigned to complementation group V, the G gene, 
while the remaining host range mutant analysed (hrTK“7) 
could not be assigned to a specific VSV gene.
5. (b ) CHARACTERIZATION OF THE GROUP I MUTANTS
Since the L gene comprises 2109 codons out of a total 
of 3 536 codons representing the five genes (Gallione et a l ., 
1981; Rose and Gallione, 1981; Schubert et a l ., 1984), this 
gene presents by far the largest target for mutagenesis.
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This is borne out by the observation that the majority of ts 
mutants isolated, whether spontaneous or induced, belonged 
to the L gene (Pringle, 1975). The results obtained in this 
study, where five out of the 7 mutants isolated were 
assigned to the L gene, are in accord with this observation.
The enzymatic role of the L protein in VSV infected 
cells may also be a factor in the isolation of mutants
defective in this function. It has been shown that L is
required in catalytic amounts during transcription (Schubert 
et a l . , 1985) as opposed to NS which is required in 
stoichiometric amounts during transcription (Banerjee,
1987). It may therefore be the case that the
catalytic/enzymatic role of the L protein puts it in a more
favourable class than structural proteins for recovery of a 
conditional lethal mutant.
The observed host range phenotype exhibited by these 
mutants, where the mutants have- been shown to grow on cells 
containing a suppressor tRNA but not on non-suppressor 
parental cells, suggests that these mutants are conditional 
lethal mutants. One presumes that this host range 
restriction is caused by the mutation of an amino acid 
specifying codon to an amber stop codon within the L gene of 
the group I mutants and the G gene of the group V mutant. 
These are thus the first conditional lethal nonsense mutants 
described for an animal virus.
Characterization of the group I mutants has provided 
supportive evidence that these are indeed suppressible 
nonsense mutants. Firstly, none of the group I mutants 
(with the possible exception of AmbLl) synthesizes 
detectable amounts of full length L protein in either the 
su+ or su~ cells. In prokaryotic and yeast systems, where 
the suppression level can be as high as 6 0%, both the 
suppressed and the truncated form of the affected protein 
are detectable in suppressor strains. The level of 
suppression in the suppressor cells used here is such that 
the failure to detect a readthrough product, by suppressing 
the nonsense codon in the group I mutants, was not 
unexpected. In addition, the fact that L protein is the 
least abundant viral protein in infected cells further
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reduces the possibility of detecting a readthrough product. 
Secondly, each mutant directs the synthesis of a 
characteristic novel polypeptide species after infection of 
su+ cells. Thirdly, this additional polypeptide species has 
been shown by immunoprecipitation and western blot analysis, 
using antisera directed against the N and C termini of the 
VSV L protein, to contain N but not C-terminal specific 
sequences. This novel polypeptide species thus represents a 
fragment of the full length polypeptide chain produced by 
premature termination at an amber codon. Finally, 
revertants of four of the group I mutants (AmbLl to AmbL4) 
all synthesized full length L but not the novel truncated 
polypeptide species. This suggests that the revertants 
represent back mutations in the same codon as the original 
mutation.
Prior to the advent of nucleic acid sequencing any 
virus that could satisfy the above criteria would certainly 
be considered to be a suppressible amber mutant. However, I 
recognize that the use of sequence analysis would provide 
definitive proof of the nature of these mutants.
In vitro translation of RNA isolated from su+ cells 
infected by the group I mutants AmbLl and AmbL2 resulted in 
the synthesis of the novel polypeptide species as well as 
the G, NS, N and M proteins. The failure to detect either 
full length or truncated L protein after in vitro 
translation of the RNA from wt or the remaining group I 
mutants respectively was in accord with expectation. A 
previous study by Preston and Szilagyi (19 77) also reported 
a failure to detect L protein after in vitro translation of 
VSV mRNA. A possible explanation for this could be provided 
by the action of RNases. The L mRNA would be more sensitive 
to RNases than the other VSV mRNAs since it is almost four 
times longer than the next longest RNA, encoded by the G 
ge ne.
Revertants of AmbL5 could not be isolated on su~ 
cells, suggesting that this may be a double mutant. This 
might also explain why the virus could be amplified only to 
105 pfu/ml when the other mutants (apart from hrTK“7) grew 
to 106 to 107 pfu/ml on the su+ cells. Since the
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restriction in host range can be complemented by the ts 
mutants representing the G, NS, N and M genes but not by 
ts 11 representing the L gene, the mutational lesion(s) must 
reside within this complementation group. There is a 
precedent for such a supposition since Evans et a l . (1979) 
reported that revertants of the complementation group E 
mutant ts E2 had not been isolated. Rae and Elliott (1986b) 
showed by sequence analysis of the affected gene that the NS 
gene of ts E2 contained a double mutation and suggested that
this could account for the unsuccessful isolation of
revertants.
The polymerase complex of VSV performs diverse 
functions such as capping (Banerjee, 1980), methylation 
(Testa and Banerjee, 1977; Horikami and Moyer, 1982;
Horikami et a l . , 1984) and polyadenylat ion (Schubert et a l . ,
1980; Herman et a l . , 1980; Schubsrt and Lazzarini, 1981;
Hunt et a l . , 1984) of the messages, as well as chain 
initiation and elongation. It also contains the machinery 
to facilitate the replication/transcription choice. 
Investigations using the L nonsense mutants described here 
should allow the study of the organization of the multiple 
functional domains of the polymerase complex of which the L 
protein, as well as the NS protein, is a component. For 
example, it would be of interest to determine whether any of 
the mutants produce in su~ cells L fragments which are 
defective in say, methylation or polyadenylation while the 
elongation function is unaffected.
A recent report by Yusoff et a l . (19 87) described the
nucleotide sequence of the L gene of the paramyxovirus 
Newcastle disease virus (NDV) and compared the amino acid 
sequence of the L protein with the L proteins of another 
paramyxovirus, Sendai virus (SV) and with VSV. Regions of 
conserved amino acid sequence were found between the three 
viruses within the N-terminal two-thirds of the L protein. 
These consisted of two conserved regions separated by a 
variable hydrophili.c region and it was suggested that these 
could thus represent separate domains of the L protein which 
were involved in most of the RNA synthetic and modification 
activities. The most variable region of the protein,
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located at the C-terminal one-third of the sequence, was 
postulated to have virus specific functions such as 
interactions with the NS polypeptide. From the estimated 
position of the amber mutations within the group I mutants 
described here, these comparisons suggest that two of the 
mutants (AmbLl and AmbL2) contain an amber mutation within 
the N-terminal two-thirds of the L protein while AmbL3 and 
AmbL4 contain an amber mutation within the C-terminal 
one-third of the protein. Potentially then, these mutants 
could provide information on the putative domains and their 
respective functions, postulated by Yusoff et a l . (1987) to 
reside within the L protein.
5.(c) CONTROL OF L PROTEIN SYNTHESIS IN INFECTED CELLS
An unexpected and interesting observation arising 
from the analysis of the proteins synthesized by the mutants 
AmbLl and AmbL2 (and possibly AmbL4) in su+ cells, was that 
the novel polypeptide species synthesized by these mutants 
was present at a much higher abundance than full length L 
protein in wt infected cells. Also, the novel polypeptide 
species produced by the mutant ambL3 in su+ cells was 
present at the normal wt level. This observed overabundance 
may possibly reflect an extension of the control mechanism 
which directs the differential synthesis of the five VSV 
gene products. The recognized model which accounts for 
differential synthesis of the VSV proteins involves 
attenuation of transcription at or near the intergenic 
boundaries (Iverson and Rose, 1981). This results in mRNA 
species being made in successively lower amounts with 
respect to distance from the 3' terminus of the genomic RNA 
(Villarreal et a l ., 1976). Additional attenuation sites 
within the L gene probably provide the best explanation for 
the overabundance of the truncated version of the L protein. 
Support for this interpretation was provided by Iverson and 
Rose (1981), who suggested that in view of the apparent 
conflict between the results of Villarreal et a l . (1976) and 
Rose (1978), that possibly some attenuation occurs within 
the L gene. Rose (19 78) observed that the yield of the L 
mRNA ribosome binding site was about 50% lower than that of
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the G mRNA suggesting that the level of transcription 
attenuation at the G-L gene junction was similar to the 
level of attenuation at the other gene junctions.
Villarreal et a l . (1976), however, on measuring the molar 
ratios of VSV induced RNA species, found only a low level of 
L mRNA.
Further support for this interpretation is not 
available however since no measurement of the level of 
attenuation at the G-L gene boundary or within the L gene 
was provided by Iverson and Rose (1981).
Alternatively, it is conceivable that attenuation of 
VSV transcription might occur by a mechanism similar to that 
found for the amino acid biosynthetic operons where, in the 
case of the tryptophan operon (Bertrand et a l ., 1975) many 
polymerases terminate shortly after initiation of 
transcription. This interpretation is supported by the 
observation by Testa et a l . (1980) that, during in vitro 
synthesis of full length positive strand genome RNA, small 
in vitro transcripts (30-60 bases) were made which appeared 
to represent the 5 1 terminal portion of individual mRNA 
species.
Alternatively, but I believe less appealing, is the 
possibility that translational attenuation could also 
account for this phenomenon.
5.(d) CHARACTERIZATION OF THE GROUP V MUTANT AMBG
The group V mutant AmbG is a less convincing 
candidate for being a nonsense mutant than the group I 
mutants described above, although it was isolated in exactly 
the same way. Quantitation of the restriction in host range 
revealed a difference in titre between the two cell lines of 
only 30 fold. This is at least 10 fold lower than that 
obtained for any of the group I mutants. Thus, it appears 
that AmbG is slightly leaky in the su~ cells. Several 
observations support this hypothesis. Analysis of the 
proteins synthesized by this mutant in su~ cells showed that 
the mutant was not restricted to the same extent as the 
group I mutants since the putative truncation product, 
observed after infection of su+ cells, was present in
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significant amounts 24 h post infection. There was also a 
marked inhibition of host cell protein synthesis at this 
time, in contrast to the infection of su" cells by the 
group I mutants. In addition, virus isolated from su~ cells 
and initially thought to represent revertants all appeared 
to synthesize the faster migrating glycoprotein. Finally, 
these so-called 'revertants' exhibited the same restricted 
host range as the original mutant from which they were 
derived, suggesting that these were not true revertants but 
in fact the original mutant AmbG. Due to the leakiness of 
this mutant, it would appear that many more plaques need to 
be picked on the su~ cells to pick up revertants. Several 
reports provide a possible explanation for the observed 
leakiness of AmbG in the su~ cells.
It has been shown that alterations to the amino acid 
sequence of the cytoplasmic domain of the G protein has a 
deleterious effect on the rate of transport of G to the cell 
surface (Rose and Bergmann, 1983; Puddington et a l ., 1986). 
Specifically, Rose and Bergmann generated deletions within 
the cytoplasmic domain of a plasmid borne cDNA encoded G 
protein gene. Two of these deletions which lacked 16 amino 
acid residues were transported at a significantly lower rate 
to the Golgi apparatus (possibly accumulating in the rough 
endoplasmic reticulum). One could extend these observations 
and postulate that the shortened G protein specified by 
AmbG, which has been calculated to have lost approximately 
10 terminal amino acids of its cytoplasmic domain (results 
section 4.(b).1.7), may also have an altered rate of 
transport to the Golgi apparatus and hence the cell surface 
in su~ cells. The results of Lodish and Porter (19 80) 
showed that the presence of G protein on the cell surface 
(although not a prerequisite for virus maturation) may 
facilitate the extent of budding and one might suspect that 
G protein, which has an altered rate of transport to the 
plasma membrane, might alter the extent of budding of 
progeny virions. Alternatively, an altered rate of 
transport may result in fewer G molecules at the plasma 
membrane at a given time resulting in a corresponding 
reduction in the number of G molecules on the virion
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envelope. It is conceivable that either of these 
explanations might contribute to the observed leakiness of 
this mutant in su~ cells.
RNA was isolated from su+ cells infected with wt and 
mutant virus. Preliminary analysis of the RNAs involved in 
vitro translation using a rabbit reticulocyte system. An 
interesting result arising from the in vitro translation of 
the RNA isolated from su+ cells infected by AmbG was that 
the pre-G protein synthesized by the mutant AmbG possessed a 
greater mobility than the pre-G synthesized by wt virus.
This confirms that the aberrant mobility of this protein is 
not the result of a defect in glycosylation.
5. (e) CHARACTERIZATION OF THE HOST RANGE MUTANT HRTK"~7
The mutant hrTK~7 appeared more complex than any of 
the other suppressible host range mutants characterized. 
Analysis of the viral proteins synthesized in su+ cells 
showed that the N protein migrated slower than wt N. In 
addition, no full length NS protein was detectable and an 
additional polypeptide species, thought to represent a 
shortened form of the NS protein, was present, migrating 
between the N and M proteins. However, unequivocal evidence 
that this is a truncated version of the NS protein is
lacking. The observation that this mutant failed to
complement the defect in any of the representative ts 
mutants suggests that the defects in this mutant lie in more 
than one cistron. In addition, although very small plaques 
were visible on the su~ cells they did not grow appreciably 
even after extended incubation and consistently could not be 
amplified. The available evidence thus suggests that this 
may be a multiple mutant. It is conceivable that the 
mutation affecting the NS protein, resulting in the 
detection of a faster migrating version in polyacrylamide
gels, may be a constituent of the multiple mutation.
However, the mutation affecting the mobility of the N 
protein could only be regarded as suppressible if the 
mutation resided within the termination codon, perhaps 
altering the normal ochre stop codon to an amber.
Termination would then occur further downstream.
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Examination of the sequence for this region however does not 
reveal any stop codons within 3 0 nucleotides of the 
termination codon. Alternatively, it has been reported that 
a sixth complementation group has been identified for the 
Orsay (Deutsch et a l . , 1979) and Massachusetts (Rettenmeier 
et a l . , 1975) strains of VSV Indiana which has been 
tentatively assigned to the NS gene (or possibly the L gene 
of the Massachusetts strain) suggesting that the NS gene may 
contain two cistrons. In addition, Iferman (1986) reported 
the existence of an additional small polypeptide in the 
Indiana serotype, both in vivo and in vitro encoded by the 
C-terminal portion of the NS protein gene. Thus it is 
possible that the proposed multiple mutation affecting this 
mutant resides within the NS gene but in different 
complementation groups. A simple charge difference might 
then explain the aberrant mobility of the N protein 
synthesized by this mutant. These offered explanations can 
only be regarded as speculative however. At this time it is 
not possible to be more definitive regarding the nature of 
the mutation conferring the restriction in host range to 
this mutant and as a result this mutant must remain 
unclassified.
Although the results obtained by complementation 
analysis, in which the mutants were assigned to a specific 
complementation group, did not take into account any 
possible effect of recombination between the mutants, the 
validity of the gene assignments should not be affected.
This is because attempts to detect wt recombinant virus in 
the progeny of mixed infections of ts mutant parents have 
all been unsuccessful. In a study by Pringle et a l . (1981) 
no wt recombinant virus was recovered in a cross of two 
complementing ts mutants of VSV New Jersey which could also 
be scored for four independent non-ts markers affecting the 
G, NS, N and M proteins, Therefore, although the 
occurrence of genetic recombination cannot be excluded, it 
must be a rare event, if it occurs at all.
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5.(f ) THE EFFECT OF THE AMINOGLYCOSIDE G418
The aminoglycosides have been reported to promote 
readthrough of nonsense codons in various systems by 
affecting the fidelity of translation and, in consequence, 
the accuracy of chain termination. The recent report by 
Burke and Mogg (19 85) showed that the antibiotics G418 and 
paromomycin suppressed a characterized amber mutation in the 
CAT gene of the mammalian cell transfection vector 
pRSVCATam >^3 8 ^ ieveT Q f readthrough promoted by G418 was
calculated to be 19.6% (Burke and Mogg, 1985).
It seemed appropriate to investigate the effect of 
G418 on the suppressible host range mutants described 
herein. Wt and AmbLl virus was grown on the su~ cells in 
the presence of varying concentrations of G418 and either 
(1) the supernatant titrated on the su+ cells to assay for 
growth of the mutant or (2) the intracellular proteins were 
labelled and analysed for detection of a readthrough product 
in a polyacrylamide gel presumably promoted by the action of 
G418. However, it was found that G418 failed to facilitate 
readthrough of the mutation affecting AmbLl, since, neither 
an increase in growth of the mutant in su~ cells nor the 
synthesis of a readthrough product in su~ cells could be 
detected. It is possible, however, that the deleterious 
effect that G418 has on growth of the virus negates any 
effect resulting from suppression of the mutation. Also, 
since the L protein is the least abundant protein in wt 
infected cells, a 19.6% suppression level might still not be 
enough to allow detection of a readthrough product.
Although the optimum level of suppression promoted by G418 
was obtained at 50 ug/ml this was achieved using COS cells 
and not the LMTK“ cells which were used here. A difference 
in permeability between the two cell lines might affect the 
concentration of drug needed to promote optimum suppression. 
It may have been more appropriate to use COS cells for this 
analysis. LMTK” cells, however, were used because they 
represented the non-pemissive host used throughout this 
study.
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5 . ( g ) FUTURE DIRECTIONS
As mentioned previously, nucleic acid sequencing 
would provide conclusive proof that these are indeed 
nonsense mutants. In addition, it would reveal the complex 
nature of the mutation specifying the restriction in host 
range of the proposed double mutant AmbL5. A sequence can 
be obtained either by directly sequencing the RNA template 
or cloned cDNAs. Nonsense mutants lend themselves to 
sequencing to the extent that the length of the truncated 
polypeptide should correlate with the position of the 
mutation in the affected gene. With respect to the mutant 
AmbG, it would be of interest to compare the rate of 
transport of the glycoprotein synthesized by AmbG with that 
of wt G protein. This could be accomplished by
investigating the time taken for the respective
glycoproteins to acquire resistance to endoglycosidase 
(endo H). It has been shown by.Rose and Bergmann (19 83)
that when G protein is transported to the Golgi apparatus
the high mannose simple oligosaccharides attached to the 
protein are converted to complex oligosaccharides which are 
endo H resistant. Work by Rose and Bergmann (1983) in which 
G protein containing deletions in the cytoplasmic domain 
exhibited a retarded rate of transport to the Golgi 
apparatus, suggests that the putative shortened G protein 
produced by AmbG will also exhibit an altered rate of 
transport.
It is envisaged that VSV nonsense mutants will be 
used in the study of VSV gene expression. In particular the 
L gene mutants may facilitate the assignment of 
sub-functions of what is a multifunctional protein to 
different regions of the polypeptide chain.
It is important to register that the utility of these 
mutants is restricted in two ways. Firstly, their utility 
will be restricted by the low suppression level of the 
already existing suppressor cells. This low level of 
suppression is probably the maximum that a mammalian cell 
line expressing a suppressor tRNA can tolerate without 
having a deleterious effect on the physiology of the cell. 
The second restriction is the high reversion rate which
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probably reflects the low fidelity of replication caused by 
the lack of a proofreading system in VSV RNA replication.
Extension of this suppression system to other viruses 
will be dependent on two factors. Firstly it will be 
dependent on the host range of the virus and secondly on the 
nature of the viral termination codons. The accumulating 
sequence data will show which, if any, gene products might 
be adversely affected by readthrough of the natural 
translation terminators in the presence of the particular 
suppressor.
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NOTE ADDED
Following completion of the text of this thesis, a 
paper has appeared which describes two significant advances 
in the field of suppressible nonsense mutants of animal 
viruses, by essentially the same group that constructed the 
L39 suppressor cell line used in this Ph.D. report (Sedivy, 
J.M. , Capone, J.P. , RajBhandary, U.L. and Sharp, P. A.
(1987). An inducible mammalian suppressor: Propagation of
an amber mutant. Cell ^0, 379-389 ). First, this paper 
describes the construction of an inducible mammalian 
suppressor system. A human amber suppressor tRNA^er gene 
(Capone et a l ., 1985) was linked to the SV40 origin of 
replication and to a gene encoding a selectable marker (neo, 
which confers resistance to G418). This plasmid was 
cotransfected into monkey cells along with a vector encoding 
a ts mutant of the SV40 large T-antigen. Cells were 
selected for G418 resistance at the non-pemissive 
temperature (39.5°C), which resulted in the stable 
integration of a few copies per cell of each plasmid. When 
these cells were shifted down to 3 3°C, production of active 
T-antigen resulted in the amplification of the tRNA gene to 
about 2 000-4000 copies per cell. The level of suppression 
achieved by such cells ranged from 10-7 0%.
The second important advance described in this paper 
was the generation of a conditional lethal amber mutant of 
poliovirus. The mutant was generated by in vitro site 
directed mutagenesis which changed a serine residue to an 
amber stop codon in the RNA replicase gene of an infectious 
cDNA clone. The alteration was confirmed fay nucleotide 
sequence analysis. The amber mutant plaqued on the 
suppressor cells only after induction of the suppressor 
phenotype, but not on the non-suppressor parental cells.
The major advantage that this type of inducible 
suppression system has over the constitutive system used in 
this thesis is the elevated suppression level which may 
permit the isolation of classes of nonsense mutants where 
larger amounts of readthrough protein are needed for 
successful production of useable amounts of infectious 
virus.
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